≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Hypertensive Renal Disease

DOID EFO Endpoint Browser PheWeb

I9_HYPTENSRD

nephrosclerosis: Hardening of the walls of the small arteries and arterioles (small arteries that convey blood from arteries to the even smaller capillaries) of the kidney. This condition is caused by hypertension (high blood pressure)

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — I12
  • Hospital discharge: ICD-9 — 4039A
  • Hospital discharge: ICD-8 — 40399
  • Cause of death: ICD-10 — I12
  • Cause of death: ICD-9 — 4039A
  • Cause of death: ICD-8 — 40399

2 out of 7 registries used, show all original rules.

1647

4. Check minimum number of events

None

1647

5. Include endpoints

None

1647

6. Filter based on genotype QC (FinnGen only)

1589

Control definitions (FinnGen only)

Control exclude
I9_HYPERTENSION

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
I10-I15
Name in latin
Morbus hypertensivus renalis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 14004 5705 8046
Only index persons 9620 3999 5621
Unadjusted period prevalence (%)
Whole population 0.20 0.16 0.22
Only index persons 0.19 0.15 0.21
Median age at first event (years)
Whole population 70.24 73.64 68.06
Only index persons 72.51 76.08 69.97

-FinnGen-

Key figures

All Female Male
Number of individuals 1589 542 1047
Unadjusted period prevalence (%) 0.38 0.19 0.48
Median age at first event (years) 70.38 68.99 71.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1647
Matched controls
16470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
149.5
307.7
174
13
N18.8
ICD-10 Finland
Other chronic renal failure
90.6
307.7
430
64
I10
ICD-10 Finland
Essential (primary) hypertension
20.3
307.7
1405
3661
N19
ICD-10 Finland
Unspecified kidney failure
20.2
307.7
359
224
V03AE01
ATC
polystyrene sulfonate; oral
66.8
307.7
200
34
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
54.0
307.7
901
360
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
183.3
307.7
165
10
C08CA01
ATC
amlodipine; oral
11.9
307.7
1105
2412
Z49.1
ICD-10 Finland
Extracorporeal dialysis
227.4
307.7
267
14
A11CC03
ATC
alfacalcidol; systemic
128.9
307.7
471
51
205
Kela drug reimbursment
Chronic hypertension
+∞
307.7
1151
*
TK800
NOMESCO Finland
Hemodialysis
91.1
307.7
329
45
127
Kela drug reimbursment
Transplant complication
96.5
307.7
173
20
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
5182.6
307.7
1250
10
M04AA01
ATC
allopurinol; systemic
9.4
307.7
680
1143
N18.0
ICD-10 Finland
End-stage renal disease
176.3
307.7
241
16
A12AA04
ATC
calcium carbonate; oral
241.3
307.7
344
18
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
200.4
307.7
549
41
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
171.0
307.7
501
42
C03CA01
ATC
furosemide; systemic
9.5
307.7
1228
3898
C02AC05
ATC
moxonidine; oral
107.9
307.7
322
37
B03XA02
ATC
darbepoetin alfa; parenteral
40.2
307.7
309
94
C08CA02
ATC
felodipine; oral
19.2
307.7
392
263
C08CA13
ATC
lercanidipine; oral
11.6
307.7
479
563
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
25.9
301.0
215
95
C09AA02
ATC
enalapril; systemic
7.1
288.9
564
1129
C07AG02
ATC
carvedilol; oral
14.9
285.3
270
214
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
75.5
280.2
151
22
L04AA06
ATC
mycophenolic acid; systemic
40.0
269.8
166
46
40399
ICD-8 Finland
Hypertensive renal disease
+∞
267.1
249
*
A12BA01
ATC
potassium chloride; oral
19.7
249.5
200
115
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2561.7
247.1
233
*
M10.9
ICD-10 Finland
Gout, unspecified
9.1
239.8
329
441
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.9
235.6
327
444
N17.9
ICD-10 Finland
Acute renal failure, unspecified
11.3
229.0
258
266
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
12.0
227.1
245
237
Z49.0
ICD-10 Finland
Preparatory care for dialysis
495.6
222.4
217
5
C09BA02
ATC
enalapril and diuretics; systemic
15.3
222.0
203
150
C02EA02, ,
ATC
26.8
213.6
149
61
C03AA03
ATC
hydrochlorothiazide; oral
10.2
209.1
253
287
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
99.8
198.5
103
11
I12.9
ICD-10 Finland
Hypertensive renal disease without renal failure
+∞
196.9
185
*
A10BH05
ATC
linagliptin; oral
10.3
193.3
231
257
137
Kela drug reimbursment
Uraemia requiring dialysis
417.6
190.0
187
5
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.3
189.0
274
388
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2101.8
187.1
178
*
U14
ICPC
Kidney symptom/complaint
23.3
186.3
137
64
Z94.0
ICD-10 Finland
Kidney transplant status
666.3
184.5
179
*
I50.9
ICD-10 Finland
Heart failure, unspecified
4.6
174.7
562
1667
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
9.3
173.9
224
274
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
467.0
172.1
169
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
28.4
167.8
114
43
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
167.3
432
1071
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
6.6
167.3
306
554
C09CA01
ATC
losartan; oral
4.4
166.3
586
1853
C09CA03
ATC
valsartan; oral
7.4
156.0
248
387
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
1669.2
155.8
149
*
B05DA
ATC
Isotonic solutions
550.9
154.4
151
*
C07AB07
ATC
bisoprolol; oral
3.9
151.7
1097
5566
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
28.1
151.2
103
39
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
16.0
148.3
130
88
215
Kela drug reimbursment
Diabetes, non-insulin-treated
4.3
148.0
503
1533
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
1556.3
147.2
141
*
B05DB
ATC
Hypertonic solutions
514.7
144.8
142
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
11.9
143.4
151
139
Z49.2
ICD-10 Finland
Other dialysis
384.5
143.2
142
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
4.0
140.2
542
1803
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
+∞
139.6
132
*
C08CA05
ATC
nifedipine; systemic
7.0
138.8
231
377
C02CA01
ATC
prazosin; oral
17.0
133.8
113
71
C10AA05
ATC
atorvastatin; oral
3.4
131.0
931
4533
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.7
129.9
147
150
103
Kela drug reimbursment
Diabetes, insulin-treated
3.7
129.5
579
2110
M10.3
ICD-10 Finland
Gout due to impairment of renal function
67.4
129.4
71
11
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.7
129.0
352
899
4019X
ICD-9 Finland
Essential hypertension, Unspecified
+∞
128.9
122
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
4.7
127.4
342
862
B03XA01
ATC
erythropoietin; parenteral
19.7
127.3
100
54
A10AE04
ATC
insulin glargine; parenteral
6.0
125.6
242
456
C07AB02
ATC
metoprolol; systemic
3.7
124.6
535
1892
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
+∞
124.6
118
*
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
5.2
121.6
281
624
L04AD02
ATC
tacrolimus; systemic
219.4
119.4
122
6
C09DA01
ATC
losartan and diuretics; oral
6.6
118.2
206
351
N18
ICD-10 Finland
Chronic kidney disease
17.7
117.6
97
58
R80
ICD-10 Finland
Isolated proteinuria
57.3
116.9
66
12
I50.0
ICD-10 Finland
Congestive heart failure
4.7
115.3
309
774
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
114.9
1022
5538
196
Kela drug reimbursment
Paricalcitol and cinacalcet
1165.2
113.0
109
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.4
112.7
556
2131
H05BX01
ATC
cinacalcet; oral
304.5
112.5
113
*
C10AA01
ATC
simvastatin; oral
3.1
110.5
949
5004
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
569.4
109.1
107
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
237.8
109.1
111
5
E66.00
ICD-10 Finland
Metabolic syndrome
11.2
108.7
118
113
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.4
107.3
231
480
C09DA03
ATC
valsartan and diuretics; oral
13.0
107.0
105
86
B01AC04
ATC
clopidogrel; oral
3.6
105.4
447
1549
V03AE02
ATC
sevelamer; oral
1074.0
104.4
101
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
8.1
104.4
146
195
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.5
103.1
471
1708
A10AB05
ATC
insulin aspart; parenteral
6.3
102.4
184
322
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
102.4
452
1604
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
1051.3
102.3
99
*
C03DA01
ATC
spironolactone; oral
4.2
102.0
323
914
T90
ICPC
Diabetes non-insulin dependent
3.4
101.4
471
1724
TK820
NOMESCO Finland
Peritoneal dialysis
+∞
99.0
94
*
C03BA11
ATC
indapamide; oral
19.7
98.4
77
41
C09CA06
ATC
candesartan; oral
3.5
97.6
429
1513
40199
ICD-8 Finland
Essential benign hypertension
+∞
95.8
91
*
321
Kela drug reimbursment
Paricalcitol and cinacalcet
150.3
94.2
99
7
C09DA06
ATC
candesartan and diuretics; oral
8.0
93.9
132
177
3AC01, ,
NOMESCO Finland
22.8
92.7
68
31
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
938.8
91.7
89
*
L04AD01
ATC
ciclosporin; systemic
16.8
91.2
77
48
SPAT1262
SPAT
Handing over of treatment supplies
3.5
88.8
379
1305
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
87.9
350
1152
I15.0
ICD-10 Finland
Renovascular hypertension
+∞
87.3
83
*
TK810
NOMESCO Finland
Hemofiltration
190.2
87.1
90
5
E87.5
ICD-10 Finland
Hyperkalaemia
10.4
87.1
99
101
C08DB01
ATC
diltiazem; oral
6.0
86.9
162
293
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
51.5
86.6
50
10
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
86.2
523
2213
3025
Kela drug reimbursment
Calcium carbonate
137.5
85.9
91
7
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.8
85.6
626
2926
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.0
84.9
527
2255
B01AA03
ATC
warfarin; systemic
2.9
84.2
558
2473
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
82.3
482
1993
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
8.7
81.6
106
129
C01DA14
ATC
isosorbide mononitrate; oral
3.0
81.2
476
1967
XF602
NOMESCO Finland
Bloodpressure monitoring
20.7
78.6
60
30
C07FB02
ATC
metoprolol and felodipine; systemic
17.3
78.4
65
39
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
+∞
77.7
74
*
C09AA03
ATC
lisinopril; oral
8.8
76.9
99
119
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.7
76.0
594
2842
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.5
75.4
156
310
R4190
NOMESCO Finland
Nutritional therapy
6.9
74.2
118
181
V03AE03
ATC
lanthanum carbonate; oral
750.8
73.8
72
*
I70.1
ICD-10 Finland
Atherosclerosis of renal artery
36.4
73.3
46
13
D64.9
ICD-10 Finland
Anaemia, unspecified
3.3
72.9
332
1179
ZX120
NOMESCO Finland
Intravenous
3.7
72.2
256
774
A46
ICD-10 Finland
Erysipelas
3.1
70.9
355
1331
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
718.0
70.6
69
*
RD210, ,
NOMESCO Finland
12.6
70.6
70
58
A10BH01
ATC
sitagliptin; oral
4.3
70.2
198
508
K65.0
ICD-10 Finland
Acute peritonitis
9.9
70.0
82
87
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.1
69.8
359
1366
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.1
68.1
123
215
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
68.0
605
3052
C07AB03
ATC
atenolol; systemic
5.2
67.8
147
304
WW200
NOMESCO Finland
Immunization
8.0
67.6
94
124
C09DB01
ATC
valsartan and amlodipine; oral
10.7
67.1
74
72
C10AA04
ATC
fluvastatin; oral
3.7
67.1
243
744
ZXD05
NOMESCO Finland
Urgent procedure
2.6
66.8
578
2872
L04AA01
ATC
[U] ciclosporin
14.4
65.8
60
43
A10BA02
ATC
metformin; oral
2.7
65.6
485
2231
212
Kela drug reimbursment
Gout
7.5
64.4
95
134
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
652.8
64.3
63
*
C08CA10
ATC
nilvadipine; oral
18.8
64.0
51
28
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.7
62.9
450
2030
I13.2
ICD-10 Finland
Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
330.5
62.8
63
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
19.4
62.4
49
26
A10BK01
ATC
dapagliflozin; oral
4.4
61.8
166
409
C02DE04, ,
ATC
8.3
61.4
82
103
M10
ICD-10 Finland
Gout
5.1
61.2
135
283
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
60.3
715
4055
WX203
NOMESCO Finland
Infraclavicular plexus blockade
7.9
60.2
84
111
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
6.7
60.1
98
154
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
609.6
60.1
59
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
59.8
263
907
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
7.2
59.7
91
133
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
58.7
56
*
4039A
ICD-9 Finland
Hypertensive renal disease, Unspecified
+∞
58.7
56
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
58.4
658
3639
C09BA03
ATC
lisinopril and diuretics; oral
16.8
58.3
49
30
Z3231
NOMESCO Finland
Registered nurse
2.5
58.2
530
2667
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.0
57.9
290
1079
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.4
57.5
581
3061
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
57.3
317
1246
M10.0
ICD-10 Finland
Idiopathic gout
6.0
57.2
105
186
A10AC01
ATC
insulin (human); parenteral
4.1
57.1
170
452
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
56.7
237
791
A10BB12
ATC
glimepiride; oral
4.1
56.6
167
441
R06.0
ICD-10 Finland
Dyspnoea
2.4
56.5
529
2690
C09AA05
ATC
ramipril; oral
2.4
56.1
505
2522
H02AB04
ATC
methylprednisolone; systemic
2.9
55.6
317
1265
AN1
HP
Coronary angiography
3.1
54.7
268
982
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
54.6
281
1059
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
54.6
277
1036
C02DE02, ,
ATC
9.4
54.5
66
73
N17.8
ICD-10 Finland
Other acute renal failure
12.1
54.3
55
47
A10BH02
ATC
vildagliptin; oral
10.0
53.9
62
64
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
53.3
208
664
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
142.2
52.1
55
*
C09CA07
ATC
telmisartan; oral
4.4
51.2
134
323
C09DX01
ATC
valsartan, amlodipine and hydrochlorothiazide; oral
19.5
51.1
40
21
AA1AD
NOMESCO Finland
CT of head and brain
2.3
50.8
577
3162
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
6.7
50.6
82
128
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
136.8
50.1
53
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
49.6
135
335
I20.09
ICD-10 Finland
Unstable angina
3.9
49.3
153
418
C10AX09
ATC
ezetimibe; oral
2.7
49.3
319
1353
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
175.3
49.1
51
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.4
49.1
131
320
K87
ICPC
Hypertension complicated
7.0
49.1
76
113
R4110
NOMESCO Finland
Physiotherapy
2.3
48.8
506
2662
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
15.2
48.6
43
29
C02DE10, ,
ATC
171.8
48.1
50
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
48.1
331
1446
WX722
NOMESCO Finland
PEEP
4.5
46.7
118
276
J01DB01
ATC
cefalexin; oral
2.4
46.7
1284
9838
Z3226
NOMESCO Finland
Physiotherapist
2.5
46.5
349
1587
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.2
46.3
62
78
A10AE05
ATC
insulin detemir; parenteral
5.1
45.2
97
198
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.6
45.1
88
165
J01MA02
ATC
ciprofloxacin; systemic
2.1
45.0
744
4669
H02AB06
ATC
prednisolone; systemic
2.1
44.8
826
5392
C09AA01
ATC
captopril; oral
6.9
44.8
70
105
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.7
44.6
107
240
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.2
44.3
476
2527
A28
ICPC
Limited function/disability NOS
2.3
43.3
432
2221
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
118.2
42.9
46
*
PC5DE
NOMESCO Finland
Ultrasound of kidney circulation with Doppler technic
+∞
42.9
41
*
A10BJ06
ATC
semaglutide; parenteral
6.4
42.7
72
117
C02EA01, ,
ATC
10.5
42.3
47
46
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
70.5
42.2
48
7
C07AB08
ATC
celiprolol; oral
7.3
41.7
62
88
A02BC02
ATC
pantoprazole; systemic
2.1
41.5
1119
8287
I12
ICD-10 Finland
Hypertensive renal disease
215.3
41.0
42
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
40.5
302
1361
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
3.3
40.3
164
535
I35.0
ICD-10 Finland
Aortic (valve) stenosis
3.3
40.2
167
552
N25.0
ICD-10 Finland
Renal osteodystrophy
210.1
40.0
41
*
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.2
40.0
462
2509
K78
ICPC
Atrial fibrillation/flutter
2.9
39.6
204
763
SPAT1097
SPAT
Recording of ECG
2.5
39.2
288
1288
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
39.1
310
1435
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.7
38.6
131
380
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
9.0
38.5
48
55
SPAT1263
SPAT
Sampling
2.0
38.4
654
4085
SPAT1255
SPAT
Intravenous administration of medicine
3.4
38.2
148
468
WX002
NOMESCO Finland
Sedation and analgesia
2.3
38.0
359
1793
S97
ICPC
Chronic ulcer skin
3.3
37.9
152
491
XF402
NOMESCO Finland
ECG with work load test
2.8
37.9
209
810
I13.1
ICD-10 Finland
Hypertensive heart and renal disease with renal failure
136.6
37.9
40
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
37.8
343
1683
SPAT1254
SPAT
Administration of medicine
2.4
37.4
303
1414
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
14.4
37.4
34
24
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
37.3
230
944
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.1
37.2
484
2739
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
375.6
37.2
37
*
I50.1
ICD-10 Finland
Left ventricular failure
3.2
37.1
155
513
E66.01
ICD-10 Finland
Obesity due to excess calories
4.4
37.1
97
233
L28
ICPC
Limited function/disability (L)
2.2
36.9
387
2014
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
7.6
36.6
52
70
UJF32
NOMESCO Finland
Coloscopy
2.1
36.4
482
2743
E66.8
ICD-10 Finland
Other obesity
6.9
36.2
56
83
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
36.2
606
3746
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.9
36.2
66
116
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.1
36.1
479
2725
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
6.4
36.1
60
96
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.8
36.0
193
736
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
49.0
35.8
43
9
WX882
NOMESCO Finland
High dependency care
5.1
35.7
76
154
K92.1
ICD-10 Finland
Melaena
3.2
35.6
148
488
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
+∞
35.5
34
*
N02BE01
ATC
paracetamol; systemic, rectal
2.4
35.3
1401
11604
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
3.6
35.1
123
364
C07AB12
ATC
nebivolol; oral
6.7
35.0
56
86
B01AF02
ATC
apixaban; oral
2.4
34.7
290
1370
B01AB10
ATC
tinzaparin; parenteral
2.7
34.6
210
854
WX892
NOMESCO Finland
Monitored bed care
3.0
34.5
162
574
WX202
NOMESCO Finland
Supraclavicular plexus blockade
7.3
34.4
51
72
J01FF01
ATC
clindamycin; systemic
2.1
34.4
438
2448
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
34.1
241
1054
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
33.8
106
291
C09DA07
ATC
telmisartan and diuretics; oral
6.2
33.8
58
96
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.3
33.6
90
220
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
33.2
265
1224
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
35.9
32.9
42
12
A12AA12
ATC
[U] calcium acetate
92.0
32.8
36
*
C02LM02, ,
ATC
173.5
32.8
34
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.9
32.5
99
266
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
32.4
31
*
R50.9
ICD-10 Finland
Fever, unspecified
2.3
32.4
279
1332
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.7
32.2
182
712
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
8.1
32.1
43
54
R60.0
ICD-10 Finland
Localized oedema
2.4
31.9
247
1125
XPX08
NOMESCO Finland
Intraoperative flow measurement
9.5
31.9
38
41
C07BB07
ATC
bisoprolol and thiazides; systemic
5.9
31.6
57
99
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
31.1
366
1977
288
Kela drug reimbursment
Febuxostat
71.3
31.0
35
5
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.8
30.9
98
271
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
30.9
171
662
Z2446
NOMESCO Finland
Social worker
3.2
30.8
127
416
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
7.7
30.7
43
57
B82
ICPC
Anaemia other/unspecified
4.2
30.6
84
209
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.6
30.6
74
167
N02AX02
ATC
tramadol; systemic, rectal
1.8
30.2
707
4799
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.9
30.1
152
560
PE1AT
NOMESCO Finland
Femoral artery PTA
7.9
29.9
41
53
349
Kela drug reimbursment
Febuxostat
84.2
29.8
33
*
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
8.6
29.7
38
45
ZXA05
NOMESCO Finland
Left side
1.9
29.5
457
2716
207
Kela drug reimbursment
Chronic arrhythmias
2.1
29.4
333
1769
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
+∞
29.3
28
*
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
+∞
29.3
28
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.8
29.2
93
258
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.2
29.1
79
195
I50
ICD-10 Finland
Heart failure
3.8
29.0
90
245
M04AA03
ATC
febuxostat; oral
67.2
29.0
33
5
T92
ICPC
Gout
5.3
28.9
59
115
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.8
28.9
151
566
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
28.8
168
667
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.1
28.8
332
1775
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.4
28.6
230
1062
I48.1
ICD-10 Finland
Persistent atrial fibrillation
3.5
28.5
103
311
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
28.4
129
448
L04AX01
ATC
azathioprine; systemic
3.9
28.3
86
231
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.7
28.0
166
664
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
28.0
310
1630
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
65.2
28.0
32
5
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
286.2
27.8
28
*
WW500
NOMESCO Finland
Blood transfusion
3.4
27.8
105
326
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
27.7
152
585
SPAT1211
SPAT
Application of soft bandage
2.6
27.6
170
693
XCK10
NOMESCO Finland
Photography of fundus of eye
2.6
27.6
177
737
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
27.5
275
1389
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
27.4
185
789
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.5
26.9
96
287
G47.3
ICD-10 Finland
Sleep apnoea
2.1
26.9
301
1588
R55
ICD-10 Finland
Syncope and collapse
2.3
26.8
235
1125
A10BJ02
ATC
liraglutide; parenteral
8.7
26.7
34
40
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.1
26.6
301
1594
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
3.1
26.3
113
379
SPAT1104
SPAT
Monitoring of emergency patient
2.8
26.3
137
513
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
6.3
26.2
44
71
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
26.1
200
903
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.5
25.8
173
735
ZXA00
NOMESCO Finland
Right side
1.8
25.7
468
2910
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.8
25.7
138
525
I25.2
ICD-10 Finland
Old myocardial infarction
2.4
25.6
184
807
A02BC01
ATC
omeprazole; systemic
1.8
25.4
475
2978
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.7
25.3
47
84
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
25.2
401
2386
J01MA12
ATC
levofloxacin; systemic
2.0
25.2
349
1983
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
59.0
25.1
29
5
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.9
25.0
45
78
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.7
24.9
140
545
C07AB05
ATC
betaxolol; oral
5.2
24.8
51
100
C03EA02
ATC
trichlormethiazide and potassium-sparing agents; oral
6.6
24.8
40
62
WX872
NOMESCO Finland
Intensive care
3.3
24.7
96
303
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
253.9
24.7
25
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
5.0
24.7
53
108
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
24.5
168
721
XF600
NOMESCO Finland
Bloodpressure measurement
2.9
24.5
121
440
XF404
NOMESCO Finland
Ambulatory ECG
2.5
24.4
160
672
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
24.4
162
685
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
24.3
626
4297
C02EA03, ,
ATC
35.1
24.3
31
9
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
24.3
92
286
A10AD05
ATC
insulin aspart; parenteral
5.6
24.2
46
84
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
24.0
333
1890
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
+∞
24.0
23
*
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
23.9
962
7440
K85
ICPC
Elevated blood pressure
2.1
23.9
242
1225
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.8
23.8
127
481
TFP20
NOMESCO Finland
Cardiodefibrillation
2.5
23.7
153
638
A10AB04
ATC
insulin lispro; parenteral
5.5
23.6
46
86
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.1
23.5
65
163
E83.51
ICD-10 Finland
Hypocalcemia
9.8
23.3
27
28
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
28.7
23.2
31
11
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.4
23.1
173
772
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.4
23.1
58
135
C08CA03
ATC
isradipine; systemic
36.9
23.0
29
8
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.8
23.0
118
438
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
3.8
22.9
71
193
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
22.9
132
520
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
5.1
22.9
48
96
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
65.9
22.9
26
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.6
22.9
76
217
SPAT1252
SPAT
Overall medication plan or its review
2.6
22.8
139
563
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
8.7
22.8
29
34
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
5.9
22.8
41
71
J01CA04
ATC
amoxicillin; systemic
1.8
22.7
1177
9685
NHQ40
NOMESCO Finland
Amputation of toe
5.5
22.7
44
82
PC5CG
NOMESCO Finland
Extensive MRI examination of kidney vasculature with high intensity magnet
121.7
22.6
24
*
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
4.0
22.6
66
172
Z2221
NOMESCO Finland
Medical doctor
1.8
22.6
406
2501
NFQ20
NOMESCO Finland
Amputation of femur
7.1
22.5
34
49
B01AB05
ATC
enoxaparin; parenteral
1.8
22.5
484
3143
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.4
22.5
168
749
I48.2
ICD-10 Finland
Chronic atrial fibrillation
3.1
22.4
97
327
WX204
NOMESCO Finland
Axillary plexus blockaced
3.7
22.4
72
201
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
3.1
22.4
96
322
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.5
22.3
55
126
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
6.0
22.2
39
66
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.5
22.1
153
659
E87.6
ICD-10 Finland
Hypokalaemia
4.0
21.9
62
158
KBV10
NOMESCO Finland
Removal of stent from ureter
8.2
21.8
29
36
177
Kela drug reimbursment
Insulin glargine 300 U / ml
7.8
21.7
30
39
TQW80
NOMESCO Finland
Local dermatologic skincare
4.2
21.7
59
146
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
21.7
556
3785
UKC02
NOMESCO Finland
Cystoscopy
1.9
21.7
350
2082
I20.00
ICD-10 Finland
Unstable angina
3.5
21.6
77
230
N26
ICD-10 Finland
Unspecified contracted kidney
116.6
21.6
23
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
21.4
545
3699
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
21.0
21.3
31
15
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
21.2
288
1618
K86
ICPC
Hypertension uncomplicated
2.2
21.0
184
877
ZXE00
NOMESCO Finland
One hour or less
1.7
21.0
569
3924
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.1
21.0
44
88
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
4.4
20.9
52
120
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.7
20.8
115
443
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
20.6
698
5091
58209
ICD-8 Finland
Chronic nephritis, Unspecified
111.5
20.6
22
*
R02
ICPC
Shortness of breath/dyspnoea
2.1
20.6
223
1155
R4180, ,
SPAT
8.3
20.5
27
33
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
20.4
138
587
WX402
NOMESCO Finland
General anaesthesia
1.9
20.4
287
1629
A41.8
ICD-10 Finland
Other specified sepsis
4.1
20.2
55
136
K65.8
ICD-10 Finland
Other peritonitis
33.0
20.2
26
8
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
33.0
20.2
26
8
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
48.6
20.2
24
5
R31
ICD-10 Finland
Unspecified haematuria
2.0
20.0
227
1195
H05BX02
ATC
paricalcitol; systemic
+∞
19.8
19
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
19.8
282
1606
K07
ICPC
Swollen ankles/oedema
2.9
19.7
98
357
C09AA04
ATC
perindopril; oral
3.0
19.7
87
297
A07AA09
ATC
vancomycin; oral
5.6
19.7
37
67
J01DA01
ATC
[U] cefalexin
1.6
19.6
916
7199
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
6.9
19.6
30
44
A04
ICPC
Weakness/tiredness general
2.0
19.5
257
1425
RS220, ,
NOMESCO Finland
6.1
19.5
34
57
A08
ICPC
Swelling
2.7
19.2
105
403
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
19.1
545
3791
SPAT1216
SPAT
Assessment of functional ability
1.9
19.1
299
1756
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.7
19.0
61
170
SPAT1229
SPAT
Assessment of need for aid
2.3
18.9
156
724
M48.0
ICD-10 Finland
Spinal stenosis
2.0
18.8
216
1141
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
+∞
18.8
18
*
D638, N180,
ICD-10 Finland
+∞
18.8
18
*
PB1AT
NOMESCO Finland
Upper extremity artery PTA
+∞
18.8
18
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
18.7
639
4639
PC5SC
NOMESCO Finland
Selective angiography of kidney artery with X-ray
70.7
18.7
21
*
K65.9
ICD-10 Finland
Peritonitis, unspecified
21.1
18.6
27
13
N03AX16
ATC
[U] pregabalin
1.8
18.6
316
1900
UJF92
NOMESCO Finland
Capsular endoscopy
5.1
18.6
39
78
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
101.2
18.6
20
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
192.1
18.6
19
*
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
3.2
18.6
76
248
R53
ICD-10 Finland
Malaise and fatigue
1.7
18.5
382
2431
D64.8
ICD-10 Finland
Other specified anaemias
4.4
18.3
46
107
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
7.9
18.3
25
32
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
22.0
18.2
26
12
JN4AD
NOMESCO Finland
Body CT examination
2.0
18.1
218
1170
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.8
18.0
90
329
R60.9
ICD-10 Finland
Oedema, unspecified
2.7
18.0
97
369
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.2
17.9
37
73
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
16.7
17.9
28
17
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
17.8
127
553
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
7.0
17.8
27
39
M13.9
ICD-10 Finland
Arthritis, unspecified
2.6
17.7
107
431
40299
ICD-8 Finland
Hypertensive heart disease
+∞
17.7
17
*
4029A
ICD-9 Finland
Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]
+∞
17.7
17
*
S18
ICPC
Laceration/cut
1.6
17.7
717
5402
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
17.7
420
2775
A10AE06
ATC
insulin degludec; parenteral
4.5
17.6
43
98
PC5YT
NOMESCO Finland
Stenting of renal artery
96.1
17.6
19
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
96.1
17.6
19
*
81
HP
Angiography of the heart and coronary arteries
2.3
17.6
146
680
7151
FHL
Kidney transplantation
181.9
17.5
18
*
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
6.8
17.4
27
40
A10BG03
ATC
pioglitazone; oral
4.9
17.4
38
79
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
2.5
17.4
117
497
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
17.2
175
883
E83.50
ICD-10 Finland
Hypercalcemia
5.1
17.2
36
72
A10BB01
ATC
glibenclamide; oral
2.7
17.1
96
373
J96.0
ICD-10 Finland
Acute respiratory failure
4.8
17.1
38
80
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.4
17.0
125
552
C09BA05
ATC
ramipril and diuretics; oral
6.0
17.0
30
51
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.8
17.0
51
136
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
3.9
17.0
49
127
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
16.9
218
1198
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.9
16.8
79
279
WVA20
NOMESCO Finland
Medicine administration
3.7
16.8
54
151
Y0399
ICD-8 Finland
Investigation of circulatory system
5.2
16.8
34
66
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
16.7
16
*
4059X
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA NUD]
+∞
16.7
16
*
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
3.0
16.6
75
259
C10AA03
ATC
pravastatin; oral
2.3
16.6
133
610
M01AB01
ATC
indometacin; systemic, rectal
2.1
16.5
159
785
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
3.3
16.5
63
197
E21.2
ICD-10 Finland
Other hyperparathyroidism
27.8
16.5
22
8
T89
ICPC
Diabetes insulin dependent
3.9
16.4
49
130
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.5
16.4
109
460
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
16.4
530
3772
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
3.2
16.3
66
214
SPAT1301
SPAT
No procedures
1.6
16.3
473
3278
OAB50, ,
SPAT
2.4
16.3
117
512
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
6.6
16.2
26
40
160
Kela drug reimbursment
exenatide
15.5
16.2
26
17
A10BK03
ATC
empagliflozin; oral
2.3
16.2
130
597
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
16.2
87
331
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
16.1
257
1511
E86
ICD-10 Finland
Volume depletion
3.2
16.1
63
200
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
2.9
16.1
78
281
B80
ICPC
Iron deficiency anaemia
3.9
16.0
46
119
R11
ICD-10 Finland
Nausea and vomiting
2.2
16.0
133
620
A10BX02
ATC
repaglinide; oral
5.8
15.9
29
51
PEN23
NOMESCO Finland
Plastic repair of femoral artery
12.4
15.9
28
23
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
6.7
15.8
25
38
R4180
NOMESCO Finland
Podiatric therapy
5.9
15.7
28
48
Z99.2
ICD-10 Finland
Dependence on renal dialysis
+∞
15.6
15
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
+∞
15.6
15
*
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
3.2
15.6
62
199
E26.0
ICD-10 Finland
Primary hyperaldosteronism
85.9
15.6
17
*
G63.8*N18.8
ICD-10 Finland
Uraemic neuropathy
85.9
15.6
17
*
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.5
15.5
52
150
PD5AD
NOMESCO Finland
CT of aorta
3.7
15.4
49
136
ZY010
NOMESCO Finland
Hospital outpatient
3.1
15.4
64
211
I73.9
ICD-10 Finland
Peripheral vascular disease, unspecified
6.5
15.4
25
39
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.6
15.4
50
141
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
14.9
15.4
25
17
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
6.0
15.3
27
46
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.5
15.2
97
402
RS222, ,
NOMESCO Finland
5.3
15.2
30
57
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.2
15.1
139
674
-50
ICPC
Medication/prescr/renewal
2.8
15.1
79
296
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
2.5
15.1
99
415
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.5
15.1
99
415
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.0
15.0
67
230
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
15.0
272
1659
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.5
15.0
52
153
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.3
15.0
57
178
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.0
15.0
43
111
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
5.8
14.9
27
47
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3.4
14.9
53
159
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
32.0
14.8
19
6
E0000UV, ,
ATC
1.5
14.7
568
4185
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
4.7
14.7
34
74
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
3.7
14.7
47
131
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
14.7
572
4225
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
3.1
14.6
63
212
4059A
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA RENOVASCULARIS]
+∞
14.6
14
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.5
14.6
94
391
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
14.5
151
768
XQ848
NOMESCO Finland
Dermatological photography
3.2
14.5
56
177
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
14.3
97
413
A10AB01
ATC
insulin (human); parenteral
3.5
14.3
50
148
J01MA14
ATC
moxifloxacin; systemic
2.0
14.3
155
800
H3603, E103,
ICD-10 Finland
22.5
14.2
20
9
N06.9
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, unspecified
42.9
14.1
17
*
L01BB01, ,
ATC
42.9
14.1
17
*
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
14.0
498
3595
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.3
13.9
52
161
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.8
13.8
31
66
N05CF01
ATC
zopiclone; oral
1.5
13.8
520
3803
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
13.8
556
4126
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.6
13.7
81
323
K29
ICPC
Cardiovascular sympt/complt other
2.6
13.7
82
329
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.9
13.7
194
1097
H36.01
ICD-10 Finland
Diabetic maculopathy
6.5
13.7
22
34
K77
ICPC
Heart failure
3.2
13.6
54
173
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.3
13.6
51
158
JA3FT
NOMESCO Finland
Exchange abdominal catheter with radiological guidance
75.8
13.6
15
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.8
13.6
69
255
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
+∞
13.6
13
*
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
+∞
13.6
13
*
PBM09
NOMESCO Finland
Closure of arteriovenous fistula of brachial artery
+∞
13.6
13
*
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
141.1
13.5
14
*
D638, N189,
ICD-10 Finland
141.1
13.5
14
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
13.4
82
333
SPAT1325
SPAT
Vaccination
1.5
13.3
527
3886
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
13.3
98
433
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.8
13.3
196
1121
A10BX01
ATC
guar gum; oral
2.8
13.3
68
252
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.1
13.3
36
89
ZX108
NOMESCO Finland
Inhalation
11.6
13.3
24
21
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
13.9
13.2
22
16
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
3.7
13.2
41
112
R04.0
ICD-10 Finland
Epistaxis
2.1
13.2
133
668
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
13.2
100
448
C01BD01
ATC
amiodarone; systemic
3.0
13.1
57
193
AA1
HP
Conventional CABG
3.6
13.1
43
122
WX610
NOMESCO Finland
Patient controlled analgesia
15.2
13.1
21
14
C10AB02
ATC
bezafibrate; oral
4.8
13.1
29
61
C09BA04
ATC
perindopril and diuretics; systemic
5.5
13.1
25
46
AN3
HP
Balloon angioplasty and metallic stent
2.8
13.0
63
227
ZXA10
NOMESCO Finland
Bilateral
1.7
12.9
288
1854
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
6.2
12.9
22
36
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
12.9
326
2167
N30.9
ICD-10 Finland
Cystitis, unspecified
2.3
12.9
100
453
I20.01
ICD-10 Finland
Unstable angina
3.0
12.8
58
201
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.2
12.8
49
154
C07AB04
ATC
acebutolol; systemic
4.2
12.8
34
83
L17
ICPC
Foot/toe symptom/complaint
1.6
12.8
400
2798
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.7
12.8
71
275
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
12.7
110
521
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
3.2
12.7
49
155
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.4
12.6
45
135
H3601, E113,
ICD-10 Finland
4.7
12.6
29
63
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
70.4
12.6
14
*
C07AG01
ATC
labetalol; systemic
70.4
12.6
14
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
32.3
12.6
16
5
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
12.5
109
517
J12.0
ICD-10 Finland
Adenoviral pneumonia
+∞
12.5
12
*
N0832, E112,
ICD-10 Finland
+∞
12.5
12
*
I13.9
ICD-10 Finland
Hypertensive heart and renal disease, unspecified
+∞
12.5
12
*
SPAT1304
SPAT
Counselling and guidance related to ageing
1.9
12.5
158
860
-48
ICPC
Clarification/discussion RFE/demand
4.0
12.5
35
89
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
131.0
12.4
13
*
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
131.0
12.4
13
*
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
5.7
12.4
23
41
H3600, E113,
ICD-10 Finland
5.7
12.4
23
41
TPX15
NOMESCO Finland
Removal of vascular injection port
13.3
12.4
21
16
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
3.6
12.4
41
117
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
5.4
12.3
24
45
R2110
NOMESCO Finland
Giving the first information
2.5
12.3
78
323
R03AC02
ATC
salbutamol; inhalant
1.5
12.2
687
5417
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.5
12.2
29
65
N30.0
ICD-10 Finland
Acute cystitis
1.7
12.1
218
1323
J94.8
ICD-10 Finland
Other specified pleural conditions
3.4
12.1
42
124
K28
ICPC
Limited function/disability (K)
3.3
12.1
44
134
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
12.0
220
1341
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.6
12.0
71
284
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
9.4
12.0
24
26
C09CA02
ATC
eprosartan; oral
9.4
12.0
24
26
R33
ICD-10 Finland
Retention of urine
1.8
11.9
182
1052
D07AC01
ATC
betamethasone; topical
1.5
11.9
500
3718
N28.1
ICD-10 Finland
Cyst of kidney
4.1
11.9
32
79
-45
ICPC
Observ/health educat/advice/diet
3.2
11.9
47
151
AN4
HP
Balloon angioplasty and drug eluding stent
2.8
11.8
58
211
K05.31
ICD-10 Finland
Periodontitis pronounced
1.9
11.8
158
877
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
11.7
247
1566
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
4.5
11.7
28
63
A10BD07
ATC
metformin and sitagliptin; systemic
2.9
11.7
54
190
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
65.4
11.6
13
*
280
Kela drug reimbursment
Clopidogrel
3.9
11.6
33
85
63701
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia
9.3
11.5
23
25
PC5BG
NOMESCO Finland
MRI examination of kidney vasculature with high intensity magnet
+∞
11.5
11
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.2
11.5
98
462
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
120.8
11.4
12
*
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
120.8
11.4
12
*
PBC09
NOMESCO Finland
Suture of brachial artery
120.8
11.4
12
*
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
120.8
11.4
12
*
WX730
NOMESCO Finland
Conventional respirator
3.8
11.3
34
91
C01AA05
ATC
digoxin; systemic
1.8
11.2
187
1109
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
11.2
643
5063
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.4
11.2
76
324
M18.9
ICD-10 Finland
Arthrosis of first carpometacarpal joint, unspecified
4.6
11.2
26
57
PEF25
NOMESCO Finland
Thrombendarterectomy of superficial femoral artery
12.8
11.1
19
15
XKD00
NOMESCO Finland
Uroflowmetry
1.6
11.1
338
2341
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
4.2
11.1
29
70
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
11.1
138
748
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
11.0
152
851
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
11.0
85
384
I70.0
ICD-10 Finland
Atherosclerosis of aorta
9.3
11.0
22
24
WZC30
NOMESCO Finland
Teaching
1.7
11.0
227
1430
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
11.0
246
1583
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.7
11.0
25
54
R05FB02
ATC
cough suppressants and expectorants; systemic
1.5
11.0
547
4194
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
10.9
448
3304
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.7
10.9
57
214
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
10.9
57
214
C02EA05, ,
ATC
43.6
10.9
13
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.2
10.8
91
427
WX144
NOMESCO Finland
Subconjunctival anesthesy
4.0
10.8
30
76
J01CA08
ATC
pivmecillinam; oral
1.5
10.8
432
3171
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
10.7
119
619
C02DE12, ,
ATC
28.2
10.7
14
5
M10.2
ICD-10 Finland
Drug-induced gout
28.2
10.7
14
5
NGQ20
NOMESCO Finland
Amputation of lower leg
5.6
10.7
20
36
RJ410, ,
NOMESCO Finland
21.6
10.7
15
7
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.9
10.6
49
172
M10.4
ICD-10 Finland
Other secondary gout
60.4
10.6
12
*
RS221, ,
NOMESCO Finland
4.3
10.6
27
64
C10AB05
ATC
fenofibrate; oral
4.3
10.6
27
64
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
5.1
10.5
22
44
TPH04, ,
SPAT
4.7
10.5
24
52
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
10.5
394
2852
A02BC03
ATC
lansoprazole; oral
1.5
10.4
420
3082
I49.5
ICD-10 Finland
Sick sinus syndrome
2.2
10.4
83
380
PBU99
NOMESCO Finland
Other repair after previous reconstruction of arteries of upper extremity
110.7
10.4
11
*
I13.0
ICD-10 Finland
Hypertensive heart and renal disease with (congestive) heart failure
+∞
10.4
10
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
+∞
10.4
10
*
PC5AT
NOMESCO Finland
Kidney artery PTA
+∞
10.4
10
*
D638, N185,
ICD-10 Finland
+∞
10.4
10
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
10.2
558
4336
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
2.8
10.2
50
182
G04CA02
ATC
tamsulosin; oral
1.4
10.2
523
4020
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.9
10.2
48
171
J01CE08
ATC
benzathine benzylpenicillin; parenteral
5.3
10.1
20
38
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.1
10.1
92
445
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
2.8
10.1
50
183
-34
ICPC
Blood test
2.8
10.1
50
183
-31
ICPC
Medical examin/health eval partial
2.0
10.1
103
521
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
4.8
10.0
22
46
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.0
10.0
105
536
AN2
HP
Balloon angioplasty, including several vessels
2.8
10.0
50
184
59328
ICD-8 Finland
Other diseases of kidney and ureter, Morbi renis alii
40.3
10.0
12
*
A10BX04
ATC
[U] exenatide
40.3
10.0
12
*
SPAT1234
SPAT
Support of social functional capacity
2.0
10.0
103
523
K99
ICPC
Cardiovascular disease other
2.7
9.9
51
190
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.2
9.9
88
421
M79.6
ICD-10 Finland
Pain in limb
1.4
9.9
534
4135
CKC12
NOMESCO Finland
Photocoagulation of retina
2.5
9.9
61
249
N05BA01
ATC
diazepam; systemic, rectal
1.7
9.9
192
1188
C09AA06
ATC
quinapril; systemic
16.8
9.9
15
9
R10.0
ICD-10 Finland
Acute abdomen
2.9
9.8
46
163
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
9.8
172
1035
C07AA03
ATC
pindolol; systemic
4.4
9.8
24
55
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
4.0
9.8
27
68
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
10.7
9.8
18
17
J01CF05
ATC
flucloxacillin; systemic
2.1
9.8
88
424
D09AB01
ATC
zinc bandage without supplements; topical
3.4
9.7
34
101
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.4
9.7
68
295
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.0
9.7
43
148
A10AA01, ,
ATC
3.5
9.6
32
92
U28
ICPC
Limited function/disability (U)
3.5
9.6
32
92
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
4.3
9.6
24
56
A06AD11
ATC
lactulose; oral
1.5
9.6
295
2043
EBA10
NOMESCO Finland
Operative extraction of tooth
1.9
9.6
117
630
I95.9
ICD-10 Finland
Hypotension, unspecified
3.3
9.5
35
108
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.4
9.5
62
261
ZX120, ,
SPAT
4.1
9.4
25
61
SPAT1279
SPAT
Preparation of immediate hospitalisation
4.1
9.4
25
61
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
100.6
9.4
10
*
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
100.6
9.4
10
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.2
9.4
82
390
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
30.2
9.4
12
*
A08AB01
ATC
orlistat; oral
30.2
9.4
12
*
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
17.6
9.4
14
8
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
17.6
9.4
14
8
N02AA05
ATC
oxycodone; systemic
1.5
9.4
332
2367
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
9.4
993
11184
PC6DE, ,
NOMESCO Finland
+∞
9.4
9
*
5829A
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]
+∞
9.4
9
*
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
+∞
9.4
9
*
RJ421, ,
NOMESCO Finland
12.4
9.4
16
13
K06.18
ICD-10 Finland
Another gingival hyperplasia
21.8
9.4
13
6
11
HP
Coronary artery bypass surgery
2.5
9.3
57
232
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
8.1
9.3
20
25
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.4
9.3
64
275
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.0
9.3
26
66
H36.00
ICD-10 Finland
Diabetic background retinopathy
7.0
9.3
22
32
-35
ICPC
Urine test
4.7
9.3
21
45
C07AA07
ATC
sotalol; systemic
2.2
9.2
79
373
B01AB04
ATC
dalteparin; parenteral
2.2
9.2
80
380
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.9
9.2
42
147
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
9.2
47
175
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
9.1
111
597
I44.2
ICD-10 Finland
Atrioventricular block, complete
2.5
9.1
57
235
BC1AD
NOMESCO Finland
CT of adrenal glands
5.0
9.1
19
38
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.5
9.1
30
86
I70.8
ICD-10 Finland
Atherosclerosis of other arteries
11.5
9.1
16
14
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
36.9
9.0
11
*
RJ210, ,
NOMESCO Finland
36.9
9.0
11
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
9.0
121
672
H02AB02
ATC
dexamethasone; systemic
0.4
9.0
52
1180
I20.8
ICD-10 Finland
Other forms of angina pectoris
4.2
8.9
23
55
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.4
8.9
59
250
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
2.1
8.9
83
406
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
8.0
8.9
19
24
C10BA02
ATC
simvastatin and ezetimibe; oral, topical
4.5
8.8
21
47
EBA00
NOMESCO Finland
Extraction of tooth
1.4
8.8
450
3438
A10BD03
ATC
metformin and rosiglitazone; systemic
4.0
8.8
24
60
SPAT1139
SPAT
Nutrition survey
2.5
8.8
56
233
XG405
NOMESCO Finland
Education on PEF monitoring
3.7
8.7
27
74
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
3.9
8.7
25
65
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
8.6
154
931
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.7
8.6
157
955
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
11.6
8.6
15
13
A10BX07
ATC
[U] liraglutide
16.4
8.6
13
8
B07.9
ICD-10 Finland
Verruca simplex
2.6
8.5
47
182
E66.9
ICD-10 Finland
Obesity, unspecified
3.5
8.5
28
80
K92.0
ICD-10 Finland
Haematemesis
2.6
8.5
49
194
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
3.4
8.5
30
90
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.4
8.5
30
90
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.3
8.5
31
95
H34.2
ICD-10 Finland
Other retinal artery occlusions
6.4
8.5
21
33
D07AB08
ATC
desonide; topical
1.7
8.5
146
874
Y83.0
ICD-10 Finland
Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
27.7
8.5
11
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.6
8.5
46
177
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.2
8.5
22
53
FNC30
NOMESCO Finland
Aorto-coronary venous bypass with three distal anastomoses
2.9
8.5
38
132
5602
FHL
Internal fistula (eg Cimino)
90.5
8.4
9
*
B34.9
ICD-10 Finland
Viral infection, unspecified
3.2
8.4
32
101
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
8.4
138
816
KAC00
NOMESCO Finland
Nephrectomy
12.8
8.4
14
11
H03AA01
ATC
levothyroxine sodium; systemic
1.5
8.4
282
1987
PD4AD
NOMESCO Finland
CT of lower extremity arteries
4.7
8.4
19
41
I25
ICD-10 Finland
Chronic ischaemic heart disease
2.1
8.4
82
409
4040A
ICD-9 Finland
Hypertensive heart and renal disease, Malignant
+∞
8.3
8
*
L04AA05
ATC
[U] tacrolimus
+∞
8.3
8
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
8.3
8
*
5AB14, ,
NOMESCO Finland
+∞
8.3
8
*
N08.32
ICD-10 Finland
Glomerular disorders in diabetes mellitus kidney failure
+∞
8.3
8
*
PC5BT
NOMESCO Finland
Kideney artery extensive PTA
+∞
8.3
8
*
E000006, ,
ATC
2.0
8.3
87
444
N05CD07
ATC
temazepam; oral
1.6
8.3
224
1503
C07BB02
ATC
metoprolol and thiazides; systemic
9.5
8.3
16
17
R42
ICD-10 Finland
Dizziness and giddiness
1.5
8.3
329
2397
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
8.3
243
1663
N06AX11
ATC
mirtazapine; oral
1.4
8.3
422
3220
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
3.2
8.2
32
102
R78
ICPC
Acute bronchitis/bronchiolitis
3.2
8.2
31
97
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
8.2
131
767
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
14.5
8.2
13
9
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
14.5
8.2
13
9
H3603, E113,
ICD-10 Finland
6.5
8.2
20
31
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
8.2
71
338
315
Kela drug reimbursment
Clopidogrel
4.4
8.2
20
46
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.6
8.1
19
42
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
8.1
52
217
SPAT1281
SPAT
Other administrative function
1.9
8.1
100
541
A02BA02
ATC
ranitidine; systemic
1.5
8.1
305
2198
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
8.1
167
1051
RJ411, ,
NOMESCO Finland
9.0
8.0
16
18
PEF24
NOMESCO Finland
Thrombendarterectomy of deep femoral artery
10.1
8.0
15
15
RD112, ,
NOMESCO Finland
22.1
8.0
11
5
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
4.2
8.0
21
51
SPAT1260
SPAT
Consultation of another employee
1.6
8.0
224
1516
I21.4
ICD-10 Finland
Acute subendocardial myocardial infarction
3.0
8.0
35
120
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
2.1
8.0
73
355
C10AA02
ATC
lovastatin; oral
2.1
8.0
78
389
A98
ICPC
Health maint/preventive medicine
1.4
7.9
1330
12244
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.5
7.9
19
43
KAC10
NOMESCO Finland
Total nephrectomy with capsule
6.1
7.8
20
33
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
3.5
7.8
26
75
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
4.1
7.8
21
52
J01FA06
ATC
roxithromycin; oral
1.4
7.8
520
4143
L86
ICPC
Back syndrome with radiating pain
2.1
7.8
74
365
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
6.4
7.7
19
30
A10AA02, ,
ATC
2.5
7.7
45
180
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
7.5
7.7
17
23
EB1WA, ,
NOMESCO Finland
7.5
7.7
17
23
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.7
7.7
40
151
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
7.7
58
261
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
7.7
161
1017
Z51.5
ICD-10 Finland
Palliative care
1.6
7.7
170
1089
KH1AD
NOMESCO Finland
CT of urinary organs
2.3
7.6
56
249
J01AA02
ATC
doxycycline; systemic
1.4
7.6
1107
9906
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.1
7.6
31
102
C09BB05
ATC
ramipril and felodipine; oral
18.4
7.6
11
6
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
3.6
7.6
24
67
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
2.8
7.6
37
135
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.6
7.6
41
158
X57
ICD-10 Finland
Unspecified privation
2.9
7.6
35
124
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.5
363
2735
-42
ICPC
Electrical tracing
3.4
7.5
26
77
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.7
7.5
38
141
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
3.8
7.5
22
58
SPAT1151
SPAT
Treatment of major wounds
3.8
7.5
22
58
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.5
7.5
44
176
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.4
7.5
52
225
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
7.1
7.5
17
24
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
7.4
105
593
R51.80
ICD-10 Finland
Headache
1.7
7.4
143
883
R5110, ,
SPAT
1.7
7.4
125
744
TJA30
NOMESCO Finland
Peritoneal dialysis
80.4
7.4
8
*
75302
ICD-8 Finland
Congenital anomalies of urinary system, Hypoplasia et dysplasia renis
80.4
7.4
8
*
ZYC01
NOMESCO Finland
Remote contact by phone
2.0
7.4
73
365
H26.3
ICD-10 Finland
Drug-induced cataract
6.5
7.4
18
28
D02AE01
ATC
carbamide; topical
2.0
7.4
83
435
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
7.4
220
1508
E66.0
ICD-10 Finland
Obesity due to excess calories
7.7
7.4
16
21
C09DA02
ATC
eprosartan and diuretics; oral
13.4
7.4
12
9
N05BA04
ATC
oxazepam; oral
1.4
7.4
355
2674
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
3.6
7.3
23
64
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.8
7.3
36
132
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
10.9
7.3
13
12
C02DC01
ATC
minoxidil; oral
+∞
7.3
7
*
PB1BT
NOMESCO Finland
Extensive upper extremity artery PTA
+∞
7.3
7
*
TK823
NOMESCO Finland
Peritoneal permeability analysis
+∞
7.3
7
*
C02DB01
ATC
dihydralazine; systemic
+∞
7.3
7
*
PH1AT
NOMESCO Finland
Endovascular extension of superior vena cava and of arteries of upper extremity
+∞
7.3
7
*
4029B
ICD-9 Finland
Hypertensive heart disease, Unspecified[CUM DECOMPENSATIONE CORDIS (WHO III)]
+∞
7.3
7
*
44708
ICD-8 Finland
Other disease of arteries and arterioles, Alii definiti
+∞
7.3
7
*
9968A
ICD-9 Finland
Complications peculiar to certain specified procedures, Complications of transplanted organ
+∞
7.3
7
*
D89.8
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.8
7.3
100
560
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
6.9
7.3
17
25
B04AB02, ,
ATC
2.5
7.3
44
179
FM1TQ
NOMESCO Finland
Heart perfusion SPECT with low dose CT at rest and with exercise
9.4
7.3
14
15
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.2
7.3
56
254
H26.2
ICD-10 Finland
Complicated cataract
3.5
7.3
24
69
XA402
NOMESCO Finland
ENMG
3.0
7.2
31
105
Z90.5
ICD-10 Finland
Acquired absence of kidney
15.8
7.2
11
7
J81
ICD-10 Finland
Pulmonary oedema
5.8
7.2
19
33
T78.3
ICD-10 Finland
Angioneurotic oedema
4.3
7.2
18
42
ZXC50
NOMESCO Finland
Cryotherapy
2.1
7.2
63
301
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.5
7.2
43
174
U29
ICPC
Urinary symptom/complaint other
2.3
7.2
53
236
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.7
7.2
22
60
K81.0
ICD-10 Finland
Acute cholecystitis
2.7
7.2
38
145
Y60.9
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during unspecified surgical and medical care
30.1
7.1
9
*
I15.8
ICD-10 Finland
Other secondary hypertension
30.1
7.1
9
*
PG2YT
NOMESCO Finland
Implantation of arterial endoprothesis not elsewhere classified
30.1
7.1
9
*
RJ190, ,
NOMESCO Finland
20.1
7.1
10
5
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.4
7.1
45
187
I20.91
ICD-10 Finland
Angina pectoris, unspecified
3.2
7.1
27
85
Y94.0
ICD-10 Finland
Accident at home
2.9
7.1
33
117
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.1
230
1604
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
8.0
7.1
15
19
A01
ICPC
Pain general/multiple sites
1.7
7.1
127
769
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.4
7.1
48
206
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
12.1
7.1
12
10
R94.4
ICD-10 Finland
Abnormal results of kidney function studies
12.1
7.1
12
10
78900
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Albuminuria
12.1
7.1
12
10
KA1FN
NOMESCO Finland
Isotope renography
6.1
7.1
18
30
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.0
7.1
71
358
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
3.1
7.1
29
96
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
2.5
7.0
42
170
ZX114
NOMESCO Finland
Intramuscular
3.6
7.0
22
61
-60
ICPC
Result test/procedure
1.9
7.0
87
472
PD4BD
NOMESCO Finland
Extensive CT of lower extremity arteries
7.0
7.0
16
23
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
7.0
174
1146
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.7
7.0
127
773
A29
ICPC
General symptom/complaint other
1.5
7.0
196
1327
SPAT1131
SPAT
Colonoscopy
2.4
7.0
44
183
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
7.0
263
1893
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.9
6.9
80
424
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.9
6.9
31
108
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.0
6.9
19
48
J10.8
ICD-10 Finland
Influenza with other manifestations, seasonal influenza virus identified
13.8
6.9
11
8
58399
ICD-8 Finland
Nephritis, unqualified
13.8
6.9
11
8
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.6
6.9
38
148
L57.0
ICD-10 Finland
Actinic keratosis
1.5
6.9
198
1348
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.7
6.9
35
131
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.5
6.8
23
67
A10BB07
ATC
glipizide; oral
3.0
6.8
29
98
Z02.7
ICD-10 Finland
Issue of medical certificate
1.8
6.8
92
513
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.4
6.8
44
185
E000001, ,
ATC
1.5
6.8
237
1678
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.2
6.8
53
242
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.4
6.8
43
179
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.4
6.8
43
179
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
11.0
6.8
12
11
162
Kela drug reimbursment
liraglutide
11.0
6.8
12
11
Z12.8
ICD-10 Finland
Special screening examination for neoplasms of other sites
40.2
6.8
8
*
D638, N188,
ICD-10 Finland
40.2
6.8
8
*
5850A
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA SINE URAEMIA]
40.2
6.8
8
*
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
40.2
6.8
8
*
N08.3
ICD-10 Finland
Glomerular disorders in diabetes mellitus
40.2
6.8
8
*
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
40.2
6.8
8
*
ZX136
NOMESCO Finland
Intravesicalis
4.3
6.8
17
40
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
4.3
6.8
17
40
E79.0
ICD-10 Finland
Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
16.8
6.7
10
6
PG1CG
NOMESCO Finland
Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified
16.8
6.7
10
6
J01DA09
ATC
[U] cefadroxil
1.4
6.7
320
2402
WX704
NOMESCO Finland
Intubation
1.8
6.7
93
524
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
6.7
105
614
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.6
457
3643
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
6.5
6.6
16
25
P05
ICPC
Senility, feeling/behaving old
4.0
6.6
18
45
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.6
418
3288
QDA10
NOMESCO Finland
Incision of skin of lower limb
5.5
6.6
18
33
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.3
6.6
50
226
I65.3
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral precerebral arteries
12.3
6.6
11
9
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.3
6.6
47
207
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.9
6.6
85
468
FN2AA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), balloon only
4.2
6.6
17
41
SPAT1167
SPAT
Insertion of urinary catheter
2.1
6.5
63
313
D07AC13
ATC
mometasone; topical
1.4
6.5
359
2760
XCH00
NOMESCO Finland
Eye pressure measurement
1.9
6.5
77
411
N18.2
ICD-10 Finland
Chronic kidney disease, stage 2
10.1
6.5
12
12
A10BJ01
ATC
exenatide; parenteral
10.1
6.5
12
12
A02BC05
ATC
esomeprazole; systemic
1.3
6.5
508
4123
R03BB04
ATC
tiotropium bromide; inhalant
1.5
6.5
181
1222
SPAT1310
SPAT
Counselling related to known health issue
1.4
6.5
383
2979
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
2.9
6.5
29
101
61
HP
Catheterization and pressure measurement of the left side of the heart
2.6
6.5
35
135
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
2.6
6.5
36
141
GD1UN
NOMESCO Finland
Lung circulation SPECT
6.2
6.5
16
26
XCK00
NOMESCO Finland
Perimetry
1.8
6.4
98
567
TK830
NOMESCO Finland
Ultrafiltration
70.1
6.4
7
*
SPAT1164
SPAT
Haemodialysis
70.1
6.4
7
*
187
Kela drug reimbursment
MPA
70.1
6.4
7
*
OAB70
NOMESCO Finland
Guidance related to hydration
70.1
6.4
7
*
XX_20
NOMESCO Finland
Bioimpedance measurement
70.1
6.4
7
*
ZPB96
NOMESCO Finland
Other material in vessel transplant
70.1
6.4
7
*
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.4
6.4
22
65
Z50.1
ICD-10 Finland
Other physical therapy
2.0
6.4
70
364
PG1UT
NOMESCO Finland
Percutaneous aspiration throbectomy
7.4
6.4
14
19
J01EA01
ATC
trimethoprim; systemic
1.4
6.4
333
2536
SPAT1251
SPAT
Organisation of medication
2.2
6.4
54
255
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
14.4
6.4
10
7
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.0
6.4
68
351
B01AC07
ATC
dipyridamole; systemic
1.7
6.3
102
600
S76
ICPC
Skin infection other
1.9
6.3
75
401
A49.0
ICD-10 Finland
Staphylococcal infection, unspecified site
8.2
6.3
13
16
GD2SN
NOMESCO Finland
Lung ventilation SPECT
5.2
6.3
18
35
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
5.5
6.3
17
31
XF612
NOMESCO Finland
Measurement of central venous pressure
11.1
6.3
11
10
U71
ICPC
Cystitis/urinary infection other
1.9
6.3
74
395
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
6.3
68
353
Z94.4
ICD-10 Finland
Liver transplant status
18.1
6.3
9
5
N28.0
ICD-10 Finland
Ischaemia and infarction of kidney
18.1
6.3
9
5
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
18.1
6.3
9
5
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
6.3
164
1093
C02DE13, ,
ATC
+∞
6.3
6
*
B05D
ATC
PERITONEAL DIALYTICS
+∞
6.3
6
*
44010
ICD-8 Finland
Arteriosclerosis, Of renal artery
+∞
6.3
6
*
58199
ICD-8 Finland
Nephrotic syndrome
+∞
6.3
6
*
PG5ST
NOMESCO Finland
Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance
+∞
6.3
6
*
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
+∞
6.3
6
*
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
+∞
6.3
6
*
PBW99
NOMESCO Finland
Other operation on arteries of upper extremity
+∞
6.3
6
*
C02LM03, ,
ATC
+∞
6.3
6
*
130
Kela drug reimbursment
Malignant tumour
0.5
6.2
59
1121
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
26.8
6.2
8
*
N11.0
ICD-10 Finland
Nonobstructive reflux-associated chronic pyelonephritis
26.8
6.2
8
*
L14
ICPC
Leg/thigh symptom/complaint
1.7
6.2
102
604
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.8
6.2
97
567
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
6.2
20
57
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
3.4
6.1
21
62
J04AB02
ATC
rifampicin; systemic
3.4
6.1
21
62
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.8
6.1
94
546
B01AC24
ATC
ticagrelor; oral
2.1
6.1
55
267
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1.8
6.1
86
487
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.1
6.1
16
39
I95.1
ICD-10 Finland
Orthostatic hypotension
1.9
6.1
76
414
OAB72
NOMESCO Finland
Weight control and weight loss guidance
12.6
6.1
10
8
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.6
6.1
123
771
H26.02
ICD-10 Finland
Presenil cataract
2.6
6.1
33
128
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.1
6.0
24
78
306
Kela drug reimbursment
Erythropoietin and darbepoetin
6.7
6.0
14
21
PEN25
NOMESCO Finland
Plastic repair of superficial femoral artery
10.1
6.0
11
11
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.1
6.0
53
255

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Nephrology
39 [38004479]
4.5e+00
5.2e+00
5.3e+00
—
5.5e+00
6.3e+00
5.8e+00
cases:22.90%
controls:0.32%
cases:29.91%
controls:0.22%
cases:12.35%
controls:0.07%
—
—
cases:17.64%
controls:0.09%
cases:52.00%
controls:0.20%
cases:55.44%
controls:0.39%
330
46
1111
14273
431
32
1010
14287
178
10
1263
14309
—
215
13
1004
14263
586
27
541
13620
479
41
385
10365
alfacalcidol; oral, parenteral
A11CC03 [21600818]
4.4e+00
4.4e+00
3.6e+00
1.0e+50
3.9e+00
5.0e+00
5.3e+00
cases:8.74%
controls:0.12%
cases:10.06%
controls:0.13%
cases:2.01%
controls:0.06%
cases:0.49%
controls:0.00%
cases:3.36%
controls:0.07%
cases:14.82%
controls:0.12%
cases:23.84%
controls:0.15%
126
17
1315
14302
145
19
1296
14300
29
8
1412
14311
7
0
1434
14319
41
10
1178
14266
167
16
960
13631
206
16
658
10390
Chronic kidney disease, unspecified
N18.9 [45553438]
4.0e+00
4.4e+00
4.7e+00
—
4.6e+00
4.4e+00
4.3e+00
cases:23.59%
controls:0.56%
cases:24.98%
controls:0.40%
cases:10.20%
controls:0.10%
—
—
cases:7.22%
controls:0.08%
cases:21.83%
controls:0.36%
cases:36.57%
controls:0.81%
340
80
1101
14239
360
57
1081
14262
147
15
1294
14304
—
88
11
1131
14265
246
49
881
13598
316
84
548
10322
darbepoetin alfa; parenteral
B03XA02 [21601134]
4.4e+00
4.7e+00
3.6e+00
—
3.5e+00
4.5e+00
4.3e+00
cases:4.86%
controls:0.06%
cases:6.52%
controls:0.06%
cases:2.15%
controls:0.06%
—
—
cases:2.13%
controls:0.06%
cases:8.34%
controls:0.10%
cases:12.73%
controls:0.19%
70
9
1371
14310
94
9
1347
14310
31
9
1410
14310
—
26
9
1193
14267
94
14
1033
13633
110
20
754
10386
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
2.7e+00
3.8e+00
5.5e+00
1.0e+50
4.0e+00
4.2e+00
3.6e+00
cases:16.24%
controls:1.24%
cases:21.79%
controls:0.61%
cases:22.21%
controls:0.11%
cases:1.25%
controls:0.00%
cases:5.25%
controls:0.11%
cases:28.04%
controls:0.57%
cases:38.43%
controls:1.61%
234
177
1207
14142
314
87
1127
14232
320
16
1121
14303
18
0
1423
14319
64
15
1155
14261
316
78
811
13569
332
168
532
10238
calcium carbonate
A02AC01 [21600065]
3.7e+00
3.9e+00
3.6e+00
—
3.6e+00
4.0e+00
4.2e+00
cases:7.49%
controls:0.21%
cases:8.26%
controls:0.17%
cases:2.08%
controls:0.06%
—
—
cases:2.54%
controls:0.07%
cases:11.00%
controls:0.23%
cases:18.75%
controls:0.35%
108
30
1333
14289
119
25
1322
14294
30
8
1411
14311
—
31
10
1188
14266
124
32
1003
13615
162
36
702
10370
calcium carbonate; oral
A12AA04 [21600863]
3.7e+00
3.9e+00
3.6e+00
—
3.6e+00
4.0e+00
4.2e+00
cases:7.49%
controls:0.21%
cases:8.26%
controls:0.17%
cases:2.08%
controls:0.06%
—
—
cases:2.54%
controls:0.07%
cases:11.00%
controls:0.23%
cases:18.75%
controls:0.35%
108
30
1333
14289
119
25
1322
14294
30
8
1411
14311
—
31
10
1188
14266
124
32
1003
13615
162
36
702
10370
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2.6e+00
3.7e+00
5.5e+00
1.0e+50
3.6e+00
3.7e+00
3.4e+00
cases:13.46%
controls:1.15%
cases:16.52%
controls:0.49%
cases:14.50%
controls:0.07%
cases:0.49%
controls:0.00%
cases:2.46%
controls:0.07%
cases:20.67%
controls:0.62%
cases:32.29%
controls:1.54%
194
164
1247
14155
238
70
1203
14249
209
10
1232
14309
7
0
1434
14319
30
10
1189
14266
233
85
894
13562
279
160
585
10246
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
2.6e+00
3.5e+00
5.2e+00
1.0e+50
3.3e+00
3.8e+00
3.3e+00
cases:19.29%
controls:1.82%
cases:25.33%
controls:1.02%
cases:24.77%
controls:0.19%
cases:0.90%
controls:0.00%
cases:5.50%
controls:0.21%
cases:30.43%
controls:0.97%
cases:41.90%
controls:2.56%
278
260
1163
14059
365
146
1076
14173
357
27
1084
14292
13
0
1428
14319
67
30
1152
14246
343
133
784
13514
362
266
502
10140
moxonidine; oral
C02AC05 [21600401]
5.0e+00
5.1e+00
—
1.0e+50
—
5.3e+00
4.9e+00
cases:8.54%
controls:0.06%
cases:8.12%
controls:0.06%
—
—
cases:0.49%
controls:0.00%
—
—
cases:9.05%
controls:0.05%
cases:11.92%
controls:0.11%
123
9
1318
14310
117
8
1324
14311
—
7
0
1434
14319
—
102
7
1025
13640
103
11
761
10395
prazosin; oral
C02CA01 [21600411]
3.9e+00
4.9e+00
—
1.0e+50
—
5.4e+00
5.1e+00
cases:6.59%
controls:0.14%
cases:7.70%
controls:0.06%
—
—
cases:0.97%
controls:0.00%
—
—
cases:10.47%
controls:0.05%
cases:13.66%
controls:0.10%
95
20
1346
14299
111
9
1330
14310
—
14
0
1427
14319
—
118
7
1009
13640
118
10
746
10396
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
2.9e+00
3.9e+00
5.0e+00
—
—
3.8e+00
3.7e+00
cases:4.51%
controls:0.25%
cases:5.07%
controls:0.10%
cases:4.79%
controls:0.03%
—
—
—
—
cases:5.41%
controls:0.13%
cases:11.81%
controls:0.34%
65
36
1376
14283
73
15
1368
14304
69
5
1372
14314
—
—
61
18
1066
13629
102
35
762
10371
Unspecified kidney failure
N19 [45601718]
3.3e+00
4.0e+00
4.0e+00
—
2.5e+00
2.8e+00
2.6e+00
cases:6.94%
controls:0.28%
cases:7.01%
controls:0.13%
cases:2.64%
controls:0.05%
—
—
cases:0.74%
controls:0.06%
cases:2.93%
controls:0.18%
cases:6.37%
controls:0.50%
100
40
1341
14279
101
19
1340
14300
38
7
1403
14312
—
9
9
1210
14267
33
25
1094
13622
55
52
809
10354
Gas panel - Venous blood
24339-4 [3000991]
1.9e+00
3.0e+00
4.5e+00
—
4.1e+00
3.0e+00
2.4e+00
cases:6.66%
controls:1.05%
cases:8.67%
controls:0.46%
cases:7.29%
controls:0.08%
—
—
cases:2.05%
controls:0.04%
cases:9.14%
controls:0.48%
cases:17.48%
controls:1.86%
96
151
1345
14168
125
66
1316
14253
105
12
1336
14307
—
25
5
1194
14271
103
66
1024
13581
151
194
713
10212
Chronic kidney disease
N18 [45582391]
4.2e+00
4.5e+00
1.0e+50
—
1.0e+50
5.1e+00
4.6e+00
cases:6.66%
controls:0.11%
cases:5.20%
controls:0.06%
cases:1.32%
controls:0.00%
—
—
cases:2.38%
controls:0.00%
cases:5.68%
controls:0.04%
cases:13.54%
controls:0.15%
96
16
1345
14303
75
9
1366
14310
19
0
1422
14319
—
29
0
1190
14276
64
5
1063
13642
117
16
747
10390
Internal Medicine
11 [38004456]
1.3e+00
1.8e+00
2.6e+00
6.5e+00
2.4e+00
2.0e+00
1.6e+00
cases:50.17%
controls:21.87%
cases:35.67%
controls:8.26%
cases:14.09%
controls:1.19%
cases:27.83%
controls:0.06%
cases:12.88%
controls:1.39%
cases:39.49%
controls:8.10%
cases:55.90%
controls:20.68%
723
3131
718
11188
514
1183
927
13136
203
171
1238
14148
401
8
1040
14311
157
198
1062
14078
445
1106
682
12541
483
2152
381
8254
pH of Venous blood
2746-6 [3012544]
1.8e+00
2.9e+00
4.6e+00
—
3.5e+00
2.7e+00
2.1e+00
cases:8.05%
controls:1.37%
cases:10.76%
controls:0.66%
cases:8.26%
controls:0.09%
—
—
cases:2.38%
controls:0.07%
cases:10.83%
controls:0.78%
cases:18.87%
controls:2.82%
116
196
1325
14123
155
94
1286
14225
119
13
1322
14306
—
29
10
1190
14266
122
106
1005
13541
163
293
701
10113
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.8e+00
2.9e+00
4.6e+00
—
3.5e+00
2.7e+00
2.1e+00
cases:7.91%
controls:1.36%
cases:10.48%
controls:0.61%
cases:8.12%
controls:0.09%
—
—
cases:2.38%
controls:0.07%
cases:10.47%
controls:0.78%
cases:19.10%
controls:2.78%
114
195
1327
14124
151
88
1290
14231
117
13
1324
14306
—
29
10
1190
14266
118
107
1009
13540
165
289
699
10117
Base excess in Venous blood by calculation
1927-3 [3002032]
1.8e+00
3.0e+00
4.6e+00
—
3.5e+00
2.7e+00
2.0e+00
cases:7.91%
controls:1.36%
cases:10.34%
controls:0.59%
cases:7.98%
controls:0.09%
—
—
cases:2.38%
controls:0.07%
cases:10.74%
controls:0.77%
cases:18.17%
controls:2.81%
114
195
1327
14124
149
85
1292
14234
115
13
1326
14306
—
29
10
1190
14266
121
105
1006
13542
157
292
707
10114
felodipine; oral
C08CA02 [21601748]
2.7e+00
3.0e+00
2.6e+00
1.0e+50
3.0e+00
3.0e+00
3.1e+00
cases:8.54%
controls:0.60%
cases:8.19%
controls:0.45%
cases:2.43%
controls:0.19%
cases:0.42%
controls:0.00%
cases:2.71%
controls:0.13%
cases:8.70%
controls:0.48%
cases:12.04%
controls:0.63%
123
86
1318
14233
118
65
1323
14254
35
27
1406
14292
6
0
1435
14319
33
19
1186
14257
98
65
1029
13582
104
66
760
10340
Essential (primary) hypertension
I10 [45591453]
2.6e+00
2.9e+00
3.5e+00
—
3.6e+00
2.6e+00
2.3e+00
cases:51.35%
controls:7.61%
cases:39.49%
controls:3.33%
cases:12.28%
controls:0.44%
—
—
cases:11.57%
controls:0.36%
cases:33.72%
controls:3.70%
cases:54.28%
controls:10.96%
740
1089
701
13230
569
477
872
13842
177
63
1264
14256
—
141
52
1078
14224
380
505
747
13142
469
1140
395
9266
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.9e+00
2.9e+00
4.3e+00
—
3.2e+00
2.6e+00
2.3e+00
cases:13.67%
controls:2.31%
cases:16.86%
controls:1.12%
cases:9.58%
controls:0.15%
—
—
cases:2.79%
controls:0.12%
cases:16.33%
controls:1.37%
cases:27.89%
controls:3.89%
197
331
1244
13988
243
161
1198
14158
138
21
1303
14298
—
34
17
1185
14259
184
187
943
13460
241
405
623
10001
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.9e+00
2.8e+00
4.3e+00
—
3.3e+00
2.6e+00
2.2e+00
cases:13.88%
controls:2.42%
cases:17.28%
controls:1.26%
cases:9.99%
controls:0.15%
—
—
cases:2.87%
controls:0.11%
cases:17.13%
controls:1.52%
cases:28.47%
controls:4.22%
200
347
1241
13972
249
180
1192
14139
144
22
1297
14297
—
35
16
1184
14260
193
207
934
13440
246
439
618
9967
Protein [Mass/volume] in Urine
2888-6 [3037121]
1.9e+00
2.5e+00
4.6e+00
—
2.1e+00
3.2e+00
2.8e+00
cases:3.61%
controls:0.56%
cases:3.05%
controls:0.26%
cases:3.33%
controls:0.03%
—
—
cases:0.49%
controls:0.06%
cases:5.24%
controls:0.23%
cases:7.87%
controls:0.54%
52
80
1389
14239
44
37
1397
14282
48
5
1393
14314
—
6
9
1213
14267
59
31
1068
13616
68
56
796
10350
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.8e+00
2.8e+00
4.3e+00
—
3.2e+00
2.6e+00
2.1e+00
cases:14.30%
controls:2.60%
cases:17.77%
controls:1.33%
cases:10.27%
controls:0.16%
—
—
cases:2.95%
controls:0.13%
cases:17.30%
controls:1.59%
cases:28.82%
controls:4.55%
206
372
1235
13947
256
190
1185
14129
148
23
1293
14296
—
36
18
1183
14258
195
217
932
13430
249
473
615
9933
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
2.0e+00
2.5e+00
3.7e+00
1.0e+50
3.5e+00
2.5e+00
2.4e+00
cases:5.97%
controls:0.85%
cases:5.07%
controls:0.42%
cases:3.33%
controls:0.08%
cases:1.46%
controls:0.00%
cases:1.15%
controls:0.04%
cases:5.24%
controls:0.46%
cases:13.43%
controls:1.33%
86
122
1355
14197
73
60
1368
14259
48
12
1393
14307
21
0
1420
14319
14
5
1205
14271
59
63
1068
13584
116
138
748
10268
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2.2e+00
3.0e+00
3.8e+00
1.0e+50
2.3e+00
2.5e+00
2.5e+00
cases:2.15%
controls:0.24%
cases:2.57%
controls:0.13%
cases:1.53%
controls:0.03%
cases:0.97%
controls:0.00%
cases:0.41%
controls:0.04%
cases:2.57%
controls:0.23%
cases:6.13%
controls:0.55%
31
35
1410
14284
37
18
1404
14301
22
5
1419
14314
14
0
1427
14319
5
6
1214
14270
29
31
1098
13616
53
57
811
10349
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
2.2e+00
3.2e+00
4.8e+00
1.0e+50
—
3.4e+00
2.6e+00
cases:4.79%
controls:0.58%
cases:7.22%
controls:0.31%
cases:6.52%
controls:0.06%
cases:0.56%
controls:0.00%
—
—
cases:8.07%
controls:0.29%
cases:13.77%
controls:1.22%
69
83
1372
14236
104
45
1337
14274
94
8
1347
14311
8
0
1433
14319
—
91
39
1036
13608
119
127
745
10279
carvedilol; oral
C07AG02 [21601700]
2.4e+00
2.5e+00
2.9e+00
—
2.7e+00
3.0e+00
2.7e+00
cases:5.00%
controls:0.50%
cases:4.44%
controls:0.38%
cases:1.46%
controls:0.08%
—
—
cases:2.05%
controls:0.15%
cases:6.83%
controls:0.37%
cases:8.45%
controls:0.62%
72
71
1369
14248
64
55
1377
14264
21
12
1420
14307
—
25
21
1194
14255
77
51
1050
13596
73
64
791
10342
lercanidipine; oral
C08CA13 [21601759]
2.6e+00
2.7e+00
2.5e+00
1.0e+50
3.0e+00
2.7e+00
2.5e+00
cases:13.12%
controls:1.12%
cases:12.28%
controls:0.96%
cases:3.40%
controls:0.30%
cases:0.90%
controls:0.00%
cases:5.25%
controls:0.28%
cases:14.11%
controls:1.06%
cases:17.71%
controls:1.74%
189
160
1252
14159
177
137
1264
14182
49
43
1392
14276
13
0
1428
14319
64
40
1155
14236
159
144
968
13503
153
181
711
10225
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2.0e+00
2.6e+00
3.7e+00
1.0e+50
2.9e+00
2.4e+00
2.4e+00
cases:5.97%
controls:0.89%
cases:6.04%
controls:0.47%
cases:3.89%
controls:0.10%
cases:1.80%
controls:0.00%
cases:1.23%
controls:0.07%
cases:6.83%
controls:0.68%
cases:14.70%
controls:1.59%
86
128
1355
14191
87
67
1354
14252
56
14
1385
14305
26
0
1415
14319
15
10
1204
14266
77
93
1050
13554
127
165
737
10241
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
2.2e+00
2.7e+00
3.7e+00
—
3.0e+00
2.3e+00
2.0e+00
cases:5.34%
controls:0.64%
cases:4.72%
controls:0.32%
cases:3.19%
controls:0.08%
—
—
cases:0.98%
controls:0.05%
cases:3.11%
controls:0.32%
cases:5.67%
controls:0.83%
77
92
1364
14227
68
46
1373
14273
46
12
1395
14307
—
12
7
1207
14269
35
43
1092
13604
49
86
815
10320
pH of Capillary blood
2745-8 [3009343]
2.0e+00
2.6e+00
3.7e+00
1.0e+50
2.8e+00
2.4e+00
2.4e+00
cases:5.97%
controls:0.89%
cases:5.83%
controls:0.46%
cases:3.89%
controls:0.10%
cases:1.67%
controls:0.00%
cases:1.23%
controls:0.08%
cases:6.39%
controls:0.64%
cases:14.24%
controls:1.55%
86
127
1355
14192
84
66
1357
14253
56
14
1385
14305
24
0
1417
14319
15
11
1204
14265
72
87
1055
13560
123
161
741
10245
nifedipine; oral, parenteral
C08CA05 [21601751]
2.3e+00
2.6e+00
2.8e+00
—
2.8e+00
2.7e+00
2.6e+00
cases:4.93%
controls:0.54%
cases:3.61%
controls:0.29%
cases:0.83%
controls:0.05%
—
—
cases:1.72%
controls:0.11%
cases:3.90%
controls:0.28%
cases:5.21%
controls:0.42%
71
77
1370
14242
52
41
1389
14278
12
7
1429
14312
—
21
15
1198
14261
44
38
1083
13609
45
44
819
10362
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.5e+00
2.3e+00
4.2e+00
1.0e+50
3.6e+00
2.1e+00
1.9e+00
cases:5.14%
controls:1.14%
cases:5.34%
controls:0.54%
cases:3.12%
controls:0.05%
cases:0.56%
controls:0.00%
cases:1.56%
controls:0.04%
cases:5.24%
controls:0.68%
cases:14.47%
controls:2.48%
74
163
1367
14156
77
77
1364
14242
45
7
1396
14312
8
0
1433
14319
19
6
1200
14270
59
93
1068
13554
125
258
739
10148
amlodipine; oral
C08CA01 [21601747]
2.2e+00
2.3e+00
2.0e+00
2.6e+00
2.2e+00
2.1e+00
2.1e+00
cases:36.99%
controls:6.15%
cases:33.87%
controls:5.00%
cases:10.76%
controls:1.54%
cases:0.97%
controls:0.07%
cases:11.81%
controls:1.40%
cases:33.10%
controls:5.50%
cases:40.97%
controls:8.01%
533
881
908
13438
488
716
953
13603
155
220
1286
14099
14
10
1427
14309
144
200
1075
14076
373
750
754
12897
354
834
510
9572
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
2.1e+00
2.6e+00
3.4e+00
—
2.8e+00
2.5e+00
2.2e+00
cases:4.44%
controls:0.54%
cases:3.05%
controls:0.24%
cases:2.15%
controls:0.07%
—
—
cases:0.66%
controls:0.04%
cases:2.57%
controls:0.21%
cases:4.86%
controls:0.59%
64
78
1377
14241
44
35
1397
14284
31
10
1410
14309
—
8
6
1211
14270
29
29
1098
13618
42
61
822
10345
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
2.2e+00
2.7e+00
3.6e+00
—
2.9e+00
2.2e+00
2.0e+00
cases:5.41%
controls:0.65%
cases:4.93%
controls:0.36%
cases:3.40%
controls:0.10%
—
—
cases:0.98%
controls:0.06%
cases:3.28%
controls:0.37%
cases:6.02%
controls:0.89%
78
93
1363
14226
71
51
1370
14268
49
14
1392
14305
—
12
8
1207
14268
37
51
1090
13596
52
93
812
10313
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
2.2e+00
2.7e+00
3.6e+00
—
2.9e+00
2.2e+00
2.0e+00
cases:5.41%
controls:0.65%
cases:4.86%
controls:0.36%
cases:3.40%
controls:0.10%
—
—
cases:0.98%
controls:0.06%
cases:3.28%
controls:0.37%
cases:6.02%
controls:0.89%
78
93
1363
14226
70
51
1371
14268
49
14
1392
14305
—
12
8
1207
14268
37
51
1090
13596
52
93
812
10313
furosemide; oral, parenteral
C03CA01 [21601518]
2.0e+00
2.4e+00
1.9e+00
2.7e+00
2.0e+00
2.3e+00
2.1e+00
cases:40.11%
controls:8.39%
cases:45.11%
controls:7.26%
cases:15.20%
controls:2.49%
cases:2.29%
controls:0.15%
cases:15.34%
controls:2.48%
cases:45.70%
controls:7.77%
cases:51.04%
controls:11.26%
578
1201
863
13118
650
1039
791
13280
219
357
1222
13962
33
22
1408
14297
187
354
1032
13922
515
1061
612
12586
441
1172
423
9234
Gas panel - Capillary blood
24337-8 [3022313]
1.9e+00
2.5e+00
3.6e+00
1.0e+50
2.9e+00
2.2e+00
2.1e+00
cases:4.86%
controls:0.73%
cases:4.09%
controls:0.36%
cases:2.50%
controls:0.07%
cases:0.97%
controls:0.00%
cases:0.90%
controls:0.05%
cases:4.44%
controls:0.50%
cases:8.45%
controls:1.10%
70
105
1371
14214
59
52
1382
14267
36
10
1405
14309
14
0
1427
14319
11
7
1208
14269
50
68
1077
13579
73
114
791
10292
Kidney symptom/complaint
U14 [2002001145]
2.9e+00
4.1e+00
—
—
—
3.7e+00
4.1e+00
cases:1.94%
controls:0.11%
cases:2.08%
controls:0.03%
—
—
—
—
—
—
cases:2.04%
controls:0.05%
cases:3.82%
controls:0.07%
28
16
1413
14303
30
5
1411
14314
—
—
—
23
7
1104
13640
33
7
831
10399
Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]
3.0e+00
3.8e+00
—
—
—
4.0e+00
3.9e+00
cases:3.26%
controls:0.17%
cases:3.54%
controls:0.08%
—
—
—
—
—
—
cases:5.06%
controls:0.10%
cases:8.91%
controls:0.19%
47
25
1394
14294
51
12
1390
14307
—
—
—
57
13
1070
13634
77
20
787
10386
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
1.7e+00
2.4e+00
3.8e+00
—
3.2e+00
1.9e+00
1.7e+00
cases:8.19%
controls:1.63%
cases:7.29%
controls:0.72%
cases:6.32%
controls:0.15%
—
—
cases:1.80%
controls:0.08%
cases:4.88%
controls:0.74%
cases:10.07%
controls:2.09%
118
233
1323
14086
105
103
1336
14216
91
21
1350
14298
—
22
11
1197
14265
55
101
1072
13546
87
217
777
10189
allopurinol; oral, parenteral
M04AA01 [21604131]
2.3e+00
2.4e+00
2.4e+00
—
2.3e+00
2.6e+00
2.7e+00
cases:20.89%
controls:2.57%
cases:17.97%
controls:1.96%
cases:4.58%
controls:0.45%
—
—
cases:5.17%
controls:0.55%
cases:19.34%
controls:1.82%
cases:29.75%
controls:2.79%
301
368
1140
13951
259
280
1182
14039
66
64
1375
14255
—
63
78
1156
14198
218
248
909
13399
257
290
607
10116
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
2.0e+00
2.4e+00
4.0e+00
—
2.8e+00
1.8e+00
1.5e+00
cases:4.51%
controls:0.65%
cases:3.75%
controls:0.36%
cases:3.05%
controls:0.06%
—
—
cases:0.66%
controls:0.04%
cases:2.04%
controls:0.34%
cases:4.05%
controls:0.89%
65
93
1376
14226
54
52
1387
14267
44
8
1397
14311
—
8
6
1211
14270
23
47
1104
13600
35
93
829
10313
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2.0e+00
2.4e+00
4.0e+00
—
2.8e+00
1.8e+00
1.5e+00
cases:4.51%
controls:0.65%
cases:3.75%
controls:0.36%
cases:3.05%
controls:0.06%
—
—
cases:0.66%
controls:0.04%
cases:2.04%
controls:0.34%
cases:4.05%
controls:0.89%
65
93
1376
14226
54
52
1387
14267
44
8
1397
14311
—
8
6
1211
14270
23
47
1104
13600
35
93
829
10313
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
2.0e+00
2.4e+00
4.0e+00
—
2.8e+00
1.8e+00
1.5e+00
cases:4.51%
controls:0.65%
cases:3.75%
controls:0.36%
cases:3.05%
controls:0.06%
—
—
cases:0.66%
controls:0.04%
cases:2.04%
controls:0.34%
cases:4.05%
controls:0.89%
65
93
1376
14226
54
52
1387
14267
44
8
1397
14311
—
8
6
1211
14270
23
47
1104
13600
35
93
829
10313
Type 2 diabetes mellitus, with renal complications
E11.2 [45605400]
3.2e+00
3.9e+00
—
1.0e+50
—
3.9e+00
3.4e+00
cases:4.72%
controls:0.20%
cases:4.09%
controls:0.08%
—
—
cases:2.29%
controls:0.00%
—
—
cases:3.73%
controls:0.08%
cases:8.56%
controls:0.31%
68
28
1373
14291
59
12
1382
14307
—
33
0
1408
14319
—
42
11
1085
13636
74
32
790
10374
erythropoietin; parenteral
B03XA01 [21601133]
3.0e+00
3.4e+00
—
—
—
4.3e+00
3.6e+00
cases:1.25%
controls:0.06%
cases:1.87%
controls:0.06%
—
—
—
—
—
—
cases:2.66%
controls:0.04%
cases:4.17%
controls:0.12%
18
9
1423
14310
27
9
1414
14310
—
—
—
30
5
1097
13642
36
12
828
10394
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.8e+00
2.3e+00
4.0e+00
—
2.8e+00
1.9e+00
1.6e+00
cases:7.84%
controls:1.38%
cases:5.69%
controls:0.57%
cases:5.55%
controls:0.11%
—
—
cases:1.31%
controls:0.08%
cases:3.46%
controls:0.53%
cases:7.75%
controls:1.73%
113
198
1328
14121
82
82
1359
14237
80
16
1361
14303
—
16
12
1203
14264
39
73
1088
13574
67
180
797
10226
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2.0e+00
2.4e+00
4.0e+00
—
2.8e+00
1.7e+00
1.5e+00
cases:4.30%
controls:0.60%
cases:3.61%
controls:0.35%
cases:2.71%
controls:0.05%
—
—
cases:0.66%
controls:0.04%
cases:1.69%
controls:0.32%
cases:3.70%
controls:0.87%
62
86
1379
14233
52
50
1389
14269
39
7
1402
14312
—
8
6
1211
14270
19
44
1108
13603
32
91
832
10315
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
2.0e+00
2.4e+00
4.1e+00
—
2.5e+00
1.8e+00
1.5e+00
cases:3.96%
controls:0.54%
cases:3.54%
controls:0.32%
cases:2.78%
controls:0.05%
—
—
cases:0.49%
controls:0.04%
cases:1.60%
controls:0.27%
cases:3.82%
controls:0.86%
57
78
1384
14241
51
46
1390
14273
40
7
1401
14312
—
6
6
1213
14270
18
37
1109
13610
33
90
831
10316
Other chronic renal failure
N18.8 [45534123]
4.5e+00
4.6e+00
—
1.0e+50
—
—
5.1e+00
cases:9.23%
controls:0.11%
cases:7.91%
controls:0.08%
—
—
cases:5.48%
controls:0.00%
—
—
—
—
cases:18.75%
controls:0.13%
133
16
1308
14303
114
12
1327
14307
—
79
0
1362
14319
—
—
162
14
702
10392
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
1.9e+00
2.3e+00
3.9e+00
—
2.5e+00
1.9e+00
1.6e+00
cases:3.96%
controls:0.64%
cases:3.26%
controls:0.33%
cases:2.78%
controls:0.06%
—
—
cases:0.41%
controls:0.04%
cases:1.60%
controls:0.25%
cases:3.59%
controls:0.78%
57
91
1384
14228
47
47
1394
14272
40
8
1401
14311
—
5
5
1214
14271
18
34
1109
13613
31
81
833
10325
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
1.3e+00
2.4e+00
4.0e+00
—
3.2e+00
1.7e+00
1.5e+00
cases:3.19%
controls:0.86%
cases:3.68%
controls:0.34%
cases:1.80%
controls:0.03%
—
—
cases:0.98%
controls:0.04%
cases:2.66%
controls:0.52%
cases:7.87%
controls:1.95%
46
123
1395
14196
53
48
1388
14271
26
5
1415
14314
—
12
6
1207
14270
30
71
1097
13576
68
203
796
10203
Gout, unspecified
M10.9 [45543454]
2.2e+00
2.1e+00
2.4e+00
1.0e+50
2.3e+00
2.5e+00
2.4e+00
cases:6.18%
controls:0.71%
cases:2.91%
controls:0.35%
cases:0.90%
controls:0.08%
cases:1.80%
controls:0.00%
cases:0.66%
controls:0.06%
cases:4.26%
controls:0.36%
cases:9.26%
controls:0.95%
89
101
1352
14218
42
50
1399
14269
13
12
1428
14307
26
0
1415
14319
8
9
1211
14267
48
49
1079
13598
80
99
784
10307
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
2.5e+00
2.0e+00
—
—
2.6e+00
2.8e+00
3.9e+00
cases:0.76%
controls:0.06%
cases:0.76%
controls:0.10%
—
—
—
—
cases:0.49%
controls:0.04%
cases:1.77%
controls:0.11%
cases:5.90%
controls:0.12%
11
9
1430
14310
11
15
1430
14304
—
—
6
5
1213
14271
20
15
1107
13632
51
13
813
10393
valsartan; oral
C09CA03 [21601826]
2.2e+00
2.3e+00
2.1e+00
1.0e+50
2.6e+00
2.5e+00
2.3e+00
cases:7.15%
controls:0.85%
cases:6.80%
controls:0.76%
cases:2.01%
controls:0.26%
cases:0.35%
controls:0.00%
cases:2.95%
controls:0.23%
cases:8.61%
controls:0.78%
cases:9.26%
controls:1.05%
103
122
1338
14197
98
109
1343
14210
29
37
1412
14282
5
0
1436
14319
36
33
1183
14243
97
106
1030
13541
80
109
784
10297
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
1.5e+00
2.2e+00
3.5e+00
—
2.3e+00
2.3e+00
2.1e+00
cases:18.81%
controls:4.82%
cases:14.92%
controls:1.99%
cases:8.88%
controls:0.31%
—
—
cases:1.97%
controls:0.20%
cases:16.68%
controls:1.94%
cases:33.56%
controls:5.94%
271
690
1170
13629
215
285
1226
14034
128
44
1313
14275
—
24
29
1195
14247
188
265
939
13382
290
618
574
9788
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
1.4e+00
2.0e+00
3.5e+00
—
2.5e+00
2.4e+00
1.9e+00
cases:5.20%
controls:1.35%
cases:4.44%
controls:0.60%
cases:1.67%
controls:0.05%
—
—
cases:0.41%
controls:0.04%
cases:4.79%
controls:0.45%
cases:11.92%
controls:1.89%
75
194
1366
14125
64
86
1377
14233
24
7
1417
14312
—
5
5
1214
14271
54
61
1073
13586
103
197
761
10209
Protein [Mass/time] in 24 hour Urine
2889-4 [3020876]
2.8e+00
4.0e+00
1.0e+50
—
—
3.7e+00
3.3e+00
cases:3.68%
controls:0.22%
cases:2.50%
controls:0.05%
cases:1.94%
controls:0.00%
—
—
—
—
cases:1.77%
controls:0.04%
cases:5.67%
controls:0.23%
53
32
1388
14287
36
7
1405
14312
28
0
1413
14319
—
—
20
6
1107
13641
49
24
815
10382
valsartan and amlodipine
C09DB01 [21601842]
2.4e+00
2.1e+00
2.0e+00
1.0e+50
3.0e+00
2.4e+00
1.6e+00
cases:2.43%
controls:0.22%
cases:1.60%
controls:0.19%
cases:0.49%
controls:0.06%
cases:0.35%
controls:0.00%
cases:0.82%
controls:0.04%
cases:2.04%
controls:0.18%
cases:1.85%
controls:0.37%
35
31
1406
14288
23
27
1418
14292
7
9
1434
14310
5
0
1436
14319
10
6
1209
14270
23
25
1104
13622
16
38
848
10368
Atherosclerotic heart disease
I25.1 [45596196]
9.1e-01
1.3e+00
1.8e+00
5.1e+00
1.8e+00
1.4e+00
1.2e+00
cases:14.57%
controls:6.43%
cases:10.55%
controls:3.11%
cases:3.89%
controls:0.66%
cases:7.77%
controls:0.05%
cases:4.76%
controls:0.78%
cases:13.66%
controls:3.63%
cases:22.80%
controls:8.08%
210
920
1231
13399
152
446
1289
13873
56
95
1385
14224
112
7
1329
14312
58
112
1161
14164
154
496
973
13151
197
841
667
9565
nebivolol; oral
C07AB12 [21601694]
2.0e+00
2.3e+00
2.4e+00
—
2.3e+00
2.4e+00
2.2e+00
cases:1.94%
controls:0.26%
cases:1.80%
controls:0.18%
cases:0.56%
controls:0.05%
—
—
cases:0.66%
controls:0.06%
cases:2.04%
controls:0.20%
cases:2.20%
controls:0.26%
28
37
1413
14282
26
26
1415
14293
8
7
1433
14312
—
8
9
1211
14267
23
27
1104
13620
19
27
845
10379
linagliptin; oral
A10BH05 [40251691]
2.4e+00
2.4e+00
2.0e+00
—
2.0e+00
2.4e+00
2.4e+00
cases:5.62%
controls:0.55%
cases:6.18%
controls:0.57%
cases:2.22%
controls:0.29%
—
—
cases:2.13%
controls:0.29%
cases:6.74%
controls:0.65%
cases:8.45%
controls:0.86%
81
79
1360
14240
89
81
1352
14238
32
42
1409
14277
—
26
42
1193
14234
76
89
1051
13558
73
90
791
10316
Hyperlipidaemia, unspecified
E78.5 [45537986]
1.5e+00
2.1e+00
2.6e+00
1.0e+50
2.9e+00
2.2e+00
2.0e+00
cases:4.72%
controls:1.14%
cases:3.05%
controls:0.37%
cases:0.49%
controls:0.03%
cases:2.15%
controls:0.00%
cases:0.90%
controls:0.05%
cases:3.02%
controls:0.34%
cases:7.18%
controls:1.02%
68
163
1373
14156
44
53
1397
14266
7
5
1434
14314
31
0
1410
14319
11
7
1208
14269
34
47
1093
13600
62
106
802
10300
Immunofixation for Serum or Plasma
25700-6 [3037756]
2.1e+00
1.8e+00
3.3e+00
—
2.5e+00
1.8e+00
1.7e+00
cases:3.12%
controls:0.38%
cases:1.39%
controls:0.24%
cases:1.11%
controls:0.04%
—
—
cases:0.41%
controls:0.04%
cases:1.15%
controls:0.20%
cases:2.66%
controls:0.51%
45
55
1396
14264
20
34
1421
14285
16
6
1425
14313
—
5
5
1214
14271
13
27
1114
13620
23
53
841
10353
Inpatient Hospital
21 [8717]
7.9e-01
1.1e+00
2.0e+00
5.4e+00
1.7e+00
1.0e+00
9.3e-01
cases:49.13%
controls:30.52%
cases:27.06%
controls:11.05%
cases:11.17%
controls:1.74%
cases:13.05%
controls:0.07%
cases:9.27%
controls:1.86%
cases:25.02%
controls:10.46%
cases:46.30%
controls:25.36%
708
4370
733
9949
390
1582
1051
12737
161
249
1280
14070
188
10
1253
14309
113
266
1106
14010
282
1428
845
12219
400
2639
464
7767
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
1.9e+00
1.7e+00
3.2e+00
1.0e+50
2.8e+00
1.7e+00
1.7e+00
cases:5.76%
controls:0.91%
cases:3.26%
controls:0.62%
cases:1.53%
controls:0.06%
cases:2.36%
controls:0.00%
cases:1.64%
controls:0.11%
cases:3.64%
controls:0.70%
cases:7.75%
controls:1.59%
83
131
1358
14188
47
89
1394
14230
22
9
1419
14310
34
0
1407
14319
20
15
1199
14261
41
96
1086
13551
67
165
797
10241
Atherosclerosis of arteries of extremities
I70.2 [45538421]
2.0e+00
2.1e+00
2.5e+00
—
2.3e+00
2.3e+00
1.7e+00
cases:9.99%
controls:1.54%
cases:6.45%
controls:0.87%
cases:2.57%
controls:0.22%
—
—
cases:1.97%
controls:0.20%
cases:8.16%
controls:0.89%
cases:10.76%
controls:2.26%
144
221
1297
14098
93
124
1348
14195
37
31
1404
14288
—
24
28
1195
14248
92
121
1035
13526
93
235
771
10171
Emergency Room and Inpatient Visit
ERIP [262]
8.0e-01
1.4e+00
2.7e+00
4.7e+00
1.5e+00
8.4e-01
7.5e-01
cases:11.94%
controls:5.73%
cases:12.42%
controls:3.34%
cases:6.87%
controls:0.52%
cases:3.82%
controls:0.03%
cases:1.97%
controls:0.43%
cases:8.61%
controls:3.90%
cases:20.49%
controls:10.80%
172
820
1269
13499
179
478
1262
13841
99
74
1342
14245
55
5
1386
14314
24
62
1195
14214
97
532
1030
13115
177
1124
687
9282
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
2.1e+00
2.5e+00
4.1e+00
—
—
2.2e+00
1.7e+00
cases:3.75%
controls:0.47%
cases:3.26%
controls:0.27%
cases:2.50%
controls:0.04%
—
—
—
—
cases:1.42%
controls:0.16%
cases:3.47%
controls:0.62%
54
67
1387
14252
47
39
1394
14280
36
6
1405
14313
—
—
16
22
1111
13625
30
65
834
10341
pH of Serum or Plasma
2753-2 [3018418]
1.1e+00
2.0e+00
3.7e+00
—
2.3e+00
2.0e+00
1.5e+00
cases:17.28%
controls:6.32%
cases:20.06%
controls:3.38%
cases:16.86%
controls:0.50%
—
—
cases:4.84%
controls:0.52%
cases:21.03%
controls:3.36%
cases:30.44%
controls:9.12%
249
905
1192
13414
289
484
1152
13835
243
72
1198
14247
—
59
74
1160
14202
237
459
890
13188
263
949
601
9457
Protein [Mass] in Urine collected for unspecified duration
32551-4 [3017817]
3.0e+00
3.5e+00
—
—
—
3.4e+00
2.6e+00
cases:2.64%
controls:0.13%
cases:1.87%
controls:0.06%
—
—
—
—
—
—
cases:1.24%
controls:0.04%
cases:3.01%
controls:0.22%
38
19
1403
14300
27
8
1414
14311
—
—
—
14
6
1113
13641
26
23
838
10383
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
2.0e+00
2.5e+00
4.3e+00
—
—
2.1e+00
1.7e+00
cases:3.26%
controls:0.45%
cases:3.05%
controls:0.27%
cases:2.43%
controls:0.03%
—
—
—
—
cases:1.24%
controls:0.15%
cases:2.89%
controls:0.56%
47
65
1394
14254
44
38
1397
14281
35
5
1406
14314
—
—
14
21
1113
13626
25
58
839
10348
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
2.0e+00
2.5e+00
4.3e+00
—
—
2.0e+00
1.8e+00
cases:3.26%
controls:0.45%
cases:3.05%
controls:0.27%
cases:2.50%
controls:0.03%
—
—
—
—
cases:1.24%
controls:0.18%
cases:3.36%
controls:0.59%
47
65
1394
14254
44
38
1397
14281
36
5
1405
14314
—
—
14
24
1113
13623
29
61
835
10345
Outpatient Hospital
22 [8756]
7.0e-01
9.9e-01
2.0e+00
4.8e+00
1.8e+00
1.2e+00
1.0e+00
cases:38.58%
controls:23.69%
cases:17.21%
controls:7.17%
cases:5.97%
controls:0.87%
cases:3.96%
controls:0.03%
cases:5.17%
controls:0.88%
cases:18.46%
controls:6.37%
cases:38.43%
controls:18.64%
556
3392
885
10927
248
1026
1193
13293
86
125
1355
14194
57
5
1384
14314
63
125
1156
14151
208
869
919
12778
332
1940
532
8466
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
1.3e+00
1.9e+00
3.8e+00
—
2.0e+00
1.9e+00
1.6e+00
cases:20.40%
controls:6.59%
cases:21.72%
controls:3.97%
cases:13.81%
controls:0.36%
—
—
cases:2.38%
controls:0.34%
cases:22.18%
controls:4.18%
cases:36.69%
controls:10.15%
294
943
1147
13376
313
568
1128
13751
199
52
1242
14267
—
29
49
1190
14227
250
571
877
13076
317
1056
547
9350
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
1.3e+00
1.9e+00
3.7e+00
—
1.9e+00
1.9e+00
1.7e+00
cases:21.72%
controls:7.12%
cases:22.90%
controls:4.23%
cases:14.64%
controls:0.43%
—
—
cases:2.46%
controls:0.37%
cases:23.60%
controls:4.37%
cases:39.00%
controls:10.59%
313
1020
1128
13299
330
605
1111
13714
211
61
1230
14258
—
30
53
1189
14223
266
597
861
13050
337
1102
527
9304
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
3.0e+00
3.3e+00
—
1.0e+50
—
3.3e+00
2.7e+00
cases:5.62%
controls:0.29%
cases:4.58%
controls:0.18%
—
—
cases:3.12%
controls:0.00%
—
—
cases:5.86%
controls:0.22%
cases:7.87%
controls:0.55%
81
42
1360
14277
66
26
1375
14293
—
45
0
1396
14319
—
66
30
1061
13617
68
57
796
10349
Congestive heart failure
I50.0 [45567179]
1.4e+00
2.1e+00
3.2e+00
—
2.4e+00
1.8e+00
1.4e+00
cases:4.09%
controls:1.01%
cases:3.82%
controls:0.50%
cases:1.94%
controls:0.08%
—
—
cases:1.39%
controls:0.13%
cases:3.99%
controls:0.68%
cases:6.25%
controls:1.58%
59
145
1382
14174
55
71
1386
14248
28
11
1413
14308
—
17
19
1202
14257
45
93
1082
13554
54
164
810
10242
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1.7e+00
2.2e+00
3.5e+00
1.0e+50
—
2.8e+00
2.1e+00
cases:3.19%
controls:0.60%
cases:3.19%
controls:0.36%
cases:1.67%
controls:0.05%
cases:0.49%
controls:0.00%
—
—
cases:3.37%
controls:0.22%
cases:7.29%
controls:0.95%
46
86
1395
14233
46
51
1395
14268
24
7
1417
14312
7
0
1434
14319
—
38
30
1089
13617
63
99
801
10307
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.0e+00
1.8e+00
3.7e+00
1.0e+50
2.1e+00
2.0e+00
1.6e+00
cases:23.73%
controls:10.19%
cases:25.82%
controls:5.26%
cases:25.05%
controls:0.78%
cases:1.18%
controls:0.00%
cases:6.07%
controls:0.78%
cases:29.10%
controls:5.32%
cases:44.68%
controls:13.88%
342
1459
1099
12860
372
753
1069
13566
361
112
1080
14207
17
0
1424
14319
74
112
1145
14164
328
726
799
12921
386
1444
478
8962
Albumin [Mass/volume] in Urine
1754-1 [3012516]
1.2e+00
1.9e+00
3.7e+00
—
1.9e+00
1.9e+00
1.7e+00
cases:19.50%
controls:6.52%
cases:21.17%
controls:3.89%
cases:13.19%
controls:0.37%
—
—
cases:2.21%
controls:0.33%
cases:21.83%
controls:4.17%
cases:36.57%
controls:9.92%
281
933
1160
13386
305
557
1136
13762
190
53
1251
14266
—
27
47
1192
14229
246
569
881
13078
316
1032
548
9374
candesartan and diuretics
C09DA06 [21601838]
2.2e+00
2.1e+00
1.9e+00
—
2.6e+00
1.8e+00
1.7e+00
cases:4.02%
controls:0.47%
cases:2.57%
controls:0.34%
cases:0.62%
controls:0.10%
—
—
cases:0.74%
controls:0.06%
cases:2.22%
controls:0.36%
cases:3.13%
controls:0.57%
58
68
1383
14251
37
48
1404
14271
9
14
1432
14305
—
9
8
1210
14268
25
49
1102
13598
27
59
837
10347
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
1.5e+00
2.0e+00
3.0e+00
1.0e+50
2.2e+00
1.9e+00
1.7e+00
cases:9.51%
controls:2.33%
cases:7.63%
controls:1.14%
cases:4.37%
controls:0.23%
cases:0.42%
controls:0.00%
cases:1.80%
controls:0.20%
cases:6.57%
controls:1.07%
cases:15.86%
controls:3.33%
137
334
1304
13985
110
163
1331
14156
63
33
1378
14286
6
0
1435
14319
22
28
1197
14248
74
146
1053
13501
137
347
727
10059
Cardiology
6 [38004451]
9.0e-01
1.2e+00
1.4e+00
4.2e+00
1.8e+00
1.4e+00
1.3e+00
cases:24.84%
controls:11.80%
cases:16.86%
controls:5.62%
cases:3.75%
controls:0.92%
cases:2.85%
controls:0.04%
cases:4.59%
controls:0.83%
cases:18.46%
controls:5.47%
cases:33.68%
controls:12.05%
358
1690
1083
12629
243
805
1198
13514
54
132
1387
14187
41
6
1400
14313
56
118
1163
14158
208
746
919
12901
291
1254
573
9152
Gas panel - Central venous blood
97535-9 [1616796]
2.6e+00
3.0e+00
—
1.0e+50
—
3.3e+00
3.2e+00
cases:2.50%
controls:0.18%
cases:2.85%
controls:0.14%
—
—
cases:0.90%
controls:0.00%
—
—
cases:3.82%
controls:0.15%
cases:6.94%
controls:0.30%
36
26
1405
14293
41
20
1400
14299
—
13
0
1428
14319
—
43
20
1084
13627
60
31
804
10375
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
2.3e+00
3.1e+00
—
1.0e+50
2.3e+00
2.1e+00
2.4e+00
cases:2.78%
controls:0.28%
cases:3.40%
controls:0.16%
—
—
cases:0.97%
controls:0.00%
cases:0.49%
controls:0.05%
cases:2.93%
controls:0.38%
cases:7.87%
controls:0.77%
40
40
1401
14279
49
23
1392
14296
—
14
0
1427
14319
6
7
1213
14269
33
52
1094
13595
68
80
796
10326
enalapril; oral, parenteral
C09AA02 [21601786]
1.7e+00
1.6e+00
1.3e+00
2.6e+00
1.8e+00
1.6e+00
1.5e+00
cases:13.39%
controls:2.81%
cases:9.99%
controls:2.11%
cases:2.43%
controls:0.67%
cases:0.49%
controls:0.03%
cases:3.28%
controls:0.57%
cases:9.41%
controls:2.13%
cases:11.81%
controls:2.88%
193
402
1248
13917
144
302
1297
14017
35
96
1406
14223
7
5
1434
14314
40
82
1179
14194
106
290
1021
13357
102
300
762
10106
Atrial fibrillation and flutter
I48 [45596206]
8.6e-01
1.0e+00
1.7e+00
5.1e+00
1.5e+00
1.0e+00
8.4e-01
cases:18.46%
controls:8.73%
cases:11.73%
controls:4.67%
cases:4.16%
controls:0.78%
cases:5.27%
controls:0.03%
cases:3.94%
controls:0.88%
cases:12.07%
controls:4.60%
cases:19.56%
controls:9.50%
266
1250
1175
13069
169
668
1272
13651
60
112
1381
14207
76
5
1365
14314
48
125
1171
14151
136
628
991
13019
169
989
695
9417
Monoclonal gammopathy of undetermined significance (MGUS)
D47.2 [45566693]
2.0e+00
2.4e+00
2.6e+00
1.0e+50
—
2.5e+00
2.5e+00
cases:1.25%
controls:0.17%
cases:1.04%
controls:0.10%
cases:0.49%
controls:0.03%
cases:0.69%
controls:0.00%
—
—
cases:1.51%
controls:0.12%
cases:2.31%
controls:0.19%
18
24
1423
14295
15
14
1426
14305
7
5
1434
14314
10
0
1431
14319
—
17
17
1110
13630
20
20
844
10386
Emergency Room Visit
ER [9203]
7.7e-01
1.2e+00
2.2e+00
4.8e+00
1.3e+00
9.7e-01
8.9e-01
cases:50.52%
controls:32.12%
cases:29.63%
controls:11.19%
cases:11.17%
controls:1.43%
cases:6.32%
controls:0.06%
cases:5.58%
controls:1.66%
cases:25.02%
controls:11.25%
cases:51.62%
controls:30.48%
728
4599
713
9720
427
1603
1014
12716
161
205
1280
14114
91
8
1350
14311
68
237
1151
14039
282
1535
845
12112
446
3172
418
7234
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
9.3e-01
1.8e+00
3.7e+00
—
2.2e+00
1.9e+00
1.4e+00
cases:23.11%
controls:10.56%
cases:26.44%
controls:5.55%
cases:24.22%
controls:0.78%
—
—
cases:6.89%
controls:0.82%
cases:29.10%
controls:5.55%
cases:41.32%
controls:14.29%
333
1512
1108
12807
381
794
1060
13525
349
111
1092
14208
—
84
117
1135
14159
328
757
799
12890
357
1487
507
8919
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
9.5e-01
1.8e+00
3.7e+00
—
2.2e+00
1.9e+00
1.4e+00
cases:25.75%
controls:11.84%
cases:29.29%
controls:6.40%
cases:27.27%
controls:0.96%
—
—
cases:7.71%
controls:0.93%
cases:32.30%
controls:6.41%
cases:45.60%
controls:16.49%
371
1695
1070
12624
422
917
1019
13402
393
137
1048
14182
—
94
133
1125
14143
364
875
763
12772
394
1716
470
8690
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
6.6e-01
1.4e+00
2.9e+00
3.3e+00
1.5e+00
1.2e+00
1.0e+00
cases:30.26%
controls:18.36%
cases:28.59%
controls:8.88%
cases:20.61%
controls:1.40%
cases:1.46%
controls:0.06%
cases:4.92%
controls:1.16%
cases:25.82%
controls:9.17%
cases:43.75%
controls:22.26%
436
2629
1005
11690
412
1272
1029
13047
297
201
1144
14118
21
8
1420
14311
60
165
1159
14111
291
1251
836
12396
378
2316
486
8090
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
9.2e-01
1.6e+00
3.4e+00
—
2.7e+00
1.8e+00
1.5e+00
cases:4.09%
controls:1.67%
cases:4.23%
controls:0.85%
cases:3.26%
controls:0.11%
—
—
cases:1.31%
controls:0.09%
cases:4.70%
controls:0.80%
cases:8.91%
controls:2.21%
59
239
1382
14080
61
121
1380
14198
47
16
1394
14303
—
16
13
1203
14263
53
109
1074
13538
77
230
787
10176
enalapril and diuretics
C09BA02 [21601804]
2.5e+00
2.2e+00
1.2e+00
—
3.2e+00
1.9e+00
2.0e+00
cases:5.62%
controls:0.47%
cases:2.91%
controls:0.33%
cases:0.49%
controls:0.15%
—
—
cases:1.07%
controls:0.04%
cases:2.22%
controls:0.34%
cases:3.13%
controls:0.44%
81
67
1360
14252
42
47
1399
14272
7
21
1434
14298
—
13
6
1206
14270
25
46
1102
13601
27
46
837
10360
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.2e+00
2.1e+00
3.6e+00
—
—
2.6e+00
2.3e+00
cases:4.09%
controls:1.24%
cases:3.75%
controls:0.48%
cases:1.46%
controls:0.04%
—
—
—
—
cases:4.88%
controls:0.39%
cases:11.81%
controls:1.27%
59
177
1382
14142
54
69
1387
14250
21
6
1420
14313
—
—
55
53
1072
13594
102
132
762
10274
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
1.3e+00
1.9e+00
3.4e+00
—
2.3e+00
1.7e+00
1.3e+00
cases:4.44%
controls:1.31%
cases:4.02%
controls:0.65%
cases:3.54%
controls:0.13%
—
—
cases:1.07%
controls:0.11%
cases:5.15%
controls:1.01%
cases:8.33%
controls:2.54%
64
187
1377
14132
58
93
1383
14226
51
18
1390
14301
—
13
15
1206
14261
58
138
1069
13509
72
264
792
10142
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
1.2e+00
1.7e+00
3.3e+00
—
2.3e+00
1.8e+00
1.4e+00
cases:13.32%
controls:4.64%
cases:10.13%
controls:2.00%
cases:9.02%
controls:0.35%
—
—
cases:2.54%
controls:0.25%
cases:10.74%
controls:2.01%
cases:20.83%
controls:5.99%
192
664
1249
13655
146
286
1295
14033
130
50
1311
14269
—
31
36
1188
14240
121
274
1006
13373
180
623
684
9783
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
1.5e+00
2.1e+00
3.3e+00
1.0e+50
—
2.6e+00
2.2e+00
cases:2.78%
controls:0.63%
cases:2.43%
controls:0.30%
cases:1.67%
controls:0.06%
cases:0.56%
controls:0.00%
—
—
cases:3.46%
controls:0.27%
cases:7.29%
controls:0.87%
40
90
1401
14229
35
43
1406
14276
24
9
1417
14310
8
0
1433
14319
—
39
37
1088
13610
63
91
801
10315
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.1e+00
2.0e+00
2.8e+00
1.0e+50
3.0e+00
1.3e+00
1.4e+00
cases:7.08%
controls:2.56%
cases:5.62%
controls:0.80%
cases:2.22%
controls:0.13%
cases:0.42%
controls:0.00%
cases:0.98%
controls:0.05%
cases:3.46%
controls:0.94%
cases:11.57%
controls:3.01%
102
367
1339
13952
81
115
1360
14204
32
19
1409
14300
6
0
1435
14319
12
7
1207
14269
39
128
1088
13519
100
313
764
10093
losartan; oral
C09CA01 [21601824]
1.5e+00
1.5e+00
1.3e+00
3.5e+00
1.4e+00
1.3e+00
1.2e+00
cases:18.04%
controls:4.68%
cases:16.17%
controls:4.18%
cases:4.51%
controls:1.31%
cases:1.11%
controls:0.03%
cases:5.00%
controls:1.34%
cases:15.00%
controls:4.40%
cases:18.29%
controls:6.09%
260
670
1181
13649
233
599
1208
13720
65
187
1376
14132
16
5
1425
14314
61
192
1158
14084
169
601
958
13046
158
634
706
9772
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
1.0e+00
1.8e+00
3.6e+00
—
1.9e+00
1.8e+00
1.5e+00
cases:20.40%
controls:8.49%
cases:19.92%
controls:3.90%
cases:17.97%
controls:0.61%
—
—
cases:3.69%
controls:0.60%
cases:21.03%
controls:4.14%
cases:36.34%
controls:11.23%
294
1215
1147
13104
287
558
1154
13761
259
87
1182
14232
—
45
85
1174
14191
237
565
890
13082
314
1169
550
9237
Intravenous
ZX120 [2001311495]
1.5e+00
1.8e+00
1.7e+00
—
2.6e+00
2.0e+00
2.0e+00
cases:4.30%
controls:0.98%
cases:2.57%
controls:0.43%
cases:0.69%
controls:0.13%
—
—
cases:0.90%
controls:0.07%
cases:2.84%
controls:0.39%
cases:6.02%
controls:0.88%
62
141
1379
14178
37
61
1404
14258
10
18
1431
14301
—
11
10
1208
14266
32
53
1095
13594
52
92
812
10314
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
7.3e-01
1.3e+00
2.8e+00
3.5e+00
1.5e+00
1.1e+00
7.1e-01
cases:20.47%
controls:11.07%
cases:19.71%
controls:6.06%
cases:14.30%
controls:0.98%
cases:1.11%
controls:0.03%
cases:3.86%
controls:0.92%
cases:17.13%
controls:6.70%
cases:30.67%
controls:17.91%
295
1585
1146
12734
284
868
1157
13451
206
141
1235
14178
16
5
1425
14314
47
132
1172
14144
193
914
934
12733
265
1864
599
8542
Heart failure, unspecified
I50.9 [45576879]
1.7e+00
2.0e+00
2.5e+00
—
2.2e+00
1.8e+00
1.3e+00
cases:11.17%
controls:2.26%
cases:9.65%
controls:1.44%
cases:4.37%
controls:0.37%
—
—
cases:3.61%
controls:0.42%
cases:9.14%
controls:1.58%
cases:13.43%
controls:4.06%
161
323
1280
13996
139
206
1302
14113
63
53
1378
14266
—
44
60
1175
14216
103
216
1024
13431
116
423
748
9983
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
7.1e-01
1.3e+00
2.8e+00
3.4e+00
1.5e+00
1.1e+00
6.7e-01
cases:19.92%
controls:10.85%
cases:19.50%
controls:6.01%
cases:14.37%
controls:0.98%
cases:1.04%
controls:0.03%
cases:3.86%
controls:0.92%
cases:16.86%
controls:6.62%
cases:29.51%
controls:17.59%
287
1554
1154
12765
281
861
1160
13458
207
140
1234
14179
15
5
1426
14314
47
132
1172
14144
190
904
937
12743
255
1830
609
8576
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
7.0e-01
1.3e+00
2.8e+00
3.5e+00
1.5e+00
1.0e+00
6.5e-01
cases:20.54%
controls:11.35%
cases:19.64%
controls:6.10%
cases:14.23%
controls:0.98%
cases:1.11%
controls:0.03%
cases:3.86%
controls:0.92%
cases:16.95%
controls:6.73%
cases:29.51%
controls:17.97%
296
1625
1145
12694
283
874
1158
13445
205
141
1236
14178
16
5
1425
14314
47
132
1172
14144
191
919
936
12728
255
1870
609
8536
Vascular Surgery
77 [38004496]
1.6e+00
1.8e+00
2.2e+00
—
1.9e+00
2.2e+00
1.8e+00
cases:12.63%
controls:2.86%
cases:6.73%
controls:1.19%
cases:1.60%
controls:0.18%
—
—
cases:1.23%
controls:0.18%
cases:9.23%
controls:1.14%
cases:16.78%
controls:3.33%
182
410
1259
13909
97
171
1344
14148
23
26
1418
14293
—
15
26
1204
14250
104
155
1023
13492
145
347
719
10059
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
1.2e+00
2.0e+00
3.6e+00
—
—
2.4e+00
2.2e+00
cases:3.89%
controls:1.26%
cases:3.68%
controls:0.50%
cases:1.53%
controls:0.04%
—
—
—
—
cases:4.88%
controls:0.45%
cases:12.27%
controls:1.59%
56
180
1385
14139
53
71
1388
14248
22
6
1419
14313
—
—
55
61
1072
13586
106
165
758
10241
valsartan and diuretics
C09DA03 [21601836]
2.4e+00
2.3e+00
-1.0e+50
—
2.9e+00
2.1e+00
1.7e+00
cases:2.98%
controls:0.29%
cases:2.01%
controls:0.20%
cases:0.00%
controls:0.08%
—
—
cases:0.74%
controls:0.04%
cases:1.51%
controls:0.19%
cases:1.62%
controls:0.29%
43
41
1398
14278
29
29
1412
14290
0
12
1441
14307
—
9
6
1210
14270
17
26
1110
13621
14
30
850
10376
Acute renal failure, unspecified
N17.9 [45567829]
2.7e+00
4.0e+00
—
1.0e+50
—
2.9e+00
1.8e+00
cases:3.54%
controls:0.26%
cases:4.02%
controls:0.08%
—
—
cases:1.04%
controls:0.00%
—
—
cases:2.04%
controls:0.12%
cases:2.78%
controls:0.47%
51
37
1390
14282
58
11
1383
14308
—
15
0
1426
14319
—
23
16
1104
13631
24
49
840
10357
Cathetrisation of artery
TPH07 [2001309747]
1.1e+00
1.6e+00
2.9e+00
—
2.6e+00
1.6e+00
1.5e+00
cases:3.89%
controls:1.30%
cases:1.87%
controls:0.39%
cases:0.76%
controls:0.04%
—
—
cases:0.49%
controls:0.04%
cases:1.60%
controls:0.34%
cases:4.98%
controls:1.16%
56
186
1385
14133
27
56
1414
14263
11
6
1430
14313
—
6
5
1213
14271
18
46
1109
13601
43
121
821
10285
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.4e+00
1.9e+00
2.9e+00
—
2.0e+00
1.5e+00
1.5e+00
cases:9.30%
controls:2.35%
cases:7.15%
controls:1.09%
cases:3.05%
controls:0.17%
—
—
cases:1.31%
controls:0.18%
cases:5.15%
controls:1.24%
cases:13.43%
controls:3.40%
134
337
1307
13982
103
156
1338
14163
44
24
1397
14295
—
16
25
1203
14251
58
169
1069
13478
116
354
748
10052
Dietary counselling and surveillance
Z71.3 [45552101]
2.0e+00
3.0e+00
—
—
—
3.4e+00
2.8e+00
cases:1.94%
controls:0.26%
cases:1.25%
controls:0.06%
—
—
—
—
—
—
cases:1.77%
controls:0.06%
cases:3.01%
controls:0.18%
28
37
1413
14282
18
9
1423
14310
—
—
—
20
8
1107
13639
26
19
838
10387
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
1.2e+00
1.7e+00
3.1e+00
1.0e+50
2.6e+00
1.5e+00
1.2e+00
cases:5.83%
controls:1.82%
cases:4.93%
controls:0.97%
cases:2.29%
controls:0.10%
cases:0.62%
controls:0.00%
cases:1.31%
controls:0.10%
cases:4.17%
controls:0.98%
cases:10.53%
controls:3.48%
84
260
1357
14059
71
139
1370
14180
33
15
1408
14304
9
0
1432
14319
16
14
1203
14262
47
134
1080
13513
91
362
773
10044
Osmolality of Urine
2695-5 [3026782]
1.1e+00
1.8e+00
3.3e+00
—
1.8e+00
1.7e+00
1.6e+00
cases:13.74%
controls:4.90%
cases:9.44%
controls:1.75%
cases:7.84%
controls:0.33%
—
—
cases:1.48%
controls:0.26%
cases:8.96%
controls:1.71%
cases:20.37%
controls:4.90%
198
701
1243
13618
136
251
1305
14068
113
47
1328
14272
—
18
37
1201
14239
101
233
1026
13414
176
510
688
9896
Outpatient Visit
OP [9202]
6.2e-01
8.7e-01
9.2e-01
5.1e+00
1.3e+00
1.3e+00
1.1e+00
cases:83.55%
controls:73.19%
cases:74.18%
controls:54.64%
cases:23.11%
controls:10.69%
cases:43.03%
controls:0.47%
cases:29.29%
controls:10.25%
cases:81.01%
controls:53.43%
cases:91.44%
controls:77.55%
1204
10480
237
3839
1069
7824
372
6495
333
1530
1108
12789
620
68
821
14251
357
1463
862
12813
913
7292
214
6355
790
8070
74
2336
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
9.2e-01
1.3e+00
2.1e+00
3.3e+00
1.8e+00
1.0e+00
8.7e-01
cases:15.68%
controls:6.93%
cases:12.21%
controls:3.75%
cases:4.30%
controls:0.54%
cases:0.90%
controls:0.03%
cases:2.54%
controls:0.44%
cases:10.29%
controls:4.02%
cases:22.22%
controls:10.71%
226
992
1215
13327
176
537
1265
13782
62
78
1379
14241
13
5
1428
14314
31
63
1188
14213
116
549
1011
13098
192
1114
672
9292
Generalized and unspecified atherosclerosis
I70.9 [45538439]
3.1e+00
2.9e+00
1.0e+50
1.0e+50
1.0e+50
2.9e+00
2.3e+00
cases:1.32%
controls:0.06%
cases:0.76%
controls:0.04%
cases:0.42%
controls:0.00%
cases:1.25%
controls:0.00%
cases:0.41%
controls:0.00%
cases:1.24%
controls:0.07%
cases:2.31%
controls:0.24%
19
9
1422
14310
11
6
1430
14313
6
0
1435
14319
18
0
1423
14319
5
0
1214
14276
14
9
1113
13638
20
25
844
10381
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.4e+00
1.9e+00
3.0e+00
—
1.9e+00
1.4e+00
1.5e+00
cases:6.45%
controls:1.73%
cases:5.69%
controls:0.86%
cases:2.15%
controls:0.11%
—
—
cases:1.07%
controls:0.16%
cases:3.90%
controls:0.99%
cases:10.88%
controls:2.68%
93
248
1348
14071
82
123
1359
14196
31
16
1410
14303
—
13
23
1206
14253
44
135
1083
13512
94
279
770
10127
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
1.2e+00
1.8e+00
3.2e+00
—
1.9e+00
1.6e+00
1.3e+00
cases:20.82%
controls:7.62%
cases:20.75%
controls:4.25%
cases:11.24%
controls:0.52%
—
—
cases:3.12%
controls:0.49%
cases:19.70%
controls:4.57%
cases:33.68%
controls:12.04%
300
1091
1141
13228
299
609
1142
13710
162
74
1279
14245
—
38
70
1181
14206
222
623
905
13024
291
1253
573
9153
General Practice
1 [38004446]
6.1e-01
9.7e-01
2.0e+00
4.8e+00
1.3e+00
5.9e-01
5.4e-01
cases:27.69%
controls:17.17%
cases:18.18%
controls:7.74%
cases:8.95%
controls:1.25%
cases:6.66%
controls:0.06%
cases:5.09%
controls:1.45%
cases:14.82%
controls:8.77%
cases:31.37%
controls:21.04%
399
2458
1042
11861
262
1109
1179
13210
129
179
1312
14140
96
8
1345
14311
62
207
1157
14069
167
1197
960
12450
271
2189
593
8217
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
1.1e+00
1.8e+00
3.3e+00
—
1.8e+00
1.6e+00
1.3e+00
cases:18.18%
controls:7.10%
cases:18.11%
controls:3.67%
cases:14.99%
controls:0.62%
—
—
cases:3.12%
controls:0.53%
cases:16.86%
controls:3.93%
cases:29.51%
controls:10.20%
262
1017
1179
13302
261
525
1180
13794
216
89
1225
14230
—
38
75
1181
14201
190
536
937
13111
255
1061
609
9345
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.8e+00
2.5e+00
—
—
—
3.1e+00
3.5e+00
cases:0.69%
controls:0.12%
cases:0.76%
controls:0.06%
—
—
—
—
—
—
cases:1.24%
controls:0.06%
cases:3.01%
controls:0.10%
10
17
1431
14302
11
9
1430
14310
—
—
—
14
8
1113
13639
26
10
838
10396
Microorganisms panel - Urine sediment
58435-9 [40761536]
7.4e-01
1.3e+00
3.6e+00
—
2.2e+00
1.7e+00
1.3e+00
cases:4.16%
controls:2.04%
cases:3.19%
controls:0.89%
cases:3.68%
controls:0.10%
—
—
cases:0.82%
controls:0.09%
cases:3.73%
controls:0.72%
cases:6.83%
controls:1.98%
60
292
1381
14027
46
127
1395
14192
53
15
1388
14304
—
10
13
1209
14263
42
98
1085
13549
59
206
805
10200
Bacteria [Presence] in Urine
87829-8 [36304419]
1.0e+00
1.7e+00
3.3e+00
1.0e+50
1.8e+00
1.6e+00
1.3e+00
cases:14.71%
controls:5.91%
cases:14.57%
controls:2.93%
cases:11.52%
controls:0.46%
cases:0.49%
controls:0.00%
cases:2.30%
controls:0.37%
cases:12.51%
controls:2.84%
cases:23.73%
controls:8.02%
212
846
1229
13473
210
419
1231
13900
166
66
1275
14253
7
0
1434
14319
28
53
1191
14223
141
387
986
13260
205
835
659
9571
Kidney ultrasound examination
KA1AE [2001305627]
2.8e+00
2.8e+00
—
1.0e+50
—
3.0e+00
2.2e+00
cases:1.80%
controls:0.11%
cases:1.11%
controls:0.07%
—
—
cases:0.97%
controls:0.00%
—
—
cases:0.71%
controls:0.04%
cases:1.74%
controls:0.19%
26
16
1415
14303
16
10
1425
14309
—
14
0
1427
14319
—
8
5
1119
13642
15
20
849
10386
Metabolic syndrome
E66.00 [2000501500]
2.8e+00
2.6e+00
2.0e+00
1.0e+50
—
2.8e+00
2.5e+00
cases:2.50%
controls:0.16%
cases:1.25%
controls:0.09%
cases:0.35%
controls:0.05%
cases:1.11%
controls:0.00%
—
—
cases:2.04%
controls:0.12%
cases:2.78%
controls:0.24%
36
23
1405
14296
18
13
1423
14306
5
7
1436
14312
16
0
1425
14319
—
23
17
1104
13630
24
25
840
10381
Abdominal ultrasound examination
JN3AE [2001305555]
1.4e+00
2.4e+00
2.3e+00
1.0e+50
—
2.2e+00
2.3e+00
cases:5.62%
controls:1.47%
cases:4.02%
controls:0.37%
cases:0.56%
controls:0.06%
cases:0.62%
controls:0.00%
—
—
cases:3.02%
controls:0.34%
cases:11.11%
controls:1.24%
81
210
1360
14109
58
53
1383
14266
8
8
1433
14311
9
0
1432
14319
—
34
47
1093
13600
96
129
768
10277
Leukocytes [#/volume] in Urine
30405-5 [3018095]
1.0e+00
1.7e+00
3.2e+00
—
1.8e+00
1.6e+00
1.3e+00
cases:18.95%
controls:7.79%
cases:19.08%
controls:4.25%
cases:15.61%
controls:0.75%
—
—
cases:3.53%
controls:0.58%
cases:19.17%
controls:4.59%
cases:31.71%
controls:11.45%
273
1116
1168
13203
275
609
1166
13710
225
107
1216
14212
—
43
83
1176
14193
216
627
911
13020
274
1191
590
9215
hydrochlorothiazide; oral
C03AA03 [21601466]
1.8e+00
2.0e+00
1.6e+00
—
1.8e+00
1.7e+00
1.7e+00
cases:7.43%
controls:1.35%
cases:6.25%
controls:0.90%
cases:1.04%
controls:0.20%
—
—
cases:1.64%
controls:0.27%
cases:5.06%
controls:0.95%
cases:7.41%
controls:1.49%
107
194
1334
14125
90
129
1351
14190
15
29
1426
14290
—
20
39
1199
14237
57
129
1070
13518
64
155
800
10251
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
1.6e+00
2.5e+00
—
—
—
3.0e+00
3.4e+00
cases:0.90%
controls:0.18%
cases:0.97%
controls:0.08%
—
—
—
—
—
—
cases:1.77%
controls:0.09%
cases:5.44%
controls:0.19%
13
26
1428
14293
14
11
1427
14308
—
—
—
20
12
1107
13635
47
20
817
10386
Bacteria identified in Isolate by Culture
43409-2 [3042936]
9.9e-01
1.8e+00
2.9e+00
1.0e+50
2.2e+00
1.2e+00
1.4e+00
cases:5.69%
controls:2.20%
cases:3.96%
controls:0.71%
cases:1.25%
controls:0.07%
cases:0.35%
controls:0.00%
cases:0.98%
controls:0.11%
cases:2.84%
controls:0.84%
cases:11.23%
controls:2.91%
82
315
1359
14004
57
101
1384
14218
18
10
1423
14309
5
0
1436
14319
12
15
1207
14261
32
115
1095
13532
97
303
767
10103
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.6e-01
1.1e+00
2.3e+00
3.7e+00
1.1e+00
9.6e-01
9.1e-01
cases:30.19%
controls:21.45%
cases:28.94%
controls:12.26%
cases:19.71%
controls:2.39%
cases:2.22%
controls:0.06%
cases:6.48%
controls:2.19%
cases:27.24%
controls:12.49%
cases:48.03%
controls:27.05%
435
3072
1006
11247
417
1756
1024
12563
284
342
1157
13977
32
8
1409
14311
79
313
1140
13963
307
1705
820
11942
415
2815
449
7591
Left ventricular failure
I50.1 [45543181]
1.5e+00
1.5e+00
2.2e+00
—
2.4e+00
1.5e+00
1.5e+00
cases:2.36%
controls:0.55%
cases:1.73%
controls:0.39%
cases:1.04%
controls:0.11%
—
—
cases:0.82%
controls:0.08%
cases:1.86%
controls:0.44%
cases:4.05%
controls:0.96%
34
79
1407
14240
25
56
1416
14263
15
16
1426
14303
—
10
11
1209
14265
21
60
1106
13587
35
100
829
10306
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
2.0e+00
2.4e+00
—
1.0e+50
1.0e+50
3.7e+00
2.5e+00
cases:2.36%
controls:0.34%
cases:1.67%
controls:0.15%
—
—
cases:0.42%
controls:0.00%
cases:0.41%
controls:0.00%
cases:2.22%
controls:0.06%
cases:3.59%
controls:0.31%
34
48
1407
14271
24
22
1417
14297
—
6
0
1435
14319
5
0
1214
14276
25
8
1102
13639
31
32
833
10374
Base excess in Blood by calculation
11555-0 [3012501]
2.0e+00
2.4e+00
—
1.0e+50
1.0e+50
3.7e+00
2.5e+00
cases:2.36%
controls:0.34%
cases:1.67%
controls:0.15%
—
—
cases:0.42%
controls:0.00%
cases:0.41%
controls:0.00%
cases:2.22%
controls:0.06%
cases:3.59%
controls:0.31%
34
48
1407
14271
24
22
1417
14297
—
6
0
1435
14319
5
0
1214
14276
25
8
1102
13639
31
32
833
10374
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
2.0e+00
2.4e+00
—
1.0e+50
1.0e+50
3.7e+00
2.5e+00
cases:2.36%
controls:0.34%
cases:1.67%
controls:0.15%
—
—
cases:0.42%
controls:0.00%
cases:0.41%
controls:0.00%
cases:2.22%
controls:0.06%
cases:3.59%
controls:0.31%
34
48
1407
14271
24
22
1417
14297
—
6
0
1435
14319
5
0
1214
14276
25
8
1102
13639
31
32
833
10374
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.5e+00
1.8e+00
3.3e+00
—
2.6e+00
1.1e+00
1.3e+00
cases:1.87%
controls:0.43%
cases:1.11%
controls:0.18%
cases:0.90%
controls:0.03%
—
—
cases:0.49%
controls:0.04%
cases:0.80%
controls:0.28%
cases:3.24%
controls:0.92%
27
62
1414
14257
16
26
1425
14293
13
5
1428
14314
—
6
5
1213
14271
9
38
1118
13609
28
96
836
10310
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
4.2e-01
1.0e+00
2.5e+00
3.5e+00
1.4e+00
9.6e-01
6.3e-01
cases:40.04%
controls:30.56%
cases:39.00%
controls:19.07%
cases:32.55%
controls:3.92%
cases:8.12%
controls:0.26%
cases:13.37%
controls:3.50%
cases:38.24%
controls:19.21%
cases:56.25%
controls:40.61%
577
4376
864
9943
562
2731
879
11588
469
561
972
13758
117
37
1324
14282
163
499
1056
13777
431
2621
696
11026
486
4226
378
6180
Other malignant neoplasm of kidney, except renal pelvis
C64.88 [2000501096]
1.8e+00
1.7e+00
—
—
2.3e+00
2.3e+00
2.2e+00
cases:1.25%
controls:0.21%
cases:1.18%
controls:0.21%
—
—
—
—
cases:0.66%
controls:0.06%
cases:1.51%
controls:0.15%
cases:1.97%
controls:0.21%
18
30
1423
14289
17
30
1424
14289
—
—
8
9
1211
14267
17
21
1110
13626
17
22
847
10384
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
9.5e-01
1.7e+00
3.3e+00
—
1.6e+00
1.5e+00
1.3e+00
cases:14.71%
controls:6.24%
cases:14.50%
controls:3.13%
cases:12.07%
controls:0.50%
—
—
cases:2.21%
controls:0.43%
cases:12.95%
controls:3.16%
cases:25.58%
controls:8.69%
212
893
1229
13426
209
448
1232
13871
174
71
1267
14248
—
27
62
1192
14214
146
431
981
13216
221
904
643
9502
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
1.5e+00
2.4e+00
—
—
3.2e+00
1.9e+00
1.4e+00
cases:3.33%
controls:0.78%
cases:3.12%
controls:0.29%
—
—
—
—
cases:1.15%
controls:0.05%
cases:2.93%
controls:0.47%
cases:6.13%
controls:1.59%
48
112
1393
14207
45
41
1396
14278
—
—
14
7
1205
14269
33
64
1094
13583
53
165
811
10241
Oxygen saturation in Capillary blood
2709-4 [3021901]
2.3e+00
3.1e+00
—
1.0e+50
—
2.4e+00
2.5e+00
cases:1.94%
controls:0.20%
cases:2.36%
controls:0.11%
—
—
cases:0.97%
controls:0.00%
—
—
cases:2.31%
controls:0.21%
cases:5.67%
controls:0.47%
28
29
1413
14290
34
16
1407
14303
—
14
0
1427
14319
—
26
29
1101
13618
49
49
815
10357
potassium chloride; oral
A12BA01 [21600877]
1.7e+00
1.9e+00
1.7e+00
—
1.6e+00
1.8e+00
1.6e+00
cases:7.84%
controls:1.50%
cases:5.14%
controls:0.81%
cases:1.73%
controls:0.32%
—
—
cases:1.31%
controls:0.27%
cases:5.68%
controls:0.97%
cases:10.19%
controls:2.25%
113
215
1328
14104
74
116
1367
14203
25
46
1416
14273
—
16
39
1203
14237
64
133
1063
13514
88
234
776
10172
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
9.4e-01
1.3e+00
2.4e+00
—
2.5e+00
1.4e+00
1.6e+00
cases:5.62%
controls:2.27%
cases:3.96%
controls:1.07%
cases:1.67%
controls:0.15%
—
—
cases:1.15%
controls:0.09%
cases:4.08%
controls:1.00%
cases:10.42%
controls:2.27%
81
325
1360
13994
57
153
1384
14166
24
22
1417
14297
—
14
13
1205
14263
46
136
1081
13511
90
236
774
10170
Nutritional therapy
R4190 [2001310243]
1.5e+00
2.9e+00
—
—
—
2.9e+00
2.9e+00
cases:0.97%
controls:0.21%
cases:1.11%
controls:0.06%
—
—
—
—
—
—
cases:1.06%
controls:0.06%
cases:3.01%
controls:0.16%
14
30
1427
14289
16
9
1425
14310
—
—
—
12
8
1115
13639
26
17
838
10389
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
9.8e-01
1.7e+00
3.1e+00
1.0e+50
1.9e+00
9.7e-01
1.5e+00
cases:5.48%
controls:2.13%
cases:3.47%
controls:0.66%
cases:1.60%
controls:0.07%
cases:0.69%
controls:0.00%
cases:0.57%
controls:0.08%
cases:1.69%
controls:0.64%
cases:9.49%
controls:2.37%
79
305
1362
14014
50
94
1391
14225
23
10
1418
14309
10
0
1431
14319
7
12
1212
14264
19
88
1108
13559
82
247
782
10159
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
1.7e+00
1.9e+00
2.5e+00
—
—
2.2e+00
1.9e+00
cases:3.89%
controls:0.74%
cases:1.87%
controls:0.29%
cases:0.42%
controls:0.03%
—
—
—
—
cases:1.77%
controls:0.20%
cases:4.86%
controls:0.76%
56
106
1385
14213
27
41
1414
14278
6
5
1435
14314
—
—
20
27
1107
13620
42
79
822
10327
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
1.8e+00
2.4e+00
—
—
—
2.8e+00
3.1e+00
cases:1.25%
controls:0.20%
cases:0.97%
controls:0.09%
—
—
—
—
—
—
cases:1.86%
controls:0.11%
cases:5.44%
controls:0.27%
18
29
1423
14290
14
13
1427
14306
—
—
—
21
15
1106
13632
47
28
817
10378
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
1.8e+00
2.7e+00
—
1.0e+50
—
2.8e+00
2.7e+00
cases:1.32%
controls:0.22%
cases:2.01%
controls:0.14%
—
—
cases:0.62%
controls:0.00%
—
—
cases:1.86%
controls:0.11%
cases:5.44%
controls:0.38%
19
32
1422
14287
29
20
1412
14299
—
9
0
1432
14319
—
21
15
1106
13632
47
40
817
10366
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
4.6e-01
1.1e+00
2.2e+00
3.5e+00
1.3e+00
7.9e-01
6.3e-01
cases:26.30%
controls:18.41%
cases:22.83%
controls:8.90%
cases:11.94%
controls:1.52%
cases:1.87%
controls:0.06%
cases:4.84%
controls:1.32%
cases:18.19%
controls:9.20%
cases:35.76%
controls:22.89%
379
2636
1062
11683
329
1274
1112
13045
172
218
1269
14101
27
8
1414
14311
59
188
1160
14088
205
1256
922
12391
309
2382
555
8024
metoprolol; oral, parenteral
C07AB02 [21601684]
1.1e+00
1.2e+00
1.1e+00
2.9e+00
1.1e+00
1.2e+00
1.3e+00
cases:14.99%
controls:5.35%
cases:12.91%
controls:4.30%
cases:4.16%
controls:1.38%
cases:0.62%
controls:0.03%
cases:4.10%
controls:1.37%
cases:13.31%
controls:4.29%
cases:16.09%
controls:4.96%
216
766
1225
13553
186
616
1255
13703
60
197
1381
14122
9
5
1432
14314
50
195
1169
14081
150
586
977
13061
139
516
725
9890
Reagin Ab [Titer] in Serum by VDRL
50690-7 [3029634]
1.4e+00
2.3e+00
—
—
—
2.8e+00
3.5e+00
cases:0.83%
controls:0.21%
cases:0.69%
controls:0.07%
—
—
—
—
—
—
cases:0.80%
controls:0.05%
cases:4.17%
controls:0.12%
12
30
1429
14289
10
10
1431
14309
—
—
—
9
7
1118
13640
36
13
828
10393
INR in Blood by Coagulation assay
34714-6 [3032080]
7.8e-01
1.2e+00
1.6e+00
3.2e+00
1.3e+00
9.7e-01
1.1e+00
cases:23.66%
controls:12.45%
cases:18.95%
controls:6.80%
cases:10.96%
controls:2.45%
cases:3.05%
controls:0.13%
cases:8.37%
controls:2.51%
cases:16.68%
controls:7.06%
cases:34.03%
controls:15.27%
341
1782
1100
12537
273
973
1168
13346
158
351
1283
13968
44
19
1397
14300
102
359
1117
13917
188
964
939
12683
294
1589
570
8817
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
1.5e+00
2.3e+00
—
—
—
2.8e+00
3.2e+00
cases:0.90%
controls:0.20%
cases:0.90%
controls:0.09%
—
—
—
—
—
—
cases:1.77%
controls:0.11%
cases:5.44%
controls:0.23%
13
29
1428
14290
13
13
1428
14306
—
—
—
20
15
1107
13632
47
24
817
10382
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
8.4e-01
1.9e+00
3.9e+00
—
—
1.5e+00
1.6e+00
cases:3.61%
controls:1.59%
cases:3.26%
controls:0.48%
cases:2.08%
controls:0.04%
—
—
—
—
cases:2.48%
controls:0.54%
cases:8.22%
controls:1.86%
52
227
1389
14092
47
69
1394
14250
30
6
1411
14313
—
—
28
74
1099
13573
71
194
793
10212
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
2.1e+00
3.1e+00
—
—
—
2.4e+00
2.3e+00
cases:6.66%
controls:0.89%
cases:5.41%
controls:0.27%
—
—
—
—
—
—
cases:3.99%
controls:0.37%
cases:10.76%
controls:1.25%
96
128
1345
14191
78
38
1363
14281
—
—
—
45
51
1082
13596
93
130
771
10276
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
1.4e+00
2.5e+00
—
—
—
2.5e+00
3.3e+00
cases:0.83%
controls:0.20%
cases:0.69%
controls:0.06%
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:4.40%
controls:0.16%
12
29
1429
14290
10
8
1431
14311
—
—
—
10
10
1117
13637
38
17
826
10389
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
8.3e-01
1.6e+00
3.3e+00
—
2.2e+00
1.0e+00
9.4e-01
cases:3.68%
controls:1.63%
cases:4.30%
controls:0.94%
cases:2.15%
controls:0.08%
—
—
cases:0.98%
controls:0.11%
cases:2.84%
controls:1.06%
cases:8.10%
controls:3.33%
53
234
1388
14085
62
134
1379
14185
31
12
1410
14307
—
12
16
1207
14260
32
145
1095
13502
70
346
794
10060
Chronic kidney disease, stage 3
N18.3 [45543858]
—
3.0e+00
—
1.0e+50
—
3.5e+00
3.2e+00
—
—
cases:0.69%
controls:0.03%
—
—
cases:1.39%
controls:0.00%
—
—
cases:2.66%
controls:0.08%
cases:4.40%
controls:0.18%
—
10
5
1431
14314
—
20
0
1421
14319
—
30
11
1097
13636
38
19
826
10387
Acute tubulo-interstitial nephritis
N10 [45543856]
9.2e-01
1.4e+00
2.8e+00
—
2.6e+00
8.8e-01
1.1e+00
cases:4.86%
controls:1.99%
cases:2.85%
controls:0.71%
cases:1.39%
controls:0.08%
—
—
cases:0.74%
controls:0.06%
cases:1.86%
controls:0.78%
cases:7.41%
controls:2.58%
70
285
1371
14034
41
102
1400
14217
20
12
1421
14307
—
9
8
1210
14268
21
107
1106
13540
64
268
800
10138
indapamide; oral
C03BA11 [21601499]
2.5e+00
2.2e+00
—
—
—
2.4e+00
2.6e+00
cases:1.04%
controls:0.08%
cases:0.62%
controls:0.07%
—
—
—
—
—
—
cases:0.62%
controls:0.06%
cases:1.04%
controls:0.08%
15
12
1426
14307
9
10
1432
14309
—
—
—
7
8
1120
13639
9
8
855
10398
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.8e+00
2.8e+00
—
1.0e+50
—
2.1e+00
3.0e+00
cases:2.71%
controls:0.45%
cases:1.67%
controls:0.10%
—
—
cases:0.56%
controls:0.00%
—
—
cases:1.15%
controls:0.14%
cases:6.60%
controls:0.37%
39
64
1402
14255
24
15
1417
14304
—
8
0
1433
14319
—
13
19
1114
13628
57
38
807
10368
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.2e+00
1.9e+00
2.3e+00
—
1.2e+00
1.3e+00
1.7e+00
cases:8.05%
controls:2.47%
cases:7.98%
controls:1.30%
cases:2.91%
controls:0.30%
—
—
cases:1.07%
controls:0.32%
cases:5.41%
controls:1.54%
cases:15.05%
controls:3.06%
116
354
1325
13965
115
186
1326
14133
42
43
1399
14276
—
13
45
1206
14231
61
210
1066
13437
130
318
734
10088
Other extensive ultrasound examination of artery
PG1DE [2001309713]
2.0e+00
2.2e+00
—
—
—
3.0e+00
2.4e+00
cases:2.98%
controls:0.43%
cases:1.94%
controls:0.21%
—
—
—
—
—
—
cases:2.22%
controls:0.11%
cases:5.09%
controls:0.47%
43
61
1398
14258
28
30
1413
14289
—
—
—
25
15
1102
13632
44
49
820
10357
insulin (beef); parenteral
A10AD02 [21600730]
1.6e+00
1.6e+00
1.7e+00
—
1.4e+00
1.7e+00
1.7e+00
cases:7.49%
controls:1.67%
cases:7.98%
controls:1.75%
cases:2.01%
controls:0.36%
—
—
cases:1.56%
controls:0.40%
cases:9.14%
controls:1.78%
cases:11.23%
controls:2.24%
108
239
1333
14080
115
251
1326
14068
29
52
1412
14267
—
19
57
1200
14219
103
243
1024
13404
97
233
767
10173
insulin glargine; parenteral
A10AE04 [21600739]
1.6e+00
1.6e+00
1.7e+00
—
1.4e+00
1.7e+00
1.7e+00
cases:7.49%
controls:1.67%
cases:7.98%
controls:1.75%
cases:2.01%
controls:0.36%
—
—
cases:1.56%
controls:0.40%
cases:9.14%
controls:1.78%
cases:11.23%
controls:2.24%
108
239
1333
14080
115
251
1326
14068
29
52
1412
14267
—
19
57
1200
14219
103
243
1024
13404
97
233
767
10173
Standard cardiac ultrasound examination
FM1AE [2001303278]
8.8e-01
1.6e+00
2.0e+00
—
2.0e+00
1.7e+00
1.6e+00
cases:6.94%
controls:3.00%
cases:4.44%
controls:0.97%
cases:0.69%
controls:0.10%
—
—
cases:0.74%
controls:0.11%
cases:5.59%
controls:1.08%
cases:12.50%
controls:2.77%
100
430
1341
13889
64
139
1377
14180
10
14
1431
14305
—
9
15
1210
14261
63
147
1064
13500
108
288
756
10118
Lower extremity artery ultrasound examination with Doppler method
PD4DE [2001309218]
2.4e+00
2.4e+00
—
—
—
2.7e+00
2.2e+00
cases:1.25%
controls:0.11%
cases:0.69%
controls:0.06%
—
—
—
—
—
—
cases:0.62%
controls:0.04%
cases:1.50%
controls:0.17%
18
16
1423
14303
10
9
1431
14310
—
—
—
7
6
1120
13641
13
18
851
10388
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
1.8e+00
2.3e+00
2.5e+00
—
—
1.5e+00
1.5e+00
cases:1.80%
controls:0.31%
cases:1.53%
controls:0.15%
cases:0.49%
controls:0.04%
—
—
—
—
cases:0.98%
controls:0.21%
cases:2.43%
controls:0.53%
26
45
1415
14274
22
22
1419
14297
7
6
1434
14313
—
—
11
29
1116
13618
21
55
843
10351
Urgent procedure
ZXD05 [2001311386]
6.5e-01
1.3e+00
2.5e+00
1.0e+50
2.3e+00
1.5e+00
1.4e+00
cases:7.15%
controls:3.86%
cases:3.33%
controls:0.97%
cases:1.11%
controls:0.09%
cases:0.49%
controls:0.00%
cases:0.74%
controls:0.08%
cases:3.73%
controls:0.84%
cases:12.27%
controls:3.40%
103
553
1338
13766
48
139
1393
14180
16
13
1425
14306
7
0
1434
14319
9
11
1210
14265
42
115
1085
13532
106
354
758
10052
spironolactone; oral
C03DA01 [21601534]
1.8e+00
1.7e+00
1.4e+00
—
1.4e+00
1.7e+00
1.5e+00
cases:7.43%
controls:1.35%
cases:6.59%
controls:1.23%
cases:1.80%
controls:0.45%
—
—
cases:1.89%
controls:0.46%
cases:7.10%
controls:1.40%
cases:9.03%
controls:2.12%
107
193
1334
14126
95
176
1346
14143
26
64
1415
14255
—
23
66
1196
14210
80
191
1047
13456
78
221
786
10185
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
1.1e+00
1.6e+00
1.9e+00
—
1.9e+00
1.5e+00
1.6e+00
cases:9.92%
controls:3.67%
cases:6.59%
controls:1.45%
cases:0.97%
controls:0.15%
—
—
cases:0.90%
controls:0.13%
cases:6.03%
controls:1.44%
cases:16.32%
controls:3.89%
143
526
1298
13793
95
208
1346
14111
14
21
1427
14298
—
11
19
1208
14257
68
197
1059
13450
141
405
723
10001
insulin aspart; parenteral
A10AD05 [21600733]
1.6e+00
1.5e+00
1.7e+00
—
1.8e+00
1.4e+00
1.5e+00
cases:6.59%
controls:1.38%
cases:5.69%
controls:1.36%
cases:1.60%
controls:0.30%
—
—
cases:1.48%
controls:0.25%
cases:5.50%
controls:1.37%
cases:7.64%
controls:1.85%
95
198
1346
14121
82
195
1359
14124
23
43
1418
14276
—
18
35
1201
14241
62
187
1065
13460
66
193
798
10213
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
6.1e-01
1.1e+00
1.7e+00
3.6e+00
9.9e-01
7.3e-01
8.2e-01
cases:18.95%
controls:11.31%
cases:14.78%
controls:5.53%
cases:6.25%
controls:1.22%
cases:1.46%
controls:0.04%
cases:3.20%
controls:1.22%
cases:11.98%
controls:6.16%
cases:28.47%
controls:14.90%
273
1619
1168
12700
213
792
1228
13527
90
174
1351
14145
21
6
1420
14313
39
174
1180
14102
135
841
992
12806
246
1551
618
8855
Protein electrophoresis panel - 24 hour Urine
81231-3 [21494890]
2.3e+00
2.7e+00
—
—
—
2.6e+00
1.8e+00
cases:2.15%
controls:0.22%
cases:1.39%
controls:0.09%
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:1.62%
controls:0.27%
31
32
1410
14287
20
13
1421
14306
—
—
—
10
9
1117
13638
14
28
850
10378
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.9e-01
7.5e-01
2.4e+00
3.5e+00
1.5e+00
5.8e-01
3.4e-01
cases:44.48%
controls:37.47%
cases:47.26%
controls:29.67%
cases:40.32%
controls:5.74%
cases:9.30%
controls:0.30%
cases:20.02%
controls:5.16%
cases:44.37%
controls:30.87%
cases:59.61%
controls:51.17%
641
5366
800
8953
681
4249
760
10070
581
822
860
13497
134
43
1307
14276
244
737
975
13539
500
4213
627
9434
515
5325
349
5081
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.9e-01
7.6e-01
2.4e+00
3.6e+00
1.4e+00
5.9e-01
3.5e-01
cases:44.34%
controls:37.24%
cases:47.05%
controls:29.37%
cases:39.97%
controls:5.59%
cases:9.30%
controls:0.29%
cases:18.54%
controls:5.10%
cases:44.19%
controls:30.56%
cases:59.61%
controls:50.96%
639
5332
802
8987
678
4205
763
10114
576
800
865
13519
134
42
1307
14277
226
728
993
13548
498
4170
629
9477
515
5303
349
5103
febuxostat; oral
M04AA03 [21604133]
3.2e+00
—
—
—
—
2.9e+00
3.3e+00
cases:1.04%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.06%
cases:1.97%
controls:0.08%
15
6
1426
14313
—
—
—
—
12
8
1115
13639
17
8
847
10398
insulin aspart; parenteral
A10AB05 [21600719]
1.6e+00
1.5e+00
1.7e+00
—
1.8e+00
1.4e+00
1.5e+00
cases:6.38%
controls:1.37%
cases:5.48%
controls:1.34%
cases:1.53%
controls:0.29%
—
—
cases:1.39%
controls:0.24%
cases:5.32%
controls:1.35%
cases:7.41%
controls:1.82%
92
196
1349
14123
79
192
1362
14127
22
41
1419
14278
—
17
34
1202
14242
60
184
1067
13463
64
189
800
10217
Idiopathic gout
M10.0 [45577131]
2.5e+00
2.6e+00
—
1.0e+50
—
2.3e+00
2.0e+00
cases:2.22%
controls:0.19%
cases:1.04%
controls:0.08%
—
—
cases:0.76%
controls:0.00%
—
—
cases:0.98%
controls:0.10%
cases:2.89%
controls:0.39%
32
27
1409
14292
15
11
1426
14308
—
11
0
1430
14319
—
11
14
1116
13633
25
41
839
10365
lisinopril; oral
C09AA03 [21601787]
1.9e+00
1.6e+00
—
—
2.3e+00
1.6e+00
1.9e+00
cases:2.15%
controls:0.33%
cases:1.32%
controls:0.26%
—
—
—
—
cases:0.41%
controls:0.04%
cases:1.33%
controls:0.26%
cases:2.08%
controls:0.31%
31
47
1410
14272
19
37
1422
14282
—
—
5
6
1214
14270
15
36
1112
13611
18
32
846
10374
Emergency Medicine
93 [38004510]
4.4e-01
9.9e-01
2.1e+00
3.9e+00
9.8e-01
5.2e-01
4.1e-01
cases:21.30%
controls:14.83%
cases:18.81%
controls:7.91%
cases:8.67%
controls:1.18%
cases:3.40%
controls:0.07%
cases:3.04%
controls:1.16%
cases:13.84%
controls:8.68%
cases:30.21%
controls:22.34%
307
2123
1134
12196
271
1133
1170
13186
125
169
1316
14150
49
10
1392
14309
37
166
1182
14110
156
1185
971
12462
261
2325
603
8081
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
8.3e-01
1.6e+00
3.0e+00
—
2.1e+00
9.9e-01
8.2e-01
cases:3.54%
controls:1.57%
cases:4.58%
controls:1.01%
cases:2.22%
controls:0.11%
—
—
cases:0.98%
controls:0.12%
cases:3.19%
controls:1.22%
cases:7.99%
controls:3.67%
51
225
1390
14094
66
144
1375
14175
32
16
1409
14303
—
12
17
1207
14259
36
166
1091
13481
69
382
795
10024
Oxygen saturation in Venous blood
2711-0 [3024928]
1.8e+00
2.5e+00
—
—
—
2.5e+00
2.5e+00
cases:1.04%
controls:0.18%
cases:1.46%
controls:0.12%
—
—
—
—
—
—
cases:1.15%
controls:0.10%
cases:5.79%
controls:0.49%
15
26
1426
14293
21
17
1420
14302
—
—
—
13
13
1114
13634
50
51
814
10355
ezetimibe; oral
C10AX09 [21601896]
1.1e+00
1.0e+00
9.1e-01
2.3e+00
1.4e+00
1.3e+00
1.2e+00
cases:5.69%
controls:2.04%
cases:5.48%
controls:2.07%
cases:1.53%
controls:0.62%
cases:0.42%
controls:0.04%
cases:2.54%
controls:0.61%
cases:8.70%
controls:2.48%
cases:11.46%
controls:3.69%
82
292
1359
14027
79
297
1362
14022
22
89
1419
14230
6
6
1435
14313
31
87
1188
14189
98
339
1029
13308
99
384
765
10022
Office Visit
OMOP4822458 [581477]
8.7e-01
1.3e+00
1.9e+00
—
2.2e+00
1.5e+00
1.4e+00
cases:15.41%
controls:7.07%
cases:7.49%
controls:2.06%
cases:1.67%
controls:0.24%
—
—
cases:2.05%
controls:0.22%
cases:7.90%
controls:1.89%
cases:20.37%
controls:6.03%
222
1013
1219
13306
108
295
1333
14024
24
35
1417
14284
—
25
32
1194
14244
89
258
1038
13389
176
627
688
9779
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
2.6e+00
2.6e+00
—
—
—
2.3e+00
1.7e+00
cases:1.46%
controls:0.10%
cases:1.32%
controls:0.10%
—
—
—
—
—
—
cases:0.98%
controls:0.10%
cases:1.16%
controls:0.22%
21
15
1420
14304
19
14
1422
14305
—
—
—
11
13
1116
13634
10
23
854
10383
Endocrinology
46 [38004485]
1.1e+00
1.4e+00
1.8e+00
—
1.8e+00
1.7e+00
1.5e+00
cases:5.00%
controls:1.75%
cases:3.68%
controls:0.94%
cases:0.83%
controls:0.14%
—
—
cases:1.07%
controls:0.18%
cases:4.44%
controls:0.88%
cases:7.41%
controls:1.69%
72
251
1369
14068
53
134
1388
14185
12
20
1429
14299
—
13
26
1206
14250
50
120
1077
13527
64
176
800
10230
Normoblasts [#/volume] in Blood
715-3 [3021589]
5.6e-01
8.3e-01
2.1e+00
3.1e+00
1.2e+00
6.6e-01
7.9e-01
cases:15.13%
controls:9.23%
cases:15.68%
controls:7.49%
cases:10.90%
controls:1.53%
cases:1.53%
controls:0.07%
cases:5.09%
controls:1.54%
cases:14.02%
controls:7.79%
cases:25.58%
controls:13.44%
218
1322
1223
12997
226
1073
1215
13246
157
219
1284
14100
22
10
1419
14309
62
220
1157
14056
158
1063
969
12584
221
1399
643
9007
Cells panel - Urine sediment
58434-2 [40761535]
4.2e-01
1.0e+00
3.4e+00
—
1.7e+00
1.8e+00
1.3e+00
cases:3.68%
controls:2.44%
cases:2.22%
controls:0.83%
cases:3.19%
controls:0.10%
—
—
cases:0.74%
controls:0.14%
cases:4.44%
controls:0.75%
cases:9.26%
controls:2.82%
53
350
1388
13969
32
119
1409
14200
46
15
1395
14304
—
9
20
1210
14256
50
102
1077
13545
80
293
784
10113
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
1.3e+00
1.5e+00
1.6e+00
—
1.8e+00
1.6e+00
1.3e+00
cases:14.02%
controls:4.23%
cases:9.92%
controls:2.37%
cases:1.73%
controls:0.36%
—
—
cases:2.38%
controls:0.39%
cases:10.56%
controls:2.36%
cases:18.75%
controls:5.70%
202
606
1239
13713
143
340
1298
13979
25
51
1416
14268
—
29
55
1190
14221
119
322
1008
13325
162
593
702
9813
bisoprolol; oral
C07AB07 [21601689]
1.2e+00
1.3e+00
1.0e+00
1.8e+00
1.2e+00
1.3e+00
1.2e+00
cases:41.92%
controls:17.36%
cases:41.29%
controls:15.47%
cases:13.19%
controls:5.08%
cases:1.18%
controls:0.20%
cases:13.70%
controls:4.65%
cases:42.15%
controls:15.98%
cases:45.25%
controls:19.53%
604
2486
837
11833
595
2215
846
12104
190
728
1251
13591
17
28
1424
14291
167
664
1052
13612
475
2181
652
11466
391
2032
473
8374
Other primary hyperparathyroidism
E21.09 [2000501463]
1.7e+00
2.3e+00
—
—
—
2.5e+00
2.7e+00
cases:0.76%
controls:0.15%
cases:0.49%
controls:0.05%
—
—
—
—
—
—
cases:0.71%
controls:0.06%
cases:1.39%
controls:0.10%
11
21
1430
14298
7
7
1434
14312
—
—
—
8
8
1119
13639
12
10
852
10396
Pure hypercholesterolaemia
E78.01 [2000501514]
1.2e+00
1.4e+00
2.3e+00
—
1.5e+00
1.7e+00
1.0e+00
cases:8.67%
controls:2.86%
cases:5.76%
controls:1.51%
cases:2.22%
controls:0.22%
—
—
cases:1.56%
controls:0.34%
cases:7.72%
controls:1.52%
cases:12.04%
controls:4.67%
125
410
1316
13909
83
216
1358
14103
32
32
1409
14287
—
19
48
1200
14228
87
207
1040
13440
104
486
760
9920
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.7e-01
7.2e-01
2.2e+00
3.3e+00
1.4e+00
5.8e-01
4.5e-01
cases:35.60%
controls:27.65%
cases:38.79%
controls:23.57%
cases:32.62%
controls:4.94%
cases:6.59%
controls:0.25%
cases:15.91%
controls:4.27%
cases:36.82%
controls:24.55%
cases:50.81%
controls:39.80%
513
3959
928
10360
559
3375
882
10944
470
708
971
13611
95
36
1346
14283
194
609
1025
13667
415
3350
712
10297
439
4142
425
6264
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
1.4e+00
2.3e+00
—
—
—
2.8e+00
2.6e+00
cases:0.97%
controls:0.24%
cases:1.04%
controls:0.10%
—
—
—
—
—
—
cases:1.06%
controls:0.07%
cases:3.36%
controls:0.25%
14
35
1427
14284
15
15
1426
14304
—
—
—
12
9
1115
13638
29
26
835
10380
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
8.8e-01
1.4e+00
3.0e+00
—
1.1e+00
1.4e+00
1.3e+00
cases:18.32%
controls:8.49%
cases:15.61%
controls:4.34%
cases:7.84%
controls:0.43%
—
—
cases:1.31%
controls:0.42%
cases:16.86%
controls:4.83%
cases:34.38%
controls:12.55%
264
1215
1177
13104
225
622
1216
13697
113
62
1328
14257
—
16
60
1203
14216
190
659
937
12988
297
1306
567
9100
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
4.4e-01
7.4e-01
2.2e+00
3.4e+00
1.3e+00
6.4e-01
3.7e-01
cases:33.45%
controls:24.50%
cases:34.56%
controls:20.06%
cases:28.73%
controls:4.39%
cases:6.59%
controls:0.23%
cases:13.29%
controls:4.10%
cases:33.19%
controls:20.74%
cases:42.94%
controls:34.16%
482
3508
959
10811
498
2873
943
11446
414
628
1027
13691
95
33
1346
14286
162
585
1057
13691
374
2830
753
10817
371
3555
493
6851
Hypertension complicated
K87 [2002000614]
2.2e+00
2.0e+00
—
—
—
2.2e+00
2.6e+00
cases:1.53%
controls:0.17%
cases:0.56%
controls:0.08%
—
—
—
—
—
—
cases:0.62%
controls:0.07%
cases:1.97%
controls:0.14%
22
25
1419
14294
8
11
1433
14308
—
—
—
7
9
1120
13638
17
15
847
10391
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
7.6e-01
1.5e+00
2.2e+00
—
2.0e+00
1.2e+00
1.3e+00
cases:4.02%
controls:1.93%
cases:2.98%
controls:0.68%
cases:0.97%
controls:0.10%
—
—
cases:0.57%
controls:0.08%
cases:2.48%
controls:0.77%
cases:8.68%
controls:2.43%
58
276
1383
14043
43
97
1398
14222
14
15
1427
14304
—
7
11
1212
14265
28
105
1099
13542
75
253
789
10153
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
1.9e+00
2.1e+00
—
—
1.0e+50
2.9e+00
2.2e+00
cases:0.90%
controls:0.13%
cases:0.56%
controls:0.07%
—
—
—
—
cases:0.57%
controls:0.00%
cases:0.89%
controls:0.05%
cases:1.97%
controls:0.23%
13
19
1428
14300
8
10
1433
14309
—
—
7
0
1212
14276
10
7
1117
13640
17
24
847
10382
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
8.7e-01
1.4e+00
2.9e+00
—
1.8e+00
1.2e+00
8.1e-01
cases:12.35%
controls:5.56%
cases:10.13%
controls:2.59%
cases:7.01%
controls:0.41%
—
—
cases:2.30%
controls:0.40%
cases:8.70%
controls:2.84%
cases:16.09%
controls:7.83%
178
796
1263
13523
146
371
1295
13948
101
59
1340
14260
—
28
57
1191
14219
98
387
1029
13260
139
815
725
9591
Bacteria identified in Blood by Culture
600-7 [3023368]
8.3e-01
1.5e+00
2.9e+00
—
1.9e+00
8.5e-01
9.7e-01
cases:11.52%
controls:5.35%
cases:9.09%
controls:2.23%
cases:5.20%
controls:0.30%
—
—
cases:2.21%
controls:0.32%
cases:6.48%
controls:2.88%
cases:18.98%
controls:8.17%
166
766
1275
13553
131
319
1310
14000
75
43
1366
14276
—
27
46
1192
14230
73
393
1054
13254
164
850
700
9556
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
1.3e+00
2.3e+00
—
—
—
2.2e+00
3.2e+00
cases:0.83%
controls:0.23%
cases:0.76%
controls:0.08%
—
—
—
—
—
—
cases:0.89%
controls:0.10%
cases:4.28%
controls:0.18%
12
33
1429
14286
11
11
1430
14308
—
—
—
10
14
1117
13633
37
19
827
10387
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
1.4e+00
2.0e+00
2.8e+00
—
—
1.5e+00
1.3e+00
cases:1.53%
controls:0.36%
cases:1.46%
controls:0.21%
cases:0.56%
controls:0.03%
—
—
—
—
cases:0.80%
controls:0.18%
cases:2.55%
controls:0.72%
22
52
1419
14267
21
30
1420
14289
8
5
1433
14314
—
—
9
25
1118
13622
22
75
842
10331
Difficulties in perfomrming procedure
ZXD30 [2001311389]
9.6e-01
3.2e+00
—
—
—
2.0e+00
2.7e+00
cases:1.11%
controls:0.43%
cases:1.18%
controls:0.05%
—
—
—
—
—
—
cases:0.62%
controls:0.08%
cases:2.78%
controls:0.19%
16
61
1425
14258
17
7
1424
14312
—
—
—
7
11
1120
13636
24
20
840
10386
insulins and analogues for injection, intermediate-acting - combinations; parenteral
A10AC30 [21600727]
1.7e+00
1.7e+00
2.5e+00
—
—
1.7e+00
1.3e+00
cases:3.33%
controls:0.66%
cases:2.15%
controls:0.39%
cases:0.69%
controls:0.06%
—
—
—
—
cases:2.04%
controls:0.37%
cases:2.08%
controls:0.60%
48
94
1393
14225
31
56
1410
14263
10
8
1431
14311
—
—
23
51
1104
13596
18
62
846
10344
metoprolol and felodipine
C07FB02 [21601742]
3.1e+00
—
—
—
—
3.2e+00
2.6e+00
cases:1.46%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.04%
cases:0.93%
controls:0.07%
21
10
1420
14309
—
—
—
—
10
5
1117
13642
8
7
856
10399
pH of Blood
11558-4 [3010421]
1.9e+00
2.2e+00
—
1.0e+50
—
2.8e+00
2.0e+00
cases:2.50%
controls:0.40%
cases:1.87%
controls:0.21%
—
—
cases:0.42%
controls:0.00%
—
—
cases:2.75%
controls:0.17%
cases:4.40%
controls:0.62%
36
57
1405
14262
27
30
1414
14289
—
6
0
1435
14319
—
31
23
1096
13624
38
65
826
10341
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.4e+00
2.0e+00
—
—
—
2.4e+00
3.0e+00
cases:0.97%
controls:0.23%
cases:0.97%
controls:0.13%
—
—
—
—
—
—
cases:1.15%
controls:0.10%
cases:4.05%
controls:0.21%
14
33
1427
14286
14
19
1427
14300
—
—
—
13
14
1114
13633
35
22
829
10384
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
1.3e+00
2.0e+00
2.8e+00
—
—
1.5e+00
1.3e+00
cases:3.82%
controls:1.08%
cases:3.61%
controls:0.51%
cases:1.53%
controls:0.09%
—
—
—
—
cases:2.31%
controls:0.54%
cases:6.94%
controls:2.07%
55
155
1386
14164
52
73
1389
14246
22
13
1419
14306
—
—
26
74
1101
13573
60
215
804
10191
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
9.6e-01
1.5e+00
4.2e+00
—
—
1.2e+00
1.1e+00
cases:4.65%
controls:1.84%
cases:2.91%
controls:0.70%
cases:2.71%
controls:0.04%
—
—
—
—
cases:1.86%
controls:0.59%
cases:5.56%
controls:1.96%
67
263
1374
14056
42
100
1399
14219
39
6
1402
14313
—
—
21
81
1106
13566
48
204
816
10202
atorvastatin; oral
C10AA05 [21601860]
8.4e-01
1.0e+00
8.3e-01
2.5e+00
1.0e+00
1.2e+00
1.3e+00
cases:23.73%
controls:11.82%
cases:23.46%
controls:10.05%
cases:6.52%
controls:2.96%
cases:1.32%
controls:0.10%
cases:7.88%
controls:2.99%
cases:27.86%
controls:10.53%
cases:38.43%
controls:14.39%
342
1693
1099
12626
338
1439
1103
12880
94
424
1347
13895
19
15
1422
14304
96
427
1123
13849
314
1437
813
12210
332
1497
532
8909
Thorax X-ray examination
GD1AA [2001303617]
8.8e-01
1.5e+00
2.1e+00
—
1.5e+00
1.3e+00
1.4e+00
cases:21.24%
controls:10.06%
cases:14.71%
controls:3.79%
cases:3.61%
controls:0.44%
—
—
cases:2.21%
controls:0.48%
cases:12.51%
controls:3.72%
cases:31.25%
controls:10.18%
306
1441
1135
12878
212
542
1229
13777
52
63
1389
14256
—
27
69
1192
14207
141
507
986
13140
270
1059
594
9347
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.6e-01
9.1e-01
1.7e+00
3.0e+00
7.2e-01
8.7e-01
9.4e-01
cases:20.40%
controls:12.75%
cases:17.21%
controls:7.72%
cases:9.02%
controls:1.72%
cases:0.69%
controls:0.03%
cases:3.20%
controls:1.59%
cases:15.79%
controls:7.27%
cases:32.52%
controls:15.79%
294
1826
1147
12493
248
1105
1193
13214
130
247
1311
14072
10
5
1431
14314
39
227
1180
14049
178
992
949
12655
281
1643
583
8763
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
1.2e+00
1.5e+00
2.4e+00
—
1.7e+00
1.0e+00
9.4e-01
cases:15.75%
controls:5.49%
cases:10.96%
controls:2.71%
cases:3.75%
controls:0.35%
—
—
cases:1.72%
controls:0.32%
cases:7.81%
controls:2.94%
cases:18.52%
controls:8.13%
227
786
1214
13533
158
388
1283
13931
54
50
1387
14269
—
21
46
1198
14230
88
401
1039
13246
160
846
704
9560
Pulmonary Disease
29 [38004472]
7.1e-01
7.0e-01
1.3e+00
3.1e+00
1.0e+00
9.7e-01
9.6e-01
cases:16.72%
controls:8.96%
cases:9.30%
controls:4.86%
cases:2.91%
controls:0.85%
cases:0.76%
controls:0.03%
cases:2.79%
controls:1.02%
cases:10.91%
controls:4.44%
cases:20.95%
controls:9.21%
241
1283
1200
13036
134
696
1307
13623
42
121
1399
14198
11
5
1430
14314
34
146
1185
14130
123
606
1004
13041
181
958
683
9448
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
1.5e+00
2.8e+00
—
—
1.0e+50
2.1e+00
2.3e+00
cases:2.29%
controls:0.51%
cases:1.87%
controls:0.12%
—
—
—
—
cases:0.49%
controls:0.00%
cases:1.60%
controls:0.19%
cases:5.44%
controls:0.60%
33
73
1408
14246
27
17
1414
14302
—
—
6
0
1213
14276
18
26
1109
13621
47
62
817
10344
CBC panel - Blood by Automated count
58410-2 [40761511]
2.3e-01
6.2e-01
2.0e+00
3.6e+00
1.2e+00
5.6e-01
3.9e-01
cases:39.21%
controls:33.93%
cases:34.77%
controls:22.31%
cases:25.19%
controls:4.20%
cases:6.73%
controls:0.20%
cases:11.65%
controls:3.72%
cases:33.27%
controls:22.11%
cases:52.08%
controls:42.42%
565
4858
876
9461
501
3195
940
11124
363
602
1078
13717
97
28
1344
14291
142
531
1077
13745
375
3018
752
10629
450
4414
414
5992
PEEP
WX722 [2001310825]
1.2e+00
2.2e+00
—
—
—
2.8e+00
2.4e+00
cases:1.39%
controls:0.41%
cases:0.83%
controls:0.09%
—
—
—
—
—
—
cases:0.98%
controls:0.06%
cases:3.01%
controls:0.29%
20
58
1421
14261
12
13
1429
14306
—
—
—
11
8
1116
13639
26
30
838
10376
Other obesity
E66.8 [45533036]
1.6e+00
2.6e+00
—
—
—
2.1e+00
2.4e+00
cases:0.62%
controls:0.13%
cases:0.56%
controls:0.04%
—
—
—
—
—
—
cases:0.53%
controls:0.07%
cases:1.62%
controls:0.15%
9
18
1432
14301
8
6
1433
14313
—
—
—
6
9
1121
13638
14
16
850
10390
Implantation of vascular injection port
TPX10 [2001309608]
2.8e+00
—
—
—
—
2.8e+00
3.1e+00
cases:1.53%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.05%
cases:2.78%
controls:0.12%
22
14
1419
14305
—
—
—
—
9
7
1118
13640
24
13
840
10393
Abdominal aortic aneurysm, without mention of rupture
I71.4 [45572130]
1.6e+00
1.8e+00
2.0e+00
1.0e+50
—
2.0e+00
1.3e+00
cases:1.94%
controls:0.41%
cases:1.46%
controls:0.25%
cases:0.49%
controls:0.06%
cases:0.42%
controls:0.00%
—
—
cases:1.69%
controls:0.24%
cases:2.08%
controls:0.58%
28
59
1413
14260
21
36
1420
14283
7
9
1434
14310
6
0
1435
14319
—
19
33
1108
13614
18
60
846
10346
Chronic atrial fibrillation
I48.2 [45591467]
1.3e+00
1.5e+00
1.6e+00
—
2.1e+00
1.2e+00
9.9e-01
cases:1.11%
controls:0.29%
cases:1.39%
controls:0.32%
cases:0.62%
controls:0.13%
—
—
cases:0.82%
controls:0.11%
cases:1.42%
controls:0.43%
cases:2.31%
controls:0.87%
16
42
1425
14277
20
46
1421
14273
9
19
1432
14300
—
10
15
1209
14261
16
58
1111
13589
20
91
844
10315
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.7e+00
2.9e+00
—
—
—
2.2e+00
1.9e+00
cases:2.01%
controls:0.37%
cases:2.50%
controls:0.15%
—
—
—
—
—
—
cases:0.71%
controls:0.08%
cases:2.08%
controls:0.33%
29
53
1412
14266
36
21
1405
14298
—
—
—
8
11
1119
13636
18
34
846
10372
Urinary tract ultrasound examination
KH1AE [2001306329]
2.0e+00
2.6e+00
—
1.0e+50
—
2.0e+00
2.1e+00
cases:4.51%
controls:0.66%
cases:3.19%
controls:0.24%
—
—
cases:1.73%
controls:0.00%
—
—
cases:1.95%
controls:0.28%
cases:5.67%
controls:0.75%
65
95
1376
14224
46
35
1395
14284
—
25
0
1416
14319
—
22
38
1105
13609
49
78
815
10328
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
1.7e+00
2.8e+00
—
—
—
2.2e+00
1.8e+00
cases:2.01%
controls:0.37%
cases:2.50%
controls:0.15%
—
—
—
—
—
—
cases:0.80%
controls:0.09%
cases:1.97%
controls:0.32%
29
53
1412
14266
36
22
1405
14297
—
—
—
9
12
1118
13635
17
33
847
10373
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.4e-01
6.4e-01
2.2e+00
3.3e+00
1.4e+00
4.9e-01
2.6e-01
cases:45.25%
controls:39.44%
cases:48.30%
controls:32.93%
cases:41.01%
controls:6.93%
cases:8.74%
controls:0.35%
cases:20.75%
controls:6.25%
cases:45.52%
controls:33.89%
cases:60.19%
controls:53.87%
652
5647
789
8672
696
4715
745
9604
591
992
850
13327
126
50
1315
14269
253
892
966
13384
513
4625
614
9022
520
5606
344
4800
telmisartan; oral
C09CA07 [21601830]
1.4e+00
1.4e+00
1.5e+00
—
1.5e+00
1.4e+00
1.3e+00
cases:2.91%
controls:0.77%
cases:2.85%
controls:0.69%
cases:0.69%
controls:0.15%
—
—
cases:0.82%
controls:0.19%
cases:2.93%
controls:0.73%
cases:4.17%
controls:1.15%
42
110
1399
14209
41
99
1400
14220
10
22
1431
14297
—
10
27
1209
14249
33
99
1094
13548
36
120
828
10286
Medical doctor
Z2221 [2001311556]
5.7e-01
1.4e+00
1.7e+00
—
1.9e+00
1.7e+00
1.2e+00
cases:7.70%
controls:4.50%
cases:5.14%
controls:1.31%
cases:1.32%
controls:0.24%
—
—
cases:1.15%
controls:0.18%
cases:6.03%
controls:1.14%
cases:9.61%
controls:2.98%
111
645
1330
13674
74
187
1367
14132
19
34
1422
14285
—
14
26
1205
14250
68
156
1059
13491
83
310
781
10096
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
1.6e+00
2.1e+00
—
—
—
2.1e+00
2.8e+00
cases:1.18%
controls:0.25%
cases:0.76%
controls:0.10%
—
—
—
—
—
—
cases:0.89%
controls:0.11%
cases:4.28%
controls:0.28%
17
36
1424
14283
11
14
1430
14305
—
—
—
10
15
1117
13632
37
29
827
10377
Sleep apnoea
G47.3 [45562094]
1.1e+00
1.2e+00
1.8e+00
—
1.7e+00
1.5e+00
1.2e+00
cases:8.26%
controls:3.02%
cases:6.04%
controls:1.89%
cases:1.67%
controls:0.28%
—
—
cases:1.80%
controls:0.33%
cases:7.45%
controls:1.82%
cases:11.57%
controls:3.68%
119
432
1322
13887
87
271
1354
14048
24
40
1417
14279
—
22
47
1197
14229
84
248
1043
13399
100
383
764
10023
Bacterial infection, unspecified
A49.9 [45590816]
1.2e+00
1.7e+00
2.8e+00
—
1.2e+00
1.5e+00
1.3e+00
cases:3.89%
controls:1.24%
cases:2.08%
controls:0.38%
cases:1.46%
controls:0.09%
—
—
cases:0.41%
controls:0.13%
cases:2.84%
controls:0.65%
cases:6.71%
controls:1.95%
56
177
1385
14142
30
54
1411
14265
21
13
1420
14306
—
5
18
1214
14258
32
89
1095
13558
58
203
806
10203
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
1.8e+00
2.8e+00
—
—
—
2.1e+00
1.7e+00
cases:2.43%
controls:0.42%
cases:2.57%
controls:0.15%
—
—
—
—
—
—
cases:1.06%
controls:0.13%
cases:2.31%
controls:0.41%
35
60
1406
14259
37
22
1404
14297
—
—
—
12
18
1115
13629
20
43
844
10363
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
1.8e+00
2.7e+00
—
—
1.0e+50
2.0e+00
1.9e+00
cases:1.46%
controls:0.25%
cases:1.25%
controls:0.08%
—
—
—
—
cases:0.41%
controls:0.00%
cases:0.62%
controls:0.08%
cases:1.74%
controls:0.26%
21
36
1420
14283
18
12
1423
14307
—
—
5
0
1214
14276
7
11
1120
13636
15
27
849
10379
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
1.8e+00
2.7e+00
—
—
1.0e+50
2.0e+00
1.9e+00
cases:1.46%
controls:0.25%
cases:1.25%
controls:0.08%
—
—
—
—
cases:0.41%
controls:0.00%
cases:0.62%
controls:0.08%
cases:1.74%
controls:0.26%
21
36
1420
14283
18
12
1423
14307
—
—
5
0
1214
14276
7
11
1120
13636
15
27
849
10379
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
7.6e-01
1.4e+00
2.1e+00
—
1.9e+00
1.2e+00
1.0e+00
cases:10.34%
controls:5.13%
cases:8.33%
controls:2.22%
cases:3.19%
controls:0.39%
—
—
cases:1.72%
controls:0.25%
cases:6.74%
controls:2.22%
cases:15.16%
controls:6.06%
149
734
1292
13585
120
318
1321
14001
46
56
1395
14263
—
21
36
1198
14240
76
303
1051
13344
131
631
733
9775
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
1.8e+00
2.5e+00
—
—
—
2.5e+00
1.5e+00
cases:3.33%
controls:0.57%
cases:2.50%
controls:0.20%
—
—
—
—
—
—
cases:1.33%
controls:0.11%
cases:2.55%
controls:0.56%
48
81
1393
14238
36
29
1405
14290
—
—
—
15
15
1112
13632
22
58
842
10348
vildagliptin; oral
A10BH02 [21600785]
2.1e+00
2.3e+00
1.6e+00
—
1.7e+00
2.0e+00
1.9e+00
cases:1.94%
controls:0.24%
cases:1.87%
controls:0.19%
cases:0.35%
controls:0.07%
—
—
cases:0.57%
controls:0.11%
cases:1.51%
controls:0.21%
cases:1.97%
controls:0.29%
28
34
1413
14285
27
27
1414
14292
5
10
1436
14309
—
7
15
1212
14261
17
28
1110
13619
17
30
847
10376
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
7.8e-01
1.4e+00
2.8e+00
—
1.7e+00
8.7e-01
8.8e-01
cases:5.20%
controls:2.46%
cases:5.83%
controls:1.47%
cases:2.78%
controls:0.18%
—
—
cases:1.07%
controls:0.20%
cases:3.73%
controls:1.60%
cases:11.11%
controls:4.91%
75
352
1366
13967
84
211
1357
14108
40
26
1401
14293
—
13
29
1206
14247
42
218
1085
13429
96
511
768
9895
Obesity due to excess calories
E66.01 [2000501501]
1.8e+00
1.8e+00
—
1.0e+50
—
2.6e+00
2.2e+00
cases:1.60%
controls:0.27%
cases:0.83%
controls:0.14%
—
—
cases:0.83%
controls:0.00%
—
—
cases:1.69%
controls:0.13%
cases:3.13%
controls:0.36%
23
38
1418
14281
12
20
1429
14299
—
12
0
1429
14319
—
19
18
1108
13629
27
37
837
10369
Old myocardial infarction
I25.2 [45601025]
1.0e+00
1.5e+00
1.6e+00
—
2.9e+00
1.6e+00
1.4e+00
cases:3.47%
controls:1.26%
cases:2.50%
controls:0.58%
cases:0.42%
controls:0.08%
—
—
cases:0.98%
controls:0.06%
cases:3.02%
controls:0.63%
cases:4.63%
controls:1.20%
50
181
1391
14138
36
83
1405
14236
6
12
1435
14307
—
12
8
1207
14268
34
86
1093
13561
40
125
824
10281
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
9.8e-01
1.7e+00
3.2e+00
—
9.7e-01
1.4e+00
1.1e+00
cases:8.12%
controls:3.20%
cases:8.67%
controls:1.78%
cases:6.45%
controls:0.28%
—
—
cases:0.74%
controls:0.28%
cases:7.36%
controls:1.99%
cases:13.77%
controls:4.87%
117
458
1324
13861
125
255
1316
14064
93
40
1348
14279
—
9
40
1210
14236
83
272
1044
13375
119
507
745
9899
Gout
M10 [45533711]
2.0e+00
2.5e+00
—
—
—
1.8e+00
2.0e+00
cases:3.26%
controls:0.46%
cases:1.25%
controls:0.10%
—
—
—
—
—
—
cases:1.06%
controls:0.18%
cases:4.28%
controls:0.59%
47
66
1394
14253
18
15
1423
14304
—
—
—
12
24
1115
13623
37
61
827
10345
Oxygen saturation in Arterial blood
2708-6 [3016502]
9.1e-01
1.9e+00
3.2e+00
1.0e+50
1.6e+00
1.2e+00
1.1e+00
cases:3.61%
controls:1.48%
cases:3.61%
controls:0.57%
cases:1.80%
controls:0.08%
cases:0.49%
controls:0.00%
cases:0.41%
controls:0.08%
cases:1.95%
controls:0.59%
cases:6.71%
controls:2.39%
52
212
1389
14107
52
81
1389
14238
26
11
1415
14308
7
0
1434
14319
5
12
1214
14264
22
80
1105
13567
58
249
806
10157
Angiography of heart and/or coronary arteries
FN1AC [2001302996]
4.6e-01
1.2e+00
2.1e+00
1.0e+50
2.3e+00
9.6e-01
1.3e+00
cases:6.38%
controls:4.12%
cases:2.85%
controls:0.91%
cases:0.69%
controls:0.08%
cases:0.56%
controls:0.00%
cases:0.82%
controls:0.08%
cases:2.40%
controls:0.93%
cases:10.19%
controls:3.10%
92
590
1349
13729
41
131
1400
14188
10
12
1431
14307
8
0
1433
14319
10
12
1209
14264
27
127
1100
13520
88
323
776
10083
liraglutide; parenteral
A10BJ02 [1123630]
1.7e+00
2.1e+00
—
—
—
1.8e+00
2.6e+00
cases:0.90%
controls:0.17%
cases:0.56%
controls:0.07%
—
—
—
—
—
—
cases:0.62%
controls:0.10%
cases:1.74%
controls:0.12%
13
24
1428
14295
8
10
1433
14309
—
—
—
7
14
1120
13633
15
13
849
10393
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.1e+00
1.7e+00
2.8e+00
—
—
1.4e+00
1.2e+00
cases:3.33%
controls:1.17%
cases:2.43%
controls:0.45%
cases:1.39%
controls:0.08%
—
—
—
—
cases:1.60%
controls:0.40%
cases:5.21%
controls:1.59%
48
167
1393
14152
35
64
1406
14255
20
12
1421
14307
—
—
18
55
1109
13592
45
165
819
10241
ECG with 12 standard connections
XF400 [2001303368]
1.1e+00
1.5e+00
3.1e+00
—
—
1.5e+00
1.1e+00
cases:5.41%
controls:1.92%
cases:2.36%
controls:0.52%
cases:1.04%
controls:0.05%
—
—
—
—
cases:2.13%
controls:0.49%
cases:4.75%
controls:1.71%
78
275
1363
14044
34
75
1407
14244
15
7
1426
14312
—
—
24
67
1103
13580
41
178
823
10228
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
7.3e-01
1.2e+00
2.9e+00
—
1.7e+00
1.1e+00
6.3e-01
cases:13.39%
controls:6.93%
cases:11.17%
controls:3.65%
cases:9.30%
controls:0.57%
—
—
cases:2.79%
controls:0.55%
cases:10.29%
controls:3.79%
cases:18.17%
controls:10.56%
193
993
1248
13326
161
523
1280
13796
134
82
1307
14237
—
34
78
1185
14198
116
517
1011
13130
157
1099
707
9307
Glomerular basement membrane Ab [Units/volume] in Serum
49774-3 [3032700]
2.4e+00
3.6e+00
—
—
—
—
2.2e+00
cases:1.18%
controls:0.11%
cases:1.73%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.12%
17
16
1424
14303
25
7
1416
14312
—
—
—
—
9
12
855
10394
Base excess in Arterial blood by calculation
1925-7 [3003396]
1.0e+00
1.9e+00
3.1e+00
1.0e+50
1.5e+00
1.1e+00
1.0e+00
cases:4.37%
controls:1.61%
cases:3.96%
controls:0.63%
cases:1.87%
controls:0.08%
cases:0.35%
controls:0.00%
cases:0.49%
controls:0.11%
cases:2.04%
controls:0.69%
cases:7.18%
controls:2.69%
63
231
1378
14088
57
90
1384
14229
27
12
1414
14307
5
0
1436
14319
6
16
1213
14260
23
94
1104
13553
62
280
802
10126
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
1.7e+00
2.4e+00
—
1.0e+50
—
1.8e+00
2.2e+00
cases:1.73%
controls:0.31%
cases:1.32%
controls:0.12%
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.98%
controls:0.17%
cases:4.98%
controls:0.56%
25
45
1416
14274
19
17
1422
14302
—
6
0
1435
14319
—
11
23
1116
13624
43
58
821
10348
amiodarone; oral, parenteral
C01BD01 [21600270]
1.2e+00
1.7e+00
1.7e+00
—
—
1.7e+00
1.8e+00
cases:1.53%
controls:0.45%
cases:1.32%
controls:0.24%
cases:0.62%
controls:0.11%
—
—
—
—
cases:1.15%
controls:0.21%
cases:1.97%
controls:0.34%
22
65
1419
14254
19
35
1422
14284
9
16
1432
14303
—
—
13
29
1114
13618
17
35
847
10371
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
7.9e-01
1.9e+00
3.1e+00
1.0e+50
—
1.4e+00
1.0e+00
cases:2.91%
controls:1.35%
cases:3.12%
controls:0.50%
cases:1.53%
controls:0.07%
cases:0.42%
controls:0.00%
—
—
cases:1.95%
controls:0.51%
cases:5.67%
controls:2.15%
42
193
1399
14126
45
71
1396
14248
22
10
1419
14309
6
0
1435
14319
—
22
70
1105
13577
49
224
815
10182
Physiotherapist
Z3226 [2001311560]
1.0e+00
1.4e+00
2.1e+00
—
1.5e+00
1.9e+00
1.7e+00
cases:5.48%
controls:2.04%
cases:2.43%
controls:0.61%
cases:0.62%
controls:0.08%
—
—
cases:0.41%
controls:0.09%
cases:3.28%
controls:0.53%
cases:7.18%
controls:1.35%
79
292
1362
14027
35
88
1406
14231
9
11
1432
14308
—
5
13
1214
14263
37
72
1090
13575
62
140
802
10266
methoxy polyethylene glycol-epoetin beta; parenteral
B03XA03 [21601135]
—
4.1e+00
—
—
—
4.0e+00
—
—
—
cases:2.01%
controls:0.03%
—
—
—
—
—
—
cases:2.40%
controls:0.04%
—
—
—
29
5
1412
14314
—
—
—
27
6
1100
13641
—
Aortic (valve) stenosis
I35.0 [45576869]
1.1e+00
1.4e+00
2.1e+00
1.0e+50
1.7e+00
9.2e-01
8.5e-01
cases:3.54%
controls:1.26%
cases:3.05%
controls:0.77%
cases:0.76%
controls:0.09%
cases:1.32%
controls:0.00%
cases:0.66%
controls:0.12%
cases:1.95%
controls:0.78%
cases:4.17%
controls:1.82%
51
180
1390
14139
44
110
1397
14209
11
13
1430
14306
19
0
1422
14319
8
17
1211
14259
22
107
1105
13540
36
189
828
10217
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
1.0e+00
1.8e+00
3.1e+00
1.0e+50
1.5e+00
1.0e+00
1.1e+00
cases:4.30%
controls:1.60%
cases:3.82%
controls:0.64%
cases:1.87%
controls:0.08%
cases:0.49%
controls:0.00%
cases:0.49%
controls:0.11%
cases:1.95%
controls:0.70%
cases:7.29%
controls:2.67%
62
229
1379
14090
55
91
1386
14228
27
12
1414
14307
7
0
1434
14319
6
16
1213
14260
22
95
1105
13552
63
278
801
10128
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
1.0e+00
1.8e+00
3.1e+00
1.0e+50
1.5e+00
1.0e+00
1.1e+00
cases:4.30%
controls:1.60%
cases:3.82%
controls:0.64%
cases:1.87%
controls:0.08%
cases:0.49%
controls:0.00%
cases:0.49%
controls:0.11%
cases:1.95%
controls:0.70%
cases:7.29%
controls:2.67%
62
229
1379
14090
55
91
1386
14228
27
12
1414
14307
7
0
1434
14319
6
16
1213
14260
22
95
1105
13552
63
278
801
10128
pH of Arterial blood
2744-1 [3019977]
9.7e-01
1.8e+00
3.2e+00
1.0e+50
1.5e+00
1.0e+00
1.0e+00
cases:4.09%
controls:1.60%
cases:3.68%
controls:0.64%
cases:1.87%
controls:0.08%
cases:0.56%
controls:0.00%
cases:0.49%
controls:0.11%
cases:1.95%
controls:0.70%
cases:7.18%
controls:2.67%
59
229
1382
14090
53
92
1388
14227
27
11
1414
14308
8
0
1433
14319
6
16
1213
14260
22
96
1105
13551
62
278
802
10128
Parathyrin related protein [Mass/volume] in Serum or Plasma
2729-2 [3037534]
—
2.3e+00
1.0e+50
—
—
2.7e+00
3.0e+00
—
—
cases:0.56%
controls:0.06%
cases:0.56%
controls:0.00%
—
—
—
—
cases:0.98%
controls:0.07%
cases:1.16%
controls:0.06%
—
8
8
1433
14311
8
0
1433
14319
—
—
11
9
1116
13638
10
6
854
10400
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
1.6e+00
2.8e+00
—
—
—
2.0e+00
1.6e+00
cases:3.05%
controls:0.64%
cases:3.61%
controls:0.22%
—
—
—
—
—
—
cases:1.51%
controls:0.21%
cases:3.36%
controls:0.70%
44
91
1397
14228
52
32
1389
14287
—
—
—
17
28
1110
13619
29
73
835
10333
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
8.6e-01
1.6e+00
3.2e+00
—
1.2e+00
1.3e+00
9.8e-01
cases:7.08%
controls:3.11%
cases:8.40%
controls:1.82%
cases:6.45%
controls:0.27%
—
—
cases:0.90%
controls:0.28%
cases:7.36%
controls:2.07%
cases:13.31%
controls:5.44%
102
445
1339
13874
121
260
1320
14059
93
39
1348
14280
—
11
40
1208
14236
83
282
1044
13365
115
566
749
9840
Abdominal CT examination
JN3AD [2001305554]
1.2e+00
1.6e+00
2.9e+00
—
1.5e+00
1.0e+00
1.3e+00
cases:3.26%
controls:1.03%
cases:2.29%
controls:0.46%
cases:0.97%
controls:0.06%
—
—
cases:0.41%
controls:0.09%
cases:1.60%
controls:0.57%
cases:5.90%
controls:1.69%
47
147
1394
14172
33
66
1408
14253
14
8
1427
14311
—
5
13
1214
14263
18
78
1109
13569
51
176
813
10230
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
1.4e+00
1.6e+00
2.5e+00
—
—
1.4e+00
1.1e+00
cases:2.50%
controls:0.66%
cases:1.80%
controls:0.36%
cases:0.97%
controls:0.08%
—
—
—
—
cases:1.51%
controls:0.38%
cases:4.17%
controls:1.44%
36
94
1405
14225
26
52
1415
14267
14
11
1427
14308
—
—
17
52
1110
13595
36
150
828
10256
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
1.4e+00
2.9e+00
—
—
—
2.6e+00
2.4e+00
cases:0.49%
controls:0.13%
cases:0.90%
controls:0.05%
—
—
—
—
—
—
cases:0.71%
controls:0.05%
cases:2.66%
controls:0.24%
7
18
1434
14301
13
7
1428
14312
—
—
—
8
7
1119
13640
23
25
841
10381
betaxolol; oral
C07AB05 [21601687]
1.8e+00
2.3e+00
—
—
-1.0e+50
2.0e+00
1.9e+00
cases:1.25%
controls:0.21%
cases:0.83%
controls:0.08%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.62%
controls:0.09%
cases:1.04%
controls:0.15%
18
30
1423
14289
12
12
1429
14307
—
—
0
6
1219
14270
7
12
1120
13635
9
16
855
10390
valsartan, amlodipine and hydrochlorothiazide
C09DX01 [21601846]
2.9e+00
2.4e+00
—
—
—
2.6e+00
1.9e+00
cases:1.04%
controls:0.06%
cases:0.62%
controls:0.06%
—
—
—
—
—
—
cases:0.80%
controls:0.06%
cases:0.58%
controls:0.09%
15
8
1426
14311
9
8
1432
14311
—
—
—
9
8
1118
13639
5
9
859
10397
Hyperkalaemia
E87.5 [45537990]
2.2e+00
3.1e+00
1.0e+50
—
—
—
2.7e+00
cases:1.32%
controls:0.15%
cases:1.18%
controls:0.06%
cases:0.35%
controls:0.00%
—
—
—
—
—
—
cases:2.08%
controls:0.14%
19
22
1422
14297
17
8
1424
14311
5
0
1436
14319
—
—
—
18
15
846
10391
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
6.5e-01
1.2e+00
2.4e+00
1.0e+50
1.6e+00
9.6e-01
1.1e+00
cases:11.80%
controls:6.54%
cases:7.70%
controls:2.43%
cases:3.61%
controls:0.34%
cases:0.35%
controls:0.00%
cases:1.39%
controls:0.29%
cases:6.12%
controls:2.43%
cases:18.40%
controls:6.94%
170
937
1271
13382
111
348
1330
13971
52
49
1389
14270
5
0
1436
14319
17
41
1202
14235
69
332
1058
13315
159
722
705
9684
methylprednisolone; oral, parenteral
H02AB04 [21602732]
5.3e-01
1.1e+00
—
—
2.3e+00
2.2e+00
2.2e+00
cases:2.43%
controls:1.44%
cases:1.67%
controls:0.54%
—
—
—
—
cases:0.66%
controls:0.06%
cases:2.93%
controls:0.33%
cases:8.56%
controls:1.06%
35
206
1406
14113
24
78
1417
14241
—
—
8
9
1211
14267
33
45
1094
13602
74
110
790
10296
Physiotherapy
R4110 [2001310233]
5.8e-01
1.4e+00
1.9e+00
—
1.7e+00
9.2e-01
1.4e+00
cases:7.98%
controls:4.61%
cases:5.48%
controls:1.47%
cases:1.60%
controls:0.24%
—
—
cases:0.82%
controls:0.15%
cases:3.99%
controls:1.63%
cases:14.47%
controls:4.13%
115
660
1326
13659
79
210
1362
14109
23
35
1418
14284
—
10
21
1209
14255
45
223
1082
13424
125
430
739
9976
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.3e+00
1.9e+00
—
—
—
2.7e+00
3.2e+00
cases:0.62%
controls:0.17%
cases:0.62%
controls:0.09%
—
—
—
—
—
—
cases:1.06%
controls:0.07%
cases:3.47%
controls:0.14%
9
25
1432
14294
9
13
1432
14306
—
—
—
12
10
1115
13637
30
15
834
10391
Inpatient Visit
IP [9201]
6.4e-01
1.1e+00
2.2e+00
—
2.0e+00
1.0e+00
8.7e-01
cases:14.99%
controls:8.53%
cases:10.06%
controls:3.46%
cases:4.30%
controls:0.50%
—
—
cases:2.87%
controls:0.41%
cases:9.14%
controls:3.58%
cases:21.30%
controls:10.15%
216
1222
1225
13097
145
495
1296
13824
62
71
1379
14248
—
35
59
1184
14217
103
489
1024
13158
184
1056
680
9350
Volume in Urine collected for unspecified duration
19153-6 [3004775]
2.1e+00
3.4e+00
—
—
—
—
2.3e+00
cases:1.04%
controls:0.13%
cases:1.04%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.14%
15
18
1426
14301
15
5
1426
14314
—
—
—
—
12
15
852
10391
Cathetrisation of vein
TPH04 [2001309597]
1.2e+00
1.6e+00
2.5e+00
—
1.2e+00
1.3e+00
1.2e+00
cases:9.16%
controls:2.86%
cases:4.58%
controls:0.94%
cases:1.39%
controls:0.12%
—
—
cases:0.41%
controls:0.12%
cases:3.64%
controls:1.06%
cases:9.72%
controls:3.14%
132
409
1309
13910
66
135
1375
14184
20
17
1421
14302
—
5
17
1214
14259
41
144
1086
13503
84
327
780
10079
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
6.0e-01
1.2e+00
2.7e+00
—
1.3e+00
1.1e+00
1.0e+00
cases:12.77%
controls:7.44%
cases:10.62%
controls:3.58%
cases:7.22%
controls:0.54%
—
—
cases:1.80%
controls:0.52%
cases:9.85%
controls:3.62%
cases:23.15%
controls:9.91%
184
1065
1257
13254
153
513
1288
13806
104
77
1337
14242
—
22
74
1197
14202
111
494
1016
13153
200
1031
664
9375
pH of Urine
2756-5 [3015736]
7.0e-01
1.3e+00
2.8e+00
—
1.3e+00
1.0e+00
6.6e-01
cases:16.24%
controls:8.81%
cases:14.57%
controls:4.38%
cases:9.65%
controls:0.68%
—
—
cases:2.38%
controls:0.68%
cases:12.78%
controls:4.89%
cases:23.38%
controls:13.61%
234
1262
1207
13057
210
627
1231
13692
139
97
1302
14222
—
29
97
1190
14179
144
667
983
12980
202
1416
662
8990
insulin lispro; parenteral
A10AD04 [21600732]
1.4e+00
1.5e+00
1.9e+00
—
—
1.5e+00
1.4e+00
cases:1.73%
controls:0.44%
cases:1.60%
controls:0.37%
cases:0.62%
controls:0.09%
—
—
—
—
cases:1.60%
controls:0.36%
cases:1.85%
controls:0.45%
25
63
1416
14256
23
53
1418
14266
9
13
1432
14306
—
—
18
49
1109
13598
16
47
848
10359
Dyspnoea
R06.0 [45558449]
1.0e+00
8.8e-01
1.9e+00
—
1.8e+00
1.2e+00
8.6e-01
cases:9.09%
controls:3.44%
cases:3.75%
controls:1.59%
cases:1.18%
controls:0.17%
—
—
cases:1.07%
controls:0.18%
cases:4.70%
controls:1.46%
cases:10.53%
controls:4.76%
131
492
1310
13827
54
227
1387
14092
17
25
1424
14294
—
13
25
1206
14251
53
199
1074
13448
91
495
773
9911
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
9.8e-01
1.2e+00
2.5e+00
—
1.6e+00
6.7e-01
6.9e-01
cases:11.03%
controls:4.46%
cases:9.65%
controls:2.98%
cases:4.09%
controls:0.34%
—
—
cases:1.15%
controls:0.23%
cases:6.57%
controls:3.47%
cases:16.78%
controls:9.22%
159
638
1282
13681
139
427
1302
13892
59
49
1382
14270
—
14
33
1205
14243
74
474
1053
13173
145
959
719
9447
Supplier / Service Provider
OMOP5117446 [33004]
-3.9e-01
-2.6e-01
5.2e-01
—
2.3e+00
2.6e+00
3.2e+00
cases:17.07%
controls:23.31%
cases:4.86%
controls:6.24%
cases:0.90%
controls:0.54%
—
—
cases:0.82%
controls:0.08%
cases:5.24%
controls:0.40%
cases:17.94%
controls:0.90%
246
3338
1195
10981
70
893
1371
13426
13
77
1428
14242
—
10
12
1209
14264
59
55
1068
13592
155
94
709
10312
candesartan; oral
C09CA06 [21601829]
1.4e+00
1.4e+00
1.1e+00
—
1.3e+00
1.2e+00
1.3e+00
cases:12.01%
controls:3.34%
cases:11.17%
controls:2.88%
cases:2.91%
controls:0.98%
—
—
cases:3.12%
controls:0.91%
cases:9.67%
controls:3.22%
cases:14.58%
controls:4.56%
173
478
1268
13841
161
412
1280
13907
42
140
1399
14179
—
38
130
1181
14146
109
439
1018
13208
126
475
738
9931
Presence of aortocoronary bypass graft
Z95.1 [45556881]
1.2e+00
1.3e+00
—
1.0e+50
2.5e+00
1.5e+00
1.1e+00
cases:2.57%
controls:0.82%
cases:1.18%
controls:0.31%
—
—
cases:0.56%
controls:0.00%
cases:0.41%
controls:0.04%
cases:1.51%
controls:0.33%
cases:2.08%
controls:0.67%
37
118
1404
14201
17
45
1424
14274
—
8
0
1433
14319
5
5
1214
14271
17
45
1110
13602
18
70
846
10336
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
8.1e-01
1.7e+00
2.6e+00
—
—
1.5e+00
1.0e+00
cases:1.87%
controls:0.85%
cases:1.80%
controls:0.35%
cases:0.49%
controls:0.03%
—
—
—
—
cases:1.42%
controls:0.32%
cases:4.05%
controls:1.50%
27
121
1414
14198
26
50
1415
14269
7
5
1434
14314
—
—
16
44
1111
13603
35
156
829
10250
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
5.7e-01
1.3e+00
2.5e+00
1.0e+50
1.3e+00
9.0e-01
9.5e-01
cases:15.48%
controls:9.41%
cases:11.03%
controls:3.25%
cases:4.93%
controls:0.41%
cases:0.42%
controls:0.00%
cases:1.56%
controls:0.41%
cases:7.90%
controls:3.36%
cases:22.34%
controls:10.04%
223
1348
1218
12971
159
465
1282
13854
71
59
1370
14260
6
0
1435
14319
19
59
1200
14217
89
458
1038
13189
193
1045
671
9361
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
PD4CG [2001309216]
2.2e+00
2.8e+00
—
—
—
—
2.6e+00
cases:0.69%
controls:0.08%
cases:0.56%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.09%
10
11
1431
14308
8
5
1433
14314
—
—
—
—
10
9
854
10397
insulin lispro; parenteral
A10AB04 [21600718]
1.4e+00
1.5e+00
1.8e+00
—
—
1.6e+00
1.4e+00
cases:1.73%
controls:0.45%
cases:1.60%
controls:0.38%
cases:0.62%
controls:0.10%
—
—
—
—
cases:1.77%
controls:0.37%
cases:1.85%
controls:0.47%
25
65
1416
14254
23
54
1418
14265
9
15
1432
14304
—
—
20
50
1107
13597
16
49
848
10357
insulin lispro; parenteral
A10AC04 [21600726]
1.4e+00
1.5e+00
1.8e+00
—
—
1.6e+00
1.4e+00
cases:1.73%
controls:0.45%
cases:1.60%
controls:0.38%
cases:0.62%
controls:0.10%
—
—
—
—
cases:1.77%
controls:0.37%
cases:1.85%
controls:0.47%
25
65
1416
14254
23
54
1418
14265
9
15
1432
14304
—
—
20
50
1107
13597
16
49
848
10357
Persistent atrial fibrillation
I48.1 [45548021]
1.3e+00
9.3e-01
1.9e+00
—
2.8e+00
1.6e+00
7.0e-01
cases:1.25%
controls:0.36%
cases:0.97%
controls:0.38%
cases:0.49%
controls:0.07%
—
—
cases:0.57%
controls:0.04%
cases:1.42%
controls:0.30%
cases:1.85%
controls:0.93%
18
51
1423
14268
14
55
1427
14264
7
10
1434
14309
—
7
5
1212
14271
16
41
1111
13606
16
97
848
10309
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
4.5e-01
1.2e+00
2.4e+00
—
1.6e+00
8.2e-01
1.0e+00
cases:7.36%
controls:4.84%
cases:6.04%
controls:1.82%
cases:2.64%
controls:0.25%
—
—
cases:1.07%
controls:0.21%
cases:3.99%
controls:1.80%
cases:13.77%
controls:5.30%
106
693
1335
13626
87
260
1354
14059
38
36
1403
14283
—
13
30
1206
14246
45
246
1082
13401
119
551
745
9855
insulin (human); parenteral
A10AD01 [21600729]
1.5e+00
1.4e+00
2.0e+00
—
—
1.4e+00
1.3e+00
cases:4.30%
controls:1.02%
cases:2.78%
controls:0.68%
cases:0.90%
controls:0.13%
—
—
—
—
cases:2.48%
controls:0.65%
cases:2.89%
controls:0.80%
62
146
1379
14173
40
97
1401
14222
13
18
1428
14301
—
—
28
89
1099
13558
25
83
839
10323
Hypertensive renal disease with renal failure
I12.0 [45596187]
—
—
1.0e+50
1.0e+50
1.0e+50
—
7.5e+00
—
—
—
—
cases:5.27%
controls:0.00%
cases:79.11%
controls:0.00%
cases:22.07%
controls:0.00%
—
—
cases:52.08%
controls:0.06%
—
—
76
0
1365
14319
1140
0
301
14319
269
0
950
14276
—
450
6
414
10400

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1020
1393
17.61
307.65
22.3
3.4
1.21
0.99
mmol/l
61.63
988
1259
823
1881
7.75
307.65
9.3
1.9
2.02
2.22
g/l
22.87
793
1688
835
2028
7.32
307.65
9.3
1.9
11.37
12.93
umol/l
8.87
806
1844
959
940
23.03
307.65
21.6
3.5
15.90
9.79
mmol/l
60.40
931
884
601
1122
7.86
307.65
11.9
2.6
0.55
1.98
mmol/l
13.22
527
972
336
279
14.87
307.65
6.0
2.2
2.42
1.41
mg/l
36.91
320
241
797
755
19.52
307.65
11.5
2.3
176.77
67.98
ng/l
53.62
739
632
801
1729
8.07
307.65
9.3
1.9
22.44
23.27
%
1.03
779
1566
617
1157
7.93
307.65
11.5
2.6
5.80
5.85
kpa
0.52
606
1127
623
1157
8.05
307.65
11.6
2.7
7.36
7.38
ph
14.16
459
649
418
582
9.28
298.29
2.4
1.6
1.61
1.50
g/l
1.32
399
478
1012
3391
6.15
296.19
8.5
3.4
53.17
3.77
mg/mmol
31.77
868
1900
920
2845
6.06
295.19
6.4
2.6
427.15
341.81
umol/l
79.06
858
2428
214
101
24.20
291.76
2.8
2.4
1.66
0.56
g/24h
6.60
156
46
430
638
8.77
290.53
12.8
2.4
23.05
24.35
mmol/l
11.14
425
625
531
1012
7.27
285.10
15.2
6.8
—
—
—
0
0
978
3342
5.74
274.75
7.3
2.9
238.83
26.84
mg/l
33.76
856
1953
982
3440
5.59
265.61
7.3
2.8
5.93
7.67
mmol/l
43.92
918
2763
480
993
6.41
233.51
7.8
2.3
5.54
4.20
kpa
17.97
466
966
203
137
16.76
233.50
10.9
1.6
16.13
8.93
pmol/l
5.02
203
137
327
457
8.68
229.80
2.2
4.0
76.30
60.57
mg/l
0.60
264
405
325
454
8.67
228.42
2.2
4.0
70.32
70.41
mg/l
0.00
262
403
309
413
8.98
225.16
2.2
3.8
1.84
5.46
ratio
1.18
170
267
507
1176
5.78
216.67
3.1
2.9
65.24
65.99
g/l
1.22
488
1057
404
806
6.32
202.02
8.2
3.0
7.39
7.42
ph
14.92
371
653
641
1933
4.79
198.19
4.9
2.9
0.83
0.83
mmol/l
0.18
608
1787
406
830
6.16
197.62
8.4
2.9
5.06
5.15
kpa
1.32
400
776
1185
5778
4.75
187.98
15.3
4.2
33.97
34.76
g/l
5.13
1141
5317
432
976
5.64
187.94
2.2
2.8
—
—
—
0
0
389
805
6.02
186.20
3.7
1.4
—
—
—
0
0
780
2903
4.20
178.62
5.9
2.5
3.40
4.67
e6/l
2.71
747
2617
551
1650
4.52
168.39
4.0
2.3
1.86
1.64
%
6.15
510
1429
405
951
5.32
167.19
3.8
1.4
—
—
—
0
0
946
4176
3.97
166.22
7.6
3.2
29.35
106.86
e6/l
3.22
854
3210
1228
6570
4.42
160.63
31.4
5.9
1.20
1.21
mmol/l
3.51
1130
5518
885
3816
3.85
159.26
19.1
3.5
7.38
7.40
ph
25.96
753
2760
985
4594
3.85
156.57
9.1
3.6
79.57
108.38
e6/l
0.68
865
3307
536
1681
4.24
152.12
2.9
1.9
29.64
29.76
s
0.15
527
1623
1143
5964
3.99
151.43
25.0
5.4
1.21
1.21
mmol/l
0.23
1110
5356
418
1105
4.73
148.18
3.7
1.4
—
—
—
0
0
161
167
10.58
140.83
2.5
1.2
—
—
—
0
0
999
4931
3.61
140.52
9.0
2.5
228.89
176.76
ug/l
6.63
961
4419
233
392
6.76
135.88
6.0
2.5
661.99
184.74
mg/l
8.48
160
133
148
145
11.12
134.64
2.6
1.2
145.65
153.25
au/ml
0.25
47
40
639
2446
3.63
133.08
6.4
2.7
467.06
560.49
mosm/kgh2o
34.85
595
2115
440
1304
4.24
133.08
4.1
2.4
66.49
64.50
e9/l
0.45
330
1001
830
3776
3.42
130.55
7.1
4.0
—
—
—
0
0
278
580
5.56
129.42
8.8
3.1
—
—
—
0
0
768
3369
3.40
127.57
3.3
2.1
3.13
2.92
mg/l
1.38
696
2796
74
16
48.38
126.66
23.8
43.7
81.12
145.63
ug/l
3.22
57
16
182
256
7.87
124.88
7.5
2.0
71.60
54.96
%
13.83
175
244
1005
5268
3.33
122.28
4.5
2.2
80.62
79.65
nmol/l
0.49
949
4533
794
3639
3.28
121.13
7.3
3.1
0.41
0.49
e6/l
0.42
697
2701
173
238
8.00
120.93
7.9
3.0
—
—
—
0
0
262
550
5.48
120.80
1.9
2.7
3.68
3.77
g/l
0.28
253
493
262
551
5.47
120.54
1.9
2.7
7.41
7.23
g/l
0.88
253
493
262
551
5.47
120.54
1.9
2.7
4.03
4.16
g/l
1.21
253
494
298
702
4.96
120.16
8.2
2.4
111.45
129.55
g/l
31.62
291
686
763
3437
3.27
119.49
6.8
3.0
0.20
914.74
estimate
—
5
14
125
9
150.15
118.96
1.9
1.0
—
—
—
0
0
138
146
10.23
118.70
1.7
1.1
287.81
298.26
u/ml
0.11
95
84
123
115
11.48
115.27
1.4
2.6
—
—
—
0
0
247
513
5.49
115.03
1.9
2.7
3.04
2.90
g/l
1.10
238
455
1087
6103
3.30
114.98
32.0
15.8
1.42
1.33
inr
4.54
970
5028
838
4085
3.14
112.90
4.8
2.9
7404.78
1451.80
ng/l
26.19
763
3511
465
1635
3.57
107.38
2.7
1.8
—
—
—
0
0
95
68
14.76
104.71
1.1
1.2
—
—
—
0
0
164
253
7.09
103.16
1.4
1.4
0.26
0.23
g/l
4.68
156
239
166
260
6.99
102.95
1.4
1.4
1.17
1.13
g/l
0.59
158
246
222
480
5.19
98.24
2.0
2.7
10.10
10.62
g/l
0.86
213
416
58
14
42.90
96.55
1.0
1.0
—
—
—
0
0
58
14
42.90
96.55
1.0
1.2
—
—
—
0
0
142
203
7.56
95.59
1.6
1.2
—
—
—
0
0
900
4873
2.87
95.19
6.5
3.4
6.32
6.29
ph
0.40
513
2616
198
401
5.48
94.24
1.3
1.3
—
—
—
0
0
128
165
8.33
94.14
3.1
1.9
314.62
94.57
ug/min
1.81
85
79
353
1126
3.72
93.38
11.2
5.9
1.13
1.39
mmol/l
6.11
345
1099
543
2280
3.06
91.51
5.1
2.8
0.86
1.09
e6/l
1.05
363
1257
226
528
4.80
90.98
8.4
2.7
23.77
25.24
mmol/l
6.30
220
518
380
1293
3.52
90.89
2.6
1.6
—
—
—
0
0
510
2074
3.11
90.83
5.4
3.0
1.43
1.53
e6/l
0.17
332
1053
1002
5851
2.82
89.75
8.6
5.8
0.66
0.61
e9/l
9.07
883
4888
950
5405
2.79
89.42
9.1
6.2
0.61
0.67
%
2.23
912
4950
1039
6200
2.83
88.88
7.9
3.8
5.22
1.34
estimate
0.33
263
1223
949
5409
2.78
88.80
9.1
6.1
3.23
2.86
%
3.74
914
4958
949
5410
2.78
88.75
9.1
6.2
9.02
9.28
%
2.10
913
4961
1003
5886
2.80
88.51
8.5
5.8
0.04
0.04
e9/l
1.83
884
4927
778
4025
2.77
87.89
7.8
5.8
—
—
—
0
0
938
5342
2.76
87.46
9.2
6.0
62.55
57.86
%
25.94
909
4999
204
453
5.00
87.17
9.8
3.0
23.75
24.85
mmol/l
5.06
196
406
953
5487
2.75
86.68
9.3
6.1
21.97
26.67
%
29.95
921
5103
1010
5989
2.77
86.61
8.8
5.9
1.65
1.88
e9/l
3.84
913
5144
1016
6069
2.76
85.40
8.7
6.0
0.24
0.20
e9/l
6.53
914
5153
1021
6120
2.76
85.13
7.9
3.8
0.00
0.00
estimate
-0.00
258
1185
54
17
32.81
83.62
2.6
1.8
0.63
0.63
mmol/l
0.04
54
17
1032
6261
2.74
83.27
8.0
3.8
0.03
0.27
estimate
0.43
241
1169
77
57
14.12
83.11
1.4
1.3
367.29
215.95
pmol/l
1.37
64
49
89
8
117.53
82.79
6.2
3.5
—
—
—
0
0
90
91
10.40
79.61
4.3
1.3
10.23
10.20
%
0.02
90
91
157
310
5.49
76.48
1.4
1.8
—
—
—
0
0
82
77
11.15
76.31
1.1
1.1
—
—
—
0
0
1117
7228
2.69
76.12
11.1
4.2
7.16
6.56
mmol/l
16.52
1094
6864
1036
6487
2.61
75.20
6.9
6.5
11.09
12.92
umol/l
3.45
994
6164
79
73
11.32
74.29
1.4
1.4
120.94
47.89
mu/l
1.18
67
62
567
2676
2.71
74.20
2.2
1.7
1288.13
1167.18
nmol/l
1.37
482
1925
133
231
6.18
74.16
8.7
1.5
74.06
56.19
%
13.97
133
231
383
1469
3.09
73.82
9.1
6.5
11.03
12.47
kpa
6.24
364
1392
383
1469
3.09
73.82
9.1
6.5
4.97
5.07
kpa
1.11
364
1390
726
3873
2.56
73.72
4.1
3.2
—
—
—
0
0
380
1453
3.10
73.62
9.2
6.5
7.39
7.42
ph
6.19
203
814
378
1459
3.06
71.88
9.1
6.4
-0.08
0.86
mmol/l
3.28
299
1163
1196
8123
2.73
71.80
8.3
4.7
2714.40
1916.28
e6/l
0.20
46
106
1045
6681
2.54
70.76
10.4
9.5
4.93
4.16
e9/l
17.43
940
5705
699
3733
2.52
69.92
2.4
2.1
178.06
234.51
u/l
1.21
670
3491
346
1291
3.13
69.61
9.5
6.8
94.41
95.67
%
3.31
334
1239
841
4925
2.45
68.22
7.1
3.5
75.82
70.41
ng/l
0.15
744
3850
149
311
5.17
68.04
4.1
2.1
120.14
127.17
g/l
2.24
134
214
103
150
7.26
67.91
6.7
5.7
13.08
12.13
mg/l
1.02
93
138
726
4006
2.45
66.88
4.5
2.5
—
—
—
0
0
331
1245
3.08
65.34
1.4
1.3
384.10
581.93
titre
1.59
83
270
787
4567
2.39
63.93
6.5
3.5
2.32
2.34
mmol/l
3.57
723
4017
53
32
17.08
63.59
2.7
1.4
476.55
525.58
min
1.65
40
19
60
46
13.50
63.32
2.7
1.7
772.77
646.42
ml
0.96
44
26
723
4056
2.39
63.29
2.3
1.7
19.17
20.36
nmol/l
1.18
670
3261
203
574
3.89
62.76
2.1
1.3
—
—
—
0
0
47
23
21.01
62.02
1.2
1.1
149.17
133.51
mmol/24h
0.31
47
23
683
3823
2.34
59.10
3.6
2.4
70.45
63.79
u/l
0.79
655
3487
98
158
6.53
58.67
1.7
1.1
—
—
—
0
0
885
5536
2.29
58.65
4.6
2.8
—
—
estimate
—
0
0
1282
9414
2.63
58.62
15.5
7.7
86.71
80.61
u/l
2.40
1248
8774
226
731
3.42
56.91
10.6
7.9
23.56
24.26
mmol/l
2.03
217
704
304
1175
2.95
56.58
10.2
7.4
110.97
119.80
g/l
9.97
297
1144
64
68
9.75
54.48
4.2
1.4
180.78
84.81
ng/l
5.43
64
68
149
375
4.27
53.82
1.5
1.8
5.07
8.80
iu/ml
1.02
35
81
562
3001
2.32
53.11
7.3
3.7
89.33
84.63
%
3.22
549
2940
797
4967
2.17
50.92
23.9
10.7
0.00
0.00
e9/l
0.23
646
4030
64
75
8.84
50.56
1.4
1.2
0.13
0.35
nmol/l
—
12
8
58
9
66.70
50.52
1.0
1.0
—
—
—
0
0
108
226
5.04
48.96
9.5
3.8
2.30
2.51
mmol/l
0.33
68
151
587
3354
2.17
45.64
3.5
2.9
35.26
38.38
u/l
0.28
557
3133
529
2913
2.20
45.05
5.5
2.9
0.20
0.01
—
10
84
55
63
9.00
44.19
1.4
1.2
—
—
nmol/l
—
0
0
443
2304
2.26
43.14
1.8
1.6
1.96
1.55
mg/l
1.02
382
1795
49
52
9.68
41.68
1.4
2.2
—
—
—
0
0
441
2318
2.23
41.65
5.5
3.5
335.84
498.13
ng/l
0.71
409
1953
878
5971
2.01
41.30
2.9
2.1
98.76
94.50
pmol/l
1.80
492
3128
53
64
8.52
40.84
1.4
1.2
0.22
0.20
nmol/l
0.28
41
52
176
598
3.18
40.43
2.4
1.7
6.14
2.49
ug/l
0.88
167
517
605
3637
2.05
39.97
8.5
3.9
0.02
0.00
estimate
0.74
193
1080
184
649
3.07
39.63
11.6
8.4
14.36
15.97
%
10.73
178
617
713
4568
1.99
39.15
8.1
3.9
0.00
0.03
estimate
3.10
230
995
486
2719
2.12
38.76
1.9
1.7
22144981.43
22067479.17
pmol/l
0.00
429
2148
127
360
3.74
38.71
2.3
1.5
—
—
—
0
0
262
1147
2.53
37.20
2.5
2.2
6.70
7.61
ug/l
0.30
223
965
239
1001
2.62
37.19
17.4
3.1
1.20
1.22
mmol/l
3.44
221
821
99
241
4.31
37.19
1.6
1.4
25.73
33.20
g/l
5.35
82
230
1145
8737
2.02
36.65
6.3
4.2
25.24
12.80
mm/h
57.97
1071
7945
276
1269
2.41
35.10
3.2
2.6
7.82
9.60
umol/l
0.55
244
1142
198
785
2.73
34.24
2.6
3.1
10.60
10.95
g/l
0.43
190
714
169
617
2.94
34.10
2.1
2.2
1.24
1.72
g/l
1.19
157
557
259
1185
2.41
33.19
3.6
2.0
0.00
0.02
estimate
0.50
55
179
573
3575
1.92
32.55
8.8
6.2
—
—
—
0
0
1372
11404
2.22
31.95
47.4
15.6
26.30
29.03
mg/l
2.58
1299
9351
68
138
5.10
31.87
11.4
4.6
7.09
7.03
mmol/l
0.05
59
116
109
318
3.60
31.77
4.9
3.2
1.32
2.07
index
0.81
60
168
498
3001
1.95
31.13
7.8
3.2
0.01
0.32
estimate
0.63
217
953
86
218
4.11
30.60
1.7
2.0
26.40
32.23
umol/l
1.53
80
178
74
167
4.59
30.58
1.6
1.4
—
—
—
0
0
206
883
2.52
30.28
2.2
2.3
353.96
381.28
nmol/l
1.11
194
805
82
209
4.08
28.96
1.7
1.4
542.96
1750.91
e6/l
5.49
55
166
158
607
2.77
28.90
3.8
1.9
0.24
1.76
estimate
0.41
42
143
27
0
+∞
28.20
17.6
0.0
158.90
—
e6/l
—
21
0
27
0
+∞
28.20
3.7
0.0
—
—
—
0
0
47
77
6.25
27.62
1.2
1.7
—
—
—
0
0
185
788
2.52
27.47
8.0
6.6
22.87
24.50
mmol/l
4.57
177
747
185
788
2.52
27.47
4.9
4.2
—
—
—
0
0
66
149
4.57
27.26
1.3
1.1
—
—
—
0
0
76
192
4.10
27.16
1.6
1.4
75067.39
77746.52
e6/l
0.02
44
126
135
494
2.89
27.01
6.0
4.3
1.55
1.52
%
0.15
127
462
1296
10769
1.95
26.87
12.3
5.7
42.19
38.64
mmol/mol
30.12
1247
9675
1261
10419
1.90
26.13
6.7
4.1
1.50
1.19
mmol/l
34.87
1194
9135
79
212
3.86
25.99
1.2
1.3
16.29
59.47
u/l
2.74
70
174
225
1074
2.27
25.80
5.5
4.3
0.58
0.97
%
2.72
97
370
124
450
2.90
25.17
6.3
4.6
0.72
0.88
%
4.16
117
422
215
1024
2.26
24.74
5.7
4.3
0.01
0.16
%
6.39
89
319
217
1049
2.23
24.06
3.5
2.3
44.83
37.73
u/l
0.44
188
883
31
37
8.52
24.05
1.2
1.0
1471.39
1602.76
miu/ml
0.22
31
37
31
37
8.52
24.05
2.0
2.5
216.43
15.36
ug/min
—
7
11
70
185
3.91
23.53
1.4
1.7
—
—
—
0
0
1106
8905
1.74
23.51
57.7
19.3
14.54
13.78
%
46.24
1098
8755
70
187
3.87
23.18
1.5
1.3
52.08
63.44
mmol/l
1.84
59
147
36
54
6.79
23.00
2.0
2.6
9.25
7.65
mmol/l
0.61
36
54
211
1029
2.20
22.85
5.2
4.3
0.67
0.75
%
0.25
90
352
76
219
3.59
22.56
2.1
2.1
0.87
0.84
%
0.23
63
143
204
1010
2.16
21.21
6.0
4.6
0.00
0.24
%
2.93
82
287
1284
10923
1.80
21.01
7.6
4.8
1.29
1.48
mmol/l
52.87
1224
9694
438
2816
1.76
20.84
7.5
4.2
1.02
1.02
kg/l
7.01
337
1853
889
6915
1.62
20.03
4.0
3.0
62.01
49.61
u/l
2.78
838
6253
41
81
5.17
19.82
1.2
1.2
69.54
111.35
pmol/l
6.43
41
81
1286
11019
1.76
19.60
7.7
4.9
4.01
4.57
mmol/l
73.73
1231
9855
368
2285
1.79
19.58
6.8
4.9
—
—
—
0
0
206
1056
2.09
19.51
3.4
2.5
593.99
224.48
ng/l
3.78
192
966
1346
11701
1.82
19.35
44.1
14.0
—
—
—
0
0
1381
12103
1.87
19.30
63.3
18.1
139.42
139.71
mmol/l
3.72
1365
11774
29
42
7.01
19.12
1.3
1.3
58.08
81.52
mg/l
0.45
24
29
124
518
2.51
19.06
1.4
1.3
—
—
—
0
0
94
343
2.85
18.88
1.7
2.0
21.89
21.57
s
0.22
89
312
1307
11294
1.76
18.80
8.3
5.6
2.16
2.67
mmol/l
89.85
1257
10034
1380
12124
1.85
18.68
65.7
18.2
4.20
4.02
mmol/l
58.04
1363
11767
1011
8189
1.61
18.65
5.9
4.1
—
3483.83
—
0
29
80
273
3.03
18.11
1.6
2.0
25.66
11.21
mg/l
1.88
74
249
1028
8416
1.59
17.63
4.4
3.9
15.20
14.96
pmol/l
2.20
952
7395
265
1539
1.86
17.38
1.3
1.3
—
—
—
0
0
54
150
3.69
16.95
1.6
2.0
3.09
5.14
mmol/24h
2.98
42
126
16
0
+∞
16.69
5.2
0.0
462.31
—
umol/l
—
16
0
52
146
3.65
16.08
2.3
1.5
1.44
0.76
nmol/l
2.01
41
117
33
65
5.16
16.03
5.2
2.2
364.06
16.33
mg/l
2.27
28
49
219
1227
1.91
15.99
2.1
2.1
0.21
0.20
g/l
2.09
199
1143
1363
12095
1.74
15.70
22.0
11.4
22.78
25.08
u/l
2.81
1339
11544
1383
12364
1.74
14.98
61.1
20.6
202.40
80.01
umol/l
149.89
1364
12122
35
77
4.62
14.97
1.1
1.3
233.75
213.33
titre
—
8
18
14
0
+∞
14.60
5.7
0.0
47.29
—
%
—
7
0
48
139
3.53
14.20
1.1
1.3
290.18
213.22
miu/ml
—
7
58
134
658
2.13
14.12
2.6
2.4
—
—
—
0
0
79
307
2.65
14.10
5.1
3.0
0.96
0.84
nmol/l
0.67
57
240
67
239
2.88
14.06
8.7
3.0
28.91
30.39
mg/l
0.13
57
151
270
1686
1.72
13.65
1.7
1.3
—
—
—
0
0
65
232
2.88
13.64
1.2
1.2
—
—
—
0
0
1201
10453
1.55
13.56
5.7
4.8
2.20
2.07
mu/l
1.91
1134
9209
298
1915
1.68
13.53
1.7
1.5
2.71
2.67
g/l
0.12
217
1061
48
145
3.38
13.33
1.4
1.2
7.20
12.20
u/l
4.30
40
136
1381
12474
1.66
12.77
69.1
23.8
7.56
6.74
e9/l
23.63
1357
12046
1380
12468
1.66
12.68
68.9
23.8
231.63
236.12
e9/l
1.69
1359
12092
1380
12470
1.66
12.65
68.7
23.7
30.57
30.58
pg
0.13
1366
12214
1380
12471
1.66
12.63
70.8
24.1
36.90
40.05
%
70.13
1363
12206
1380
12471
1.66
12.63
68.9
23.8
4.05
4.42
e12/l
87.37
1355
12048
1380
12471
1.66
12.63
68.7
23.7
93.11
92.06
fl
12.64
1365
12216
1380
12472
1.66
12.62
69.3
23.9
121.64
134.21
g/l
114.33
1366
12228
40
113
3.60
12.31
1.2
1.1
—
—
—
0
0
25
28
9.05
12.25
1.4
1.1
16.27
8.55
pmol/l
—
16
6
29
65
4.52
12.15
2.6
3.1
14.64
15.87
%
1.00
29
65
434
3138
1.52
11.80
1.5
1.3
—
—
—
0
0
1255
11176
1.52
11.37
8.2
5.1
6.36
5.87
mmol/l
24.17
1180
9800
166
950
1.83
11.24
4.0
2.7
5.95
6.03
ph
0.56
136
651
33
87
3.85
11.22
1.4
1.4
7.44
7.40
ph
0.66
26
59
78
345
2.32
10.63
1.3
1.2
0.38
1.35
u/ml
—
5
26
25
56
4.52
10.50
1.7
1.2
—
—
—
0
0
21
41
5.18
10.32
1.9
1.6
317.54
989.81
e6/l
0.97
13
27
37
112
3.36
10.29
1.7
1.3
284.55
276.68
mosm/kgh2o
1.05
31
79
158
915
1.80
10.28
10.1
3.6
—
—
—
0
0
222
1414
1.66
10.27
1.6
1.4
—
—
—
0
0
123
660
1.93
10.16
2.7
2.8
—
—
—
0
0
36
108
3.39
10.16
1.5
1.1
5.60
3.32
u/ml
0.41
20
50
42
141
3.03
9.88
1.3
1.3
—
—
—
0
0
75
342
2.25
9.54
1.5
1.4
259.55
278.60
ug/g
0.41
55
210
226
1475
1.62
9.47
19.8
3.7
7.36
7.35
ph
0.28
214
985
199
1273
1.64
9.02
1.5
1.3
—
—
—
0
0
17
17
10.09
9.02
2.5
4.0
—
—
—
0
0
102
540
1.95
8.78
2.9
3.4
3.87
4.40
pmol/l
5.41
84
469
38
130
2.97
8.69
2.5
1.9
—
—
—
0
0
60
260
2.36
8.61
1.3
1.2
17.38
1.81
u/ml
—
8
24
17
19
9.03
8.53
2.5
3.7
—
—
—
0
0
66
301
2.24
8.43
1.7
1.5
11789.00
12731.41
e6/l
0.11
46
213
56
240
2.38
8.25
1.2
1.2
—
1676.25
—
0
8
209
1387
1.58
8.13
3.7
3.2
5.09
5.23
e9/l
0.10
190
1111
26
74
3.55
7.98
1.5
1.4
62.05
64.54
%
0.12
16
58
37
133
2.82
7.77
1.2
1.4
—
—
—
0
0
37
133
2.82
7.77
1.2
1.4
—
—
—
0
0
37
133
2.82
7.77
1.2
1.4
—
—
—
0
0
37
133
2.82
7.77
1.2
1.4
—
—
—
0
0
49
205
2.43
7.63
1.6
1.3
—
—
—
0
0
374
2834
1.41
7.52
3.8
3.0
2.48
2.45
mmol/l
3.31
315
2543
54
238
2.31
7.50
1.2
1.2
52.00
105.63
titre
—
5
16
27
83
3.29
7.39
1.3
1.2
—
—
—
0
0
22
59
3.77
7.36
1.4
1.5
5.01
3.19
%
0.18
14
48
20
50
4.04
7.35
1.2
1.8
39.42
39.88
g/l
0.10
20
50
14
15
9.40
7.28
24.1
8.8
9.23
4.75
kpa
3.13
14
15
583
4778
1.34
7.14
2.8
2.2
—
—
—
0
0
15
19
7.96
7.10
1.1
1.1
—
—
—
0
0
32
112
2.89
7.07
1.3
1.5
58.05
58.91
%
0.04
19
66
14
16
8.81
7.05
1.1
1.4
65.86
99.81
nmol/24h
0.82
14
16
20
52
3.88
6.99
1.1
1.0
—
—
—
0
0
175
1159
1.57
6.86
1.5
1.3
—
—
—
0
0
14
17
8.30
6.83
3.6
1.1
4.75
9.43
mmol/l
1.88
14
17
234
1653
1.48
6.80
1.2
1.2
14.52
12.56
u/ml
0.14
77
573
46
198
2.36
6.77
2.4
2.8
—
—
—
0
0
18
32
5.68
6.76
1.8
1.3
—
—
—
0
0
25
79
3.20
6.58
1.2
1.3
38.95
27.71
%
0.73
17
47
23
70
3.32
6.42
1.0
1.2
—
—
—
0
0
1011
9032
1.31
6.40
58.4
20.9
327.84
331.73
g/l
32.56
1004
8944
20
56
3.60
6.32
2.4
1.9
7.00
3.38
u/field
0.60
14
34
564
4670
1.32
6.24
6.3
3.4
—
0.76
—
0
21
19
52
3.68
6.20
1.4
1.4
22.41
22.36
%
0.00
14
47
38
157
2.45
6.13
1.1
1.1
—
—
—
0
0
726
6233
1.29
6.09
5.1
6.2
2.60
4.97
ug/l
2.06
670
5548
58
288
2.05
6.06
6.7
4.2
—
—
—
0
0
64
330
1.98
6.03
7.4
4.8
1.17
1.32
mmol/l
0.72
56
285
16
29
5.56
5.99
3.9
3.5
57.19
53.74
%
0.18
16
29
21
64
3.31
5.87
1.0
1.1
—
—
—
0
0
30
114
2.66
5.75
3.9
2.8
11.43
11.03
index
0.12
21
58
20
60
3.36
5.73
1.1
1.1
—
—
—
0
0
100
604
1.70
5.69
2.7
1.8
—
—
—
0
0
37
162
2.31
5.30
1.2
1.4
—
—
—
0
0
90
542
1.70
5.20
1.3
1.2
—
—
—
0
0
17
49
3.50
5.18
1.0
1.4
1.03
1.07
nmol/l
—
10
33
36
158
2.31
5.14
1.6
1.4
0.88
0.83
g/l
0.08
30
126
33
141
2.37
5.01
1.1
1.1
—
—
—
0
0
26
99
2.65
4.99
3.0
2.0
1.00
0.94
u/field
0.03
17
47
26
99
2.65
4.99
1.0
1.1
1.00
275.62
iu/ml
—
6
13
8
7
11.48
4.78
1.8
1.6
—
—
—
0
0
59
322
1.86
4.76
1.3
1.2
—
—
—
0
0
45
225
2.03
4.68
7.8
5.6
106.25
105.87
mmol/l
0.17
40
198
45
225
2.03
4.68
7.8
5.6
13.35
10.86
mmol/l
4.34
40
198
48
246
1.98
4.67
2.5
3.1
59.47
59.22
%
0.05
48
246
23
87
2.67
4.49
2.8
2.0
—
—
—
0
0
15
37
4.08
4.40
2.0
1.4
7230.57
6207.70
e6/l
—
7
20
6
238
0.25
4.35
1.5
1.7
—
—
—
0
0
231
1764
1.36
4.30
1.2
1.3
33.71
41.39
iu/ml
0.61
70
503
8
9
8.93
4.28
1.1
1.1
—
—
—
0
0
28
120
2.36
4.26
1.0
1.3
—
—
—
0
0
136
949
1.47
4.23
1.6
1.6
—
—
—
0
0
25
102
2.47
4.22
1.2
1.1
—
—
—
0
0
26
112
2.34
3.93
2.2
2.7
—
—
—
0
0
18
65
2.79
3.86
1.6
1.4
—
—
—
0
0
16
56
2.88
3.63
1.8
1.7
152.96
1119.67
u/l
—
5
15
12
30
4.02
3.59
1.6
1.1
27.59
33.02
g/l
0.50
12
23
26
118
2.22
3.52
1.1
1.1
—
—
—
0
0
10
22
4.57
3.43
1.2
1.1
25.70
27.68
s
—
10
22
11
28
3.95
3.29
1.0
1.0
—
—
—
0
0
26
124
2.11
3.15
1.7
1.4
18.75
26.66
ng/l
1.08
26
124
9
20
4.52
3.11
1.0
1.0
—
—
—
0
0
78
521
1.52
3.06
2.6
3.4
49.55
2810.94
u/ml
0.82
67
445
23
106
2.19
3.03
1.2
1.3
321070.00
76289.66
e6/l
0.57
16
70
10
26
3.86
2.98
1.2
1.1
—
—
—
0
0
10
27
3.72
2.88
1.8
1.5
—
—
—
0
0
12
38
3.17
2.85
1.5
1.6
—
—
—
0
0
10
28
3.59
2.78
2.1
1.8
—
—
—
0
0
15
61
2.47
2.62
1.1
1.3
200.64
52.49
ug/l
—
5
35
262
2175
1.24
2.61
1.2
1.3
1.02
1.79
u/ml
1.62
60
525
33
186
1.79
2.54
2.5
2.6
—
—
—
0
0
6
181
0.33
2.53
1.0
1.1
—
0.68
—
0
31
152
1188
1.31
2.47
2.2
2.2
185.10
151.34
ug/g
0.76
128
933
53
344
1.56
2.42
1.7
1.5
0.39
0.32
mg/l
0.23
23
143
8
23
3.49
2.27
1.0
1.2
—
—
—
0
0
51
341
1.51
2.08
1.5
1.5
16.49
23.84
u/ml
0.60
11
62
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
10
37
2.71
2.07
2.1
2.2
31.72
47.23
umol/l
—
10
27
19
96
1.99
2.05
1.7
1.3
6.37
7.26
g/l
0.46
14
72
19
96
1.99
2.05
1.7
1.3
2.42
2.72
g/l
0.28
14
71
19
96
1.99
2.05
1.7
1.3
0.43
0.42
g/l
0.06
14
71
11
245
0.45
2.00
1.8
1.8
—
—
—
0
0
13
57
2.29
1.98
2.2
2.4
292.92
188.35
e6/l
0.48
13
49
12
51
2.36
1.95
1.2
1.1
—
—
—
0
0
7
22
3.19
1.88
1.4
2.1
0.68
0.77
ug/l
—
7
22
185
1536
1.23
1.87
2.8
4.4
7.11
20.77
ug/l
1.66
163
1292
9
35
2.58
1.80
1.2
1.1
13.00
14.33
g/l
—
9
25
10
41
2.45
1.64
1.8
1.1
473.50
247.13
iu/ml
—
10
41
18
98
1.85
1.62
1.7
1.3
—
—
—
0
0
23
136
1.70
1.59
3.1
2.8
8.17
4.15
nmol/l
0.88
23
136
6
21
2.86
1.50
2.0
1.7
2.00
4.66
ug/l
—
6
21
207
1784
1.18
1.45
6.7
4.7
33.41
33.16
%
0.14
186
1030
14
73
1.93
1.44
2.7
2.5
—
—
—
0
0
26
164
1.59
1.43
1.8
1.6
400.19
283.59
mu/l
1.48
26
153
29
188
1.55
1.43
1.1
1.3
—
—
—
0
0
19
110
1.74
1.43
1.2
1.1
—
—
—
0
0
10
199
0.50
1.40
1.1
1.2
1.39
1.53
g/l
—
10
199
17
98
1.74
1.31
1.4
1.2
303.08
335.07
nmol/l
0.22
12
77
16
91
1.77
1.29
1.0
1.1
0.87
1.94
u/ml
—
9
46
19
114
1.67
1.28
1.1
1.3
—
—
—
0
0
12
62
1.94
1.27
1.4
1.2
—
—
—
0
0
30
202
1.49
1.27
1.2
1.3
2.56
44.20
e6/l
0.77
25
147
9
44
2.05
1.27
1.0
1.6
—
—
—
0
0
8
36
2.23
1.24
2.6
2.6
32.63
31.58
%
—
8
36
8
40
2.00
1.12
2.1
1.6
—
—
—
0
0
5
21
2.38
1.09
1.2
1.4
—
—
—
0
0
7
33
2.13
1.05
1.1
1.4
—
—
—
0
0
7
33
2.13
1.05
1.1
1.3
—
—
—
0
0
66
529
1.26
1.01
1.1
1.2
70.28
105.79
u/ml
0.49
25
186
11
62
1.78
0.94
1.0
1.1
315.09
278.13
mg/l
2.08
11
54
13
78
1.67
0.91
2.8
2.9
—
—
—
0
0
52
414
1.26
0.87
1.0
1.1
—
303.75
—
0
12
37
481
0.76
0.86
1.1
1.2
—
—
—
0
0
92
780
1.19
0.85
1.1
1.2
—
—
—
0
0
16
237
0.67
0.82
1.4
1.4
—
—
—
0
0
112
1286
0.86
0.80
2.6
2.1
11.07
13.71
nmol/l
2.58
99
1141
9
54
1.67
0.74
1.0
1.1
34.67
39.23
mg/l
—
9
44
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
28
211
1.33
0.72
1.1
1.3
4.16
3.60
mmol/l
1.37
28
194
5
26
1.93
0.70
1.6
1.5
—
—
—
0
0
368
3463
1.08
0.65
5.2
3.1
—
—
—
0
0
5
29
1.73
0.64
1.4
2.2
49.42
159.57
ug/l
—
5
23
11
71
1.55
0.62
1.0
1.1
0.83
1.48
u/ml
—
5
29
8
50
1.60
0.61
1.6
1.7
419.88
404.27
mu/l
—
8
41
13
89
1.46
0.58
1.1
1.1
—
—
—
0
0
481
4601
1.06
0.54
2.5
1.8
1.45
1.21
mmol/l
7.33
422
3710
11
74
1.49
0.53
1.0
1.1
1.83
3.33
u/ml
—
5
33
10
66
1.52
0.52
1.0
1.1
0.38
0.78
u/ml
—
5
32
44
518
0.85
0.49
1.3
1.3
—
—
—
0
0
7
46
1.52
0.48
1.4
1.1
—
—
—
0
0
10
68
1.47
0.47
1.5
1.8
—
—
—
0
0
81
727
1.12
0.42
1.2
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
2.9
—
0.76
—
0
17
45
392
1.15
0.38
15.4
11.7
—
—
—
0
0
10
136
0.73
0.37
1.2
1.6
—
—
—
0
0
520
5045
1.04
0.35
4.4
4.9
27.33
21.48
%
11.65
292
2698
6
44
1.36
0.34
1.0
1.4
23.72
18.27
umol/l
—
6
39
12
91
1.32
0.33
1.2
1.2
—
—
—
0
0
6
47
1.28
0.32
1.2
1.0
—
—
—
0
0
6
47
1.28
0.32
1.2
1.0
—
—
—
0
0
7
57
1.23
0.29
7.3
4.1
—
—
—
0
0
10
129
0.77
0.28
1.2
1.6
—
—
—
0
0
11
139
0.79
0.27
1.2
1.5
—
—
—
0
0
11
139
0.79
0.27
1.2
1.5
—
—
—
0
0
27
234
1.16
0.26
1.7
1.8
2.90
3.40
iu/l
—
9
92
11
137
0.80
0.24
1.2
1.6
—
—
—
0
0
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
3.08
—
0
12
8
104
0.77
0.21
1.5
1.5
—
—
—
0
0
8
105
0.76
0.21
1.5
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
91.08
—
0
13
6
52
1.15
0.19
1.0
1.0
—
—
—
0
0
32
353
0.90
0.18
2.0
1.7
47.88
47.01
nmol/l
0.07
32
337
7
63
1.11
0.17
7.3
3.8
—
—
—
0
0
69
731
0.94
0.16
2.2
2.6
—
25.25
—
0
55
13
114
1.14
0.11
1.2
1.3
—
—
—
0
0
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
376
3716
1.02
0.08
3.1
3.5
0.91
0.83
ug/l
0.84
286
2601
31
321
0.97
0.03
2.0
3.5
1127.31
413.60
u/ml
0.30
25
298
12
112
1.07
0.03
1.1
1.1
—
—
—
0
0
12
112
1.07
0.03
1.1
1.1
—
—
—
0
0
11
103
1.07
0.02
2.9
2.2
2.07
1.95
ug/l
0.09
11
94
23
223
1.03
0.01
1.0
1.1
—
—
—
0
0
11
104
1.06
0.01
2.9
2.2
5.40
3.08
ug/l
0.55
11
97
30
299
1.00
0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
0.05
—
0
7
6
61
0.98
0.00
1.0
1.2
144.67
140.07
nmol/l
—
6
61
7
71
0.99
-0.00
1.9
1.5
273.00
87.06
umol/l
—
7
71
0
5
0.00
-0.00
0.0
1.0
—
0.03
—
0
5
7
69
1.01
-0.00
1.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
-0.00
1.0
1.1
—
12.61
—
0
14
0
5
0.00
-0.00
0.0
1.2
—
100.20
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint I9_HYPTENSRD and mortality.

Females

Parameter HR [95% CI] p-value
I9_HYPTENSRD 2.586 [2.17, 3.08] < 0.001
Birth year 0.994 [0.99, 1.0] 0.155

During the follow-up period (1.1.1998 — 31.12.2019), 1318 out of 2344 females with I9_HYPTENSRD died.

Males

Parameter HR [95% CI] p-value
I9_HYPTENSRD 2.628 [2.25, 3.08] < 0.001
Birth year 0.986 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 2041 out of 3952 males with I9_HYPTENSRD died.

Mortality risk

Mortality risk for people of age

years, who have I9_HYPTENSRD.

N-year risk Females Males
1 0.294% 0.514%
5 1.466% 3.231%
10 3.662% 7.2%
15 6.979% 13.563%
20 12.004% 21.28%

Relationships between endpoints

↥

Index endpoint: I9_HYPTENSRD – Hypertensive Renal Disease

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data